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Abstract
The long-term prognosis of pediatric epilepsy is favorable with respect to seizures,
whereby 66% to 80% of children attain seizure control. However, psychiatric and psychosocial
problems among children with epilepsy (CWE) and their parents are common, and little is
known about their long-term outcomes. The objectives of this dissertation were to: 1) validate a
parent-reported measure of young adult’s health-related quality of life (HRQOL), to allow for a
consistent informant to report on CWE’s HRQOL from childhood into young adulthood; 2)
delineate the long-term course of CWE’s HRQOL and identify the clinical, parent, and family
characteristics associated with the trajectory of HRQOL; 3) evaluate the long-term HRQOL of
mothers of CWE and identify the factors associated with long-term HRQOL; and 4) delineate the
long-term course of depressive symptoms for mothers of CWE and identify factors associated
with the trajectory of depressive symptoms.
Data came from the Heath-related Quality of Life in Children with Epilepsy Study
(HERQULES), a Canada-wide prospective cohort study of 373 children, aged 4 – 12 years, with
newly diagnosed epilepsy. Parents completed questionnaires at the time of epilepsy diagnosis,
and 0.5, 1, 2, 8, and 10 years later. CWE’s and their mothers’ HRQOL were measured using the
Quality of Life in Childhood Epilepsy Questionnaire, and the Short Form Health Survey,
respectively. Mothers’ depressive symptoms were measured using the Center for
Epidemiological Studies Depression Scale. Latent class growth models were used to evaluate the
trajectory of CWE’s HRQOL and their mothers’ depressive symptoms over the long-term.
We found that changes in CWE’s HRQOL observed within the first two years after
diagnosis of epilepsy remained stable over the long-term, and that mothers’ depressive
symptoms largely remained stable over the entire follow-up period . The long-term trajectory of
CWE’s HRQOL and mothers’ depressive symptoms were associated with the severity of
epilepsy, neuropsychological comorbidities and family functioning at the time of epilepsy
diagnosis. These results are important in identifying long-term outcomes and showing that
targeting the family environment early on may lead to optimal HRQOL and mental health for
children with epilepsy and their parents.
Keywords: epilepsy, child, mother, quality of life, depression, family environment, trajectory
modeling, longitudinal study, long-term outcomes

Summary for Lay Audience
Epilepsy is a condition of the brain characterized by repeated seizures. In the long-term,
most children with epilepsy attain seizure control. However, there is increasing evidence about
the impact of epilepsy beyond seizures, finding that children and their parents commonly have
mental health problems (such as depression) and poor quality of life. Little is known about the
long-term outcome of quality of life and mental health for children with epilepsy and their
parents. The primary objective of this dissertation was to describe the course of quality of life
and depression over the long-term for children with epilepsy and their mothers, respectively. A
secondary objective was to identify the characteristics of epilepsy, children, parents, and the
family that are associated with the patterns of quality of life and depression observed over time.
Neurologists practising across Canada identified children, aged 4 – 12 years, with newly
diagnosed epilepsy. A total of 373 families participated by completing questionnaires at the time
of epilepsy diagnosis and 0.5, 1, 2, 8, and 10 years later. At each time parents completed
questionnaires reporting on their children’s quality of life and their own depressive symptoms.
We found that children’s quality of life changed most during the first two years after their
epilepsy diagnosis, and remained stable thereafter over the long-term. One-third of children had
a relatively poor quality of life at the time of epilepsy diagnosis and throughout the 10-year
follow-up. We also found that mothers’ depressive symptoms remained stable over the long-term
for most mothers, with 20% reporting high scores for depression symptoms throughout the 10year follow-up. The patterns for children’s quality of life and mothers’ depressive symptoms
over time were poorer among those with a more severe epilepsy, with cognitive/behavioral
problems, and poorer family environment at the time of epilepsy diagnosis. These results are
important in understanding long-term outcomes and showing that targeting the family
environment early on may lead to improvements in quality of life and mental health for children
with epilepsy and their parents.
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Chapter 1: Introduction and Research Objectives
1.1 Background
Epilepsy, a condition characterized by spontaneous, unprovoked seizures, is the second
most frequent neurological condition (after migraine) [1]. While the long-term prognosis for
seizure control is favorable, with 66% to 80% of children attaining seizure control [2,3], it has
long been recognized that the impact of epilepsy extends far beyond seizures [4,5]. Up to 80% of
children with epilepsy (CWE) have cognitive and/or mental health problems, which significantly
impact well-being and life outcomes [6-11]. Therefore, health-related quality of life (HRQOL) is
a key outcome considered in treating CWE and is critical in understanding the impact of epilepsy
and its treatment. The impact of epilepsy also extends beyond the child, such that families of
CWE fare worse relative to healthy families on a variety of factors, such as the quality of the
parent-child relationship, parenting confidence, family functioning and stress, and parental
psychopathology [5]. Parents of CWE have poorer HRQOL, and recent systematic reviews
report that up to 50% and 58% of parents of CWE are at risk for major depression and anxiety,
respectively [12-15]. Importantly, poor family environment and parental mental health are not
only important for the family’s well-being, but have been often shown to have a greater impact
on children’s health and well-being, relative to epilepsy-related factors [5,9,15-18].
Multiple studies have evaluated long-term seizure outcomes for CWE, however the few
long-term studies of CWE’s well-being have utilized cross-sectional designs. There have been no
studies evaluating any aspect of parental well-being in the long-term. Prospectively delineating
the course of children’s and parents’ well-being from the time of a child’s epilepsy diagnosis
over the long-term is particularly important in identifying the families at risk for poor outcomes,
and providing prognostic information to patients and families to help them prepare for potential
long-term outcomes. Although seizures often resolve, epilepsy continues to impact CWE’s social
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(e.g. employment, romantic relationships) and mental health outcomes in adulthood [19,20].
Prospective studies following CWE and their parents are needed to elucidate the long-term
impact of epilepsy on child and parental health and well-being.
Patient self-reports are important in evaluating health outcomes and the impact of the
condition and its treatment on functioning. This is especially true for outcomes such as HRQOL
and mental health. However, studies focused on children must typically rely on parent-reported
measures until children reach a developmental stage where their report is considered appropriate
and valid. Additionally, there is often a lack of comparable and validated parent-reported
measures for young-adults. Under these circumstances, following young children over the longterm requires that parent reports are utilized in childhood and youth self-reports are utilized in
young adulthood. However, delineating trajectories over time using reports from different
informants at different time points would potentially introduce bias; this is because child and
parent-proxy reports are not interchangeable given that children and parents have unique
perspectives and values [21-23]. Although self- and parent-proxy reports are both considered
reliable and valid, parents typically report children as having poorer HRQOL and mental health
relative to their children’s self-report [21-23]. This is a methodological problem in evaluating the
HRQOL trajectories of CWE over the long-term and could be addressed by validating and
utilizing a parent-reported measure for young-adults. This would allow a consistent informant,
the parent, to report at each time point over the long-term. Notably, the validation of parentreported measure for young-adults does not imply the parent-proxy reports are preferable or a
replacement for youth self-reports. Reports from multiple informants, each with unique
perspectives and advantages, are ideal and provide an opportunity to better understand clinical
problems, their course, their impact, and response to treatments [23].
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1.2 Opportunities to Advance Current Knowledge
Although the literature evaluating the role of family environment for child and parent
well-being in families with CWE is growing, there have been no studies prospectively evaluating
the long-term well-being of CWE, no reviews synthesizing the results of studies evaluating the
HRQOL of parents of CWE, and no studies evaluating any aspect of parental well-being in the
long-term. Accordingly, the long-term HRQOL trajectories of CWE are unknown, and in
addition, it is unknown whether parents of CWE continue to experience poor HRQOL and
mental health outcomes in the long-term. It is also unknown which clinical, child, parent, and
family factors are associated with the long-term trajectories of well-being for CWE and parents.
In addition, there is a need for a psychometrically sound parent-reported measure of HRQOL for
CWE for use in prospective cohort studies designed to document long-term trajectories across
developmental phases of childhood into emerging adulthood. Addressing these knowledge gaps
is the focus of this dissertation.

1.3 Research Objectives
The goals of this dissertation are to prospectively delineate the long-term course and the
factors associated with the health and well-being of CWE and their mothers, and to contribute to
strengthening the methodological rigor of longitudinal studies for this patient group. Specifically,
the objectives of this dissertation are to:
1. Evaluate the psychometric properties of a parent-reported, epilepsy-specific measure of
HRQOL, the Quality of Life in Children with Epilepsy (QOLCE) questionnaire, when used
by parents to assess the HRQOL of their young adult children.
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a. Evaluate the goodness of fit between the established factor structure of the QOLCE
and data from a sample of young adults (ages ≥18 years).
b. Evaluate the internal consistency of the overall and sub-domain scores of the
QOLCE.
c. Evaluate convergent validity between relevant subscales of the parent-rated QOLCE
and self-reported HRQOL, as measured by epilepsy-specific HRQOL instruments.
2. Describe the long-term course of HRQOL in CWE and identify key factors associated with
the trajectories of HRQOL.
a. Describe the course of HRQOL in CWE from epilepsy diagnosis to 0.5, 1, 2, 8, and
10 years later.
b. Identify the child, parental, and family characteristics at the time of diagnosis
associated with each trajectory of HRQOL in CWE.
3. Evaluate the long-term HRQOL for mothers of CWE and identify key factors associated
with mothers’ HRQOL.
a. Describe HRQOL for mothers of CWE 10 years after their child was diagnosed with
epilepsy, relative to population norms.
b. Identify the child, maternal, and family characteristics at the time of diagnosis that
are associated with mothers’ HRQOL 10-years later.
c. Identify child, maternal, and family characteristics at the 10-year follow-up that are
associated with mothers’ HRQOL at the 10-year follow-up.
4. Describe the long-term course of depressive symptoms in mothers of CWE, and identify
key factors associated with the trajectories of depressive symptoms.
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a. Identify the prevalence of risk for major depressive disorder in mothers of CWE 8
and 10 years after their child’s diagnosis of epilepsy.
b. Describe the course of mothers’ depressive symptoms from the time of their child’s
epilepsy diagnosis to 0.5, 1, 2, 8, and 10 years later.
c. Identify the child, maternal, and family characteristics at the time of their child’s
epilepsy diagnosis associated with each trajectory of mothers’ depressive symptoms.
Before beginning to address objectives 3 and 4, I conducted a systematic review of
quality of life in parents of CWE. The objectives of the review were to 1) systematically review
the literature to describe the HRQOL for parents of children with childhood-onset epilepsy, 2)
identify the child, parental, and family characteristics associated with parental HRQOL, and 3)
evaluate the association between parents’ HRQOL and their children’s psychological well-being,
namely HRQOL, depression and anxiety.
Based on the available empirical evidence from this systematic review and a broader
review of the literature (described in subsequent chapters), I formulated three hypotheses related
to the thesis objectives regarding long-term well-being for CWE and their mothers:
1. The QOLCE will be validated for parents' assessment of young adults (aged ≥18
years).
2. Distinct trajectories of children’s HRQOL will be identified, with the majority of
CWE improving over the first two years then plateauing over the long-term. Family
characteristics at the time of epilepsy diagnosis will be more strongly associated with
HRQOL trajectories than epilepsy-related factors.
3. Ten years after their child’s diagnosis of epilepsy, HRQOL of mothers will be poorer
relative to population normative data and will be associated with family
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characteristics (at baseline and follow-up). Epilepsy-related factors will not be
independently associated with mothers’ HRQOL in the long-term.
4. Distinct trajectories of mothers’ depressive symptoms will be identified, with the
majority of mothers showing improvements over the long-term and others following
a stable trajectory over time. Family characteristics at baseline, and not epilepsyrelated factors, will be associated with trajectories of depressive symptoms.

1.4 How This Dissertation is Structured
This thesis research uses an integrated-article format, with each chapter representing a
separate component. Chapter 2 provides a literature review of childhood-onset epilepsy, the
HRQOL of children and their parents, and the methodological issues associated with following
these children over the long-term. The next five chapters, Chapters 3 to 7, present versions of
published articles evaluating Objectives 1 to 4. Chapter 3 reports on methodological work to
validate a parent-reported measure of HRQOL for young adults with epilepsy (Objective 1).
Chapter 4 delineates the long-term course of CWE’s HRQOL and identifies factors associated
with HRQOL trajectories (Objective 2). Chapter 5 reports on a systematic review evaluating the
HRQOL of parents of children with epilepsy. Chapter 6 evaluates the HRQOL of mothers of
CWE in the long-term after their child’s epilepsy diagnosis (Objective 3). Chapter 7 describes
the long-term course of depressive symptoms in mothers of CWE and identifies factors
associated with trajectories of mothers’ depressive symptoms (Objective 4). Finally, Chapter 8
provides an overall conclusion and summary of findings, and the implications, limitations and
next steps of the research conducted.
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Chapter 2: Literature Review
2.1 Chapter Overview
This chapter provides the context necessary to understand the impact of epilepsy on
children and their parents, and highlights the gaps in the extant literature that will be addressed in
this dissertation. First, an overview of the clinical presentation of epilepsy is presented, followed
by the health-related quality of life (HRQOL) and mental health problems experienced by
children with epilepsy and their parents. A conceptual framework is also discussed to better
understand and summarize the factors affecting children’s and parents’ HRQOL and mental
health. Lastly, methodological issues associated with prospective evaluations of children over the
long-term are discussed.

2.2 Pediatric Epilepsy
Epilepsy, one of the most common neurological conditions, is characterized by an
enduring predisposition for epileptic seizures, and by its neurobiologic, cognitive, psychological,
and social consequences [1]. Epilepsy is diagnosed when one of the following conditions is met:
1) at least two unprovoked (or reflex) seizures occurring >24 hours apart, 2) one unprovoked (or
reflex) seizures and a probability of further seizures similar to the general recurrent risk (at least
60%) after two unprovoked seizures, occurring over the next 10 years, or 3) diagnosis of an
epilepsy syndrome [1]. Epileptic seizures are transient periods of altered behavior, including
alterations of consciousness and involuntary motor, sensory and autonomic effects, caused by
transient abnormal excessive or synchronous neuronal activity. The affected neurons determine
the clinical manifestation and subjective experience of a seizure. Seizures are categorized into
two types: focal and generalized. Focal seizures originate from a defined region of the brain and
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arise from decreased inhibition or increased activation in a group of neurons leading to a net
excitatory signal that may then propagate to other regions of the brain [2]. In contrast,
generalized seizures involve all, or most of the brain, and are believed to involve alterations to
the normal excitatory/inhibitory oscillatory rhythm of the thalamocortical circuit [2]. It is
believed that the underlying neural substrate giving rise to seizures also contributes to the
cognitive and psychological comorbidities often associated with epilepsy [3].
Worldwide epilepsy affects of 65 million people. Among children and adolescents (≤18
years of age), meta-analyses estimate a cumulative incidence of 85 per 100,000 persons (95%CI:
60, 122), an incidence rate of 47 per 100,000 person years (95% CI: 42, 52), a period prevalence
of active epilepsy of 480 per 100,000 persons (95% CI: 417, 552), and a lifetime prevalence of
724 per 100,000 persons (95% CI: 574, 914) [4]. In Canada, epilepsy affects 300,000 persons, of
whom 42,000 are children and adolescents; the incidence and prevalence of epilepsy in Canadian
children and adolescents (≤18 years of age) are 60 per 100,000 persons and 545 per 100,000
persons, respectively [5]. An estimated 57% of Canadians with epilepsy are diagnosed prior to
the age of 19 years [6]. Over the long-term, 60% of children with epilepsy attain seizure control
and discontinue antiseizure medications [7,8], however comorbid cognitive and psychological
comorbidities may continue to persist and poor social outcomes (e.g. education, employment,
romantic relationships) in adulthood are evident [9].

2.3 Comorbidities and Health-Related Quality of Life
Unequivocal evidence has shown that the majority of children with epilepsy (CWE; up to
80%) face cognitive, psychiatric, and/or behavioral comorbidities, many of which continue to go
under-recognized and untreated [10-13]. The underlying neuropathology is thought to give rise
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to both the characteristics of the epilepsy and the neuropsychological comorbidities [3].
Substantial research has evaluated the HRQOL of CWE, finding poor outcomes across HRQOL
domains, including cognitive, emotional, social, and physical functioning [14-17]. Overall,
children with newly diagnosed epilepsy have poorer HRQOL relative to normative population
data, and over the first two years after diagnosis show initial improvements that plateau with
time [18]. However, it is important to note that CWE are a heterogenous group and unique
subgroups have been identified that show distinct trajectories of HRQOL, which generally
improve over time or remain stable [19-23]. Importantly, these studies have only followed CWE
up to the first 28 months following diagnosis, and long-term HRQOL trajectories remain
unknown. Although a number of studies have evaluated long-term HRQOL outcomes, all have
utilized a cross-section design and have not evaluated HRQOL near the time of epilepsy
diagnosis [16,24-27]. Therefore, there is a need for prospective studies evaluating long-term
HRQOL trajectories for CWE.
The three studies that have cross-sectionally evaluated long-tern HRQOL have reported
on a cohort of participants 9-, [25,26], 10- [28] and >30-years [24] after epilepsy diagnosis.
These studies report similar HRQOL among adults with history of epilepsy and healthy controls
[24,28] and better HRQOL among those seizure-free [25,26] and seizure-free and not on
antiseizure medications [24]. Baca et al. [25,26] evaluated the impact of other clinical
characteristics, finding that the presence of a psychiatric disorder, particularly an internalizing
disorder, was associated with poorer HRQOL and was a stronger predictor than seizure-control.
This finding highlights that HRQOL outcomes are driven by factors beyond seizure-control, a
conclusion that is supported by other studies evaluating short-term HRQOL outcomes, as
described below.
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Studies evaluating HRQOL and mental health problems in the short-term after a
diagnosis of epilepsy find that individual- and epilepsy-related factors are not consistent
predictors [16,17,29]. Conversely, psychological factors and the response to illness are
important; attitude toward illness, external (or unknown) locus of control, hopelessness, limited
emotional support, poor family communication, inadequate support of child autonomy, parental
psychopathology, and other family factors are commonly associated with children’s HRQOL and
psychopathology [16,29]. Similar results are found from studies evaluating short-term HRQOL
trajectories [19-23]. Past research has also established that family stress and satisfaction with
family relationships mediate the negative impact of parental psychopathology on children’s
HRQOL and emotional well-being, while family mastery and extended family social support
moderate this relationship [30-32]. Therefore, in understanding the impact of epilepsy on
children, it is important to consider psychosocial factors such as family environment and parental
mental health. Section 2.5 presents the conceptual framework used to illustrate the relationships
among clinical, parent and family characteristics and their effects on children’s HRQOL and
mental health. The clinical, parent and family characteristics associated with better long-term
HRQOL outcomes are currently unknown and presents a critical knowledge gap. Prospectively
delineating the determinants of long-term HRQOL trajectories would allow for the early
identification of children at risk of poor outcomes across the life course and provide potential
targets for interventions aimed at positively altering trajectories.

2.4 Parents and Families of Children with Epilepsy
Relative to families not living with childhood-onset epilepsy, families of CWE fare worse
on the quality of parent-child relationship, parenting confidence, and family relationships,
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functioning and stress [33]. Parents of CWE report unmet psychosocial care needs [34], with
social and financial burden contributing to parents' feelings of being unable to manage their
child's specific needs [35]. Parents report a need for ongoing emotional support and education
regarding the emotional and psychological impact that epilepsy may have on their child, as well
as difficulty with changes in family roles, unpredictability of seizures, and uncertainty
surrounding long-term prognosis [36]. Section 2.5 presents the conceptual framework used to
understand and summarise the relationships among clinical, parent, and family characteristics
and their effects on parents’ HRQOL and mental health. Recent systematic reviews report that up
to 50% of mothers and 58% of parents of CWE are at risk for major depression and anxiety,
respectively [37,38]. Chapter 5 of this dissertation presents results of a systematic review
evaluating HRQOL of parents of children with epilepsy.
Relative to fathers, mothers of CWE have been found to have a poorer quality of life and
more symptoms of anxiety, depression, and stress [38-40]; however, it is unclear whether these
differences are the result of gender differences or associated with the role of primary caregiver.
Understanding the impact of childhood illness on parents is important for the well-being
of both children and parents. Family environment and parental psychopathology are often
reported to have a greater impact on CWE’s HRQOL and mental health, relative to epilepsyrelated factors [18,30,33,37,38,41]. Similarly, parents of children with developmental disabilities
and non-neurological chronic conditions, such as asthma, are also at elevated risk for symptoms
of depression and anxiety, with family and parent factors identified as robust predictors of wellbeing, rather than illness characteristics [42-44]. Overall, the long-term mental health outcomes
of parents of children with epilepsy are unknown, and there is a need for future studies to
delineate long-term outcomes for parents and their determinants.
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2.5 Conceptual Framework
The theoretical framework used to guide this research is presented on Figure 2-1. This
framework was adapted from the Stress Process Model [45] and aligns with the extant literature
evaluating HRQOL and mental health outcomes of children with epilepsy and their parents. The
Stress Process Model has been a prevailing conceptual model describing mental health as a
consequence of life experience, exposure to stresses, and the social conditions in which one lives
[45]. The focus is placed on understanding the relationships among factors contributing to stress
and understanding the ways these relationships develop, change, and contribute to mental health.
The Stress Process Model contains three main concepts: source of stress, mediating and
moderating factors, and the manifestation of stress. First, sources of stress pertain to life events
(e.g. diagnosis of epilepsy) and life strains (e.g. living with epilepsy), which develop over longer
periods of time. Second, mediating and moderating factors are those that alter the impact that
stressors have on mental health outcomes. These psychological resources include social support,
coping strategies, family functioning, and stress management strategies. Third, the manifestation
of stress can be both physical and mental. In the context of epilepsy, the underlying
neuropathology is thought to give rise to stressors: the clinical characteristics such as epilepsy
severity and presence of neuropsychological problems, such as cognitive deficits and behavioral
and emotional problems. Clinical characteristics impact children’s and parents’ psychological
resources, the stress mediators and moderators, which include family functioning, and children’s
and parents’ social support, coping strategies, and stress management skills. Notably, the clinical
characteristics and psychological resources are impacted by and unfold within the context of the
child’s and parents’ sociodemographic characteristics such as age, sex, education and income.
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Ultimately the clinical characteristics and psychological resources impact children’s and parents’
HRQOL and mental health.

2.6 Methodological Issues with Long-term Prospective Studies of Children with Epilepsy
HRQOL is a key patient-reported outcome for people living with chronic conditions, and
epilepsy is no exception [46]. However, young children often lack the cognitive maturity and
verbal comprehension to provide self reports, so parent-reported outcomes are typically used for
young children [47]. Over the course of a long-term study, children ‘grow into’ developmentally
appropriate self-reported measures, and ‘grow out of’ parent-reported measures. Therefore,
longitudinal studies following young children into adulthood are not able to use a consistent
informant to assess patient reported outcomes across stages of developments, thereby introducing
a potential bias because parents and their children have unique perspectives and values [48]. It is
clear from past research that parent-proxy and children’s self-reported HRQOL are not
interchangeable, with parents of CWE typically reporting poorer HRQOL compared to CWE
[47,49,50]. Though this discrepancy may be a consequence of the psychometric properties of the
parent and child measures, it is thought that parents and their children have unique, reliable, and
valid perspectives on how they rate the child’s HRQOL [47,51]. To facilitate methodologically
rigorous studies that evaluate the trajectories of children’s HRQOL from childhood into
adulthood, a consistent informant (e.g. the parent) is needed. A validated parent-reported
measure of young adults’ HRQOL would offer a way to address this methodological limitation
and allow parents to report across their children’s stages of development. Although the use of
multiple informants is ideal to capture varying relevant perspectives and should be employed
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whenever feasible [47], very young children are not capable of providing valid self-reports of
HRQOL, and researchers must rely on parent-reports [47].
For CWE, a commonly used measure of HRQOL is the parent-reported Quality of Life in
Children with Epilepsy (QOLCE) Questionnaire; an epilepsy-specific 76-item measure for
children aged 4-18 years [52,53]. The QOLCE has been shortened and validated, and now
includes a 55-item (QOLCE-55)[54] and a 16-item (QOLCE-16)[55] version. Compatible
HRQOL measures for other age groups and informants include the self-reported Quality of Life
in Epilepsy-Adolescent (48-item; QOLIE-48AD) [56] for adolescents ages 11-17 years, and the
self-reported Quality of Life in Epilepsy (31-item; QOLIE-31)[57,58] for adults ages ≥18 years.
There are no epilepsy-specific parent-proxy reported HRQOL measures for young adults ages
>18 years. Consequently, studies evaluating HRQOL and following young CWE into adulthood
must rely on parent-reports at the start of the study, and adolescents’ and young adults’ (AYA)
self-report at later time points even though parents’ and their children’s reports are not analogous
[47,49,50]. Therefore, there is a need for validated instruments to evaluate HRQOL across stages
of development, from childhood to young adulthood, using a consistent informant; the parent.
The call for such an instrument is not meant to imply that parent-proxy reports of their young
adult children’s HRQOL are preferable or a replacement for youths’ self-report. Reports from
multiple informants, each with unique perspectives and advantages, are ideal and provide an
opportunity to better understand clinical problems, their course, their impact, and response to
treatments [47].
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Figure 2-1. Conceptual framework of the impact of clinical and family characteristics on
children’s and parents’ health related quality of life (HRQOL) and mental health, modified from
the Stress Process Model.
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Chapter 3: Validation of the Quality of Life in Childhood Epilepsy Questionnaire for use
by parents of young adults with childhood-onset epilepsy 1

3.1 Introduction
Health-related quality of life (HRQOL) is a key outcome measure for people with
epilepsy and other chronic conditions [1]. Although self-reported measures are preferred, young
children lack the cognitive maturity and verbal comprehension capacity to provide self-reports
[2]. Consequently, clinicians and researchers working with children must rely on parent-proxy
reported HRQOL until children reach a developmental stage where their report is considered
appropriate and valid. To reliably evaluate HRQOL for these children over time, a consistent
method of measurement is needed, specifically a consistent informant across the child’s stages of
development and into emerging adulthood. Utilizing parent-proxy reports in early childhood and
adolescents’ and young adults’ (AYA) self-reports in later time points would undoubtedly
introduce systematic bias because parent and their children have unique perspectives and their
reports are not interchangeable [3]; parents typically report poorer HRQOL for their children
compared to the AYA’s self-report [2,4-6]. Therefore, to reliably evaluate change from young
childhood into emerging adulthood, a consistent informant, the parent, is needed; parent-proxy
reports may additionally be augmented by AYA’s report to provide a comprehensive account of
long-term outcomes and their course since early childhood and disease onset. Additionally,
prospective evaluation of long-term HRQOL is particularly important for the early identification
of children at risk of poor HRQOL trajectories.

1

A version of this chapter has been published: Puka K, Goodwin SW, Ferro MA, Smith ML, Widjaja E, Anderson
KK, Speechley KN (2020). Validation of the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55 and
QOLCE-16) for use by parents of young adults with childhood-onset epilepsy. Epilepsy & Behavior, 104, 106904.
DOI: 10.1016/j.yebeh.2020.106904
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For children and adolescents with epilepsy, a commonly used measure of HRQOL is the
parent-proxy reported Quality of Life in Children with Epilepsy Questionnaire (QOLCE); an
epilepsy-specific 76-item measure for those aged 4-18 years [7,8]. The QOLCE was recently
shortened and validated, with 55-item (QOLCE-55)[9,10] and 16-item (QOLCE-16)[11]
versions available. Similar HRQOL measures with respect to the structure and types of questions
are available for other age groups and informants, and include the self-reported Quality of Life in
Epilepsy-Adolescent (48-item; QOLIE-48AD) [12] for adolescents ages 11-17 years, and the
self-reported Quality of Life in Epilepsy (31-item; QOLIE-31-P)[13,14] for adults ages ≥18
years. Lastly, the PedsQL Epilepsy module was recently validated for children and adolescents
aged 2-18 years by parent-proxy report and ages 5-18 by self-report [15]. Notably, there are no
epilepsy-specific parent-proxy reported HRQOL measures for young adults ages >18 years.
Research assessing the viability of extending the use of a parent-proxy reported HRQOL
measure into the period of emerging adulthood for children with epilepsy have not been
conducted previously.
The objective of this study was to evaluate the psychometric properties of the parentproxy reported QOLCE (QOLCE-55 and QOLCE-16) when used by parents to assess HRQOL
in their children as young adults. Specifically, within a sample of young adults with childhoodonset epilepsy, we aimed to a) evaluate the goodness of fit of the established factor structure of
the QOLCE; b) evaluate the internal consistency of the overall and sub-domain scores of the
QOLCE; and c) evaluate the convergent validity between similar subscales of the parent-proxy
rated QOLCE and the AYA self-reported QOLIE-31-P. Importantly, the purpose of this research
was not to imply that parent-proxy -report of their adult children’s HRQOL is preferable and a
replacement for AYA’s self-report. Reports from multiple informants, each with unique
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perspectives and advantages, are ideal and provide an opportunity to better understand clinical
problems, their course, their impact, and response to treatments [2].

3.2 Methods
3.2.1 Participants
Data for this study were obtained from four sources, outlined below. From each source,
young adults aged ≥18 years and data from the last follow-up assessment, if multiple
assessments were eligible for inclusion, were extracted. Combining results from four Canadian
data sources is advantageous in increasing the sample size and producing results generalizable to
a wider array of individuals with childhood-onset epilepsy. Approval was obtained from all
relevant research ethics boards.
3.2.1.1 Data Source 1: HERQULES. The Health-Related Quality of Life in Children with
Epilepsy Study (HERQULES) is a prospective cohort study of children with newly-diagnosed
epilepsy, with assessments at the time of diagnosis and 0.5, 1, 2, 8, and 10 years post-diagnosis.
The study has been described in detail previously [16]. Briefly, pediatric neurologists across
Canada were invited to participate and they consecutively recruited their patients meeting
inclusion criteria. Eligible children were 4 to 12 years of age with newly diagnosed epilepsy (≥2
unprovoked seizures) and seen for the first time by a participating pediatric neurologist. Children
were not eligible if they also had a diagnosis of other progressive or degenerative neurological
disorders, or other major comorbid non-neurological health condition likely to have an impact on
HRQOL (e.g., asthma requiring daily medication, renal failure). The primary caregiving parent
completed questionnaires at each time point, and AYA completed questionnaires at the 8- and
10-year follow-up. For this report, we utilized data from the last available follow-up, at either the
8- or 10-year follow-up.

26

3.2.1.2 Data Source 2: PEPSQOL. The Impact of Pediatric Epilepsy Surgery on HealthRelated Quality of Life Study (PEPSQOL), is a prospective cohort study of children (aged 4 to
18 years) with drug-resistant epilepsy undergoing evaluations to determine candidacy for
epilepsy surgery. The study has been described in detail previously [17]. Data were collected
from nine surgical epilepsy centers across Canada, and exclusion criteria included: 1) prior
resective surgery, past or planned non-resective epilepsy surgery (e.g. corpus callosotomy) or
vagal nerve stimulator placement; 2) neurometabolic disorders, neurodegenerative disorders, and
genetic epilepsy syndromes; and 3) primary generalized epilepsy and epileptic encephalopathies.
Patients who were not able to complete self-report questionnaires, either independently or with
assistance, were also excluded. AYA were eligible for the study irrespective of whether they
underwent epilepsy surgery. Nonsurgical patients include patients that chose not to undergo
surgery and patients ineligible for surgery because a clear unilateral seizure focus could not be
identified or the benefits of surgery were not outweighed by deficits that would have arisen
subsequently. A number of studies have shown that surgical and nonsurgical groups are similar
at the time of surgical evaluation on a number of cognitive and psychosocial factors [18,19].
Data collection occurred at the time of surgical evaluation and 0.5, 1, and 2 years after a) the
surgical evaluation (for nonsurgical patients) or b) epilepsy surgery (for surgical patients).
Parents and their children completed questionnaires at each time point. For this report, we
utilized data from the last available follow-up, at which point some patients had undergone
epilepsy surgery (see Table 3-1).
3.2.1.3 Data Source 3: Epilepsy Surgery Outcomes Study. This study evaluated long-term
outcomes of children with drug-resistant epilepsy, and has been described in detail previously
[20,21]. Eligible participants underwent epilepsy surgery evaluations at the Hospital for Sick
Children in Toronto, Canada, and were 18 years or younger at that time. Patients who did and did

27

not subsequently undergo epilepsy surgery were included. Multiple cognitive, behavioral, and
social outcomes were evaluated at the time of surgical candidacy evaluation and 4 to 11 years
after a) the surgical candidacy evaluation (for nonsurgical patients) or b) epilepsy surgery (for
surgical patients). Exclusion criteria included hemispherectomy, corpus callosotomy or vagal
nerve stimulation procedures, and patients with neurodegenerative disorders. Parents and their
children completed questionnaires at each time point. For this report, we utilized data from the
last available follow-up, at which point some patients had undergone epilepsy surgery (see Table
3-1).
3.2.1.4 Data Source 4: Clinic Sample. Data were collected from medical records of
patients with drug-resistant epilepsy evaluated for epilepsy surgery at the Hospital for Sick
Children [18,19]. At the time of surgical evaluation children were aged ≤18 years, and as part of
clinical care patients were followed for a minimum of one-year past surgery. Child and clinical
factors were extracted from patient charts, which included measures of HRQOL. For this report,
we utilized data from the last available follow-up, at which point some patients had undergone
epilepsy surgery (see Table 3-1).

3.2.2 Measures
The primary measures of interest were the 55-item and 16-item versions of Quality of
Life in Childhood Epilepsy Questionnaire (QOLCE-55 [9,10,22] and QOLCE-16 [11,23]). The
QOLCE-55 was derived from the questions of the original 76-item QOLCE [7,8], and the
QOLCE-16 was derived from the questions of the QOLCE-55. Parents had completed the 76item QOLCE and data for the QOLCE-55 and QOLCE-16 were extracted. Both versions
generate an overall HRQOL score, and scores for four sub-domains: cognitive, emotional, social,
and physical functioning. Scores range from 0 to 100, with higher scores indicative of better
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HRQOL. The primary caregiving parent completed the QOLCE and questions pertaining to
demographic and clinical characteristics.
Young adults completed the self-reported Quality of Life in Epilepsy questionnaire
(QOLIE-31-P) [13,14]; these data were only available from the HERQULES and the Epilepsy
Surgery Outcomes Study. The QOLIE-31-P is an epilepsy-specific measure of HRQOL,
composed of 31-items evaluating overall HRQOL and mood (i.e. emotional functioning), daily
activities (i.e. social functioning), cognition (i.e. cognitive functioning), energy/fatigue, seizure
worry, and medication effects over the past four weeks [13,14]. Scores range from 0 to 100, with
higher scores indicative of better HRQOL. The QOLIE-31 has been reported to be internally
consistent with Cronbach alpha coefficients for the overall score of 0.93 and 0.77 to 0.85 for the
subscales [13]. Test-retest reliability coefficients reported for the QOLIE-31 are 0.89 for the
overall score and a range of 0.64 to 0.85 for the subscales [13].

3.2.3 Data Analysis
Analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC) and Mplus 6.12
(Muthen & Methun, 1998-2011) and were completed separately for the QOLCE-55 and
QOLCE-16. We excluded participants for whom a total QOLCE score could not be generated
because of missing data (n QOLCE-55 = 19 and n QOLCE-16 = 10). Given that the QOLCE-16 has
fewer items, more participants had complete QOLCE-16 data as compared with the QOLCE-55.
Confirmatory factor analysis (CFA) was used to assess the construct validity of the
parent-proxy reported QOLCE for young adults with childhood-onset epilepsy. CFA allows for
an estimation of the goodness of fit between the sample data and the established factor structure
of the QOLCE (Figure 3-1). The established factor structure of the QOLCE is composed of a
four-factor solution and a higher-order factor, whereby each item loads to a single factor
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(cognitive, emotional, social, or physical functioning), and the four-factors load onto a single
higher order factor, overall HRQOL [9,11]. Robust weighted least square estimator with delta
parameterization was used. Adequacy of model fit was evaluated using conventional criteria,
namely the Comparative Fit Index (CFI; acceptable >0.90); Tucker-Lewis Index (TLI;
acceptable >0.90); and root mean square of approximation (RMSEA; acceptable <0.08) [24-28].
The chi-square test was not used for decisions of model fit because it is sensitive to sample size
[24].
Reliability of the scales for the overall score and four sub-domains of the QOLCE was
evaluated using Cronbach’s alpha and the greatest lower bound (glb)[29], with coefficients of
>0.70 considered satisfactory. Convergent validity was evaluated using intraclass correlation
coefficient (ICC), which account for differences in means between subscales of the QOLCE and
the self-reported QOLIE-31-P purporting to assess the same construct. Specially, we evaluated
the correlation between the QOLCE overall HRQOL and the QOLIE-31-P overall HRQOL;
QOLCE cognitive functioning and QOLIE-31-P cognition; QOLCE emotional functioning and
QOLIE-31-P mood; and QOLCE social functioning and QOLIE-31-P daily activities. ICC was
calculated using a one-way random effects model, absolute agreement, and single measurement
[30], and was interpreted as poor to fair (≤.40), moderate (0.41 – 0.60), good (0.61 – 0.80), or
excellent (>0.80).
We could not evaluate convergent validity of the QOLCE physical functioning subscale
because a corresponding subscale is not available in the QOLIE-31-P. The QOLCE physical
functioning subscale evaluates restrictions in physical activities (e.g. How often has your child:
‘Been able to do the physical activities other children his/her age do?’; ‘Played freely outside
the house like other children his/her age?’). The energy subscale of the QOLIE-31-P is the most
similar subscale to QOLCE physical functioning, though the included questions are substantively
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different, asking ‘Did you feel full of pep?’, ‘Did you have a lot of energy?’, ‘Did you feel worn
out?’, and ‘Did you feel tired?’. While the original 76-item QOLCE contained an energy/fatigue
subscale, these items were removed in the development of the QOLCE-55 and QOLCE-16.

3.3 Results
A total of 123 QOLCE-55 and 134 QOLCE-16 were completed. At the time of
participation, their children (50% female) were aged 18.0 to 28.5 years, and 68% had been
seizure-free for the past 12 months (see Table 3-1). Participants were aged 1.5 months to 16.0
years at the time of epilepsy onset, and 31% had previously undergone epilepsy surgery.

3.3.1 Higher-order Factor Structure
3.3.1.1 QOLCE-55
Results from the confirmatory factor analysis for the QOLCE-55, representing the
summary of the higher-order structure, are presented in Table 3-2. The model showed acceptable
fit: CFI = 0.968, TLI = 0.966, and RMSEA = 0.061 (95% confidence interval [CI]: 0.056, 0.067).
The standardized parameter estimates for the first-order items are presented in Table 3-3; all
items loaded significantly onto their respective first-order factors (p ≤ 0.01). The four-first order
factors (cognitive, emotional, social, and physical functioning) loaded onto a single higher-order
factor (overall HRQOL). Higher order factor loadings were strong, ranging from λ = 0.71 to 0.88
(p < 0.001).
For one item in the physical functioning sub-domain (item #48 in Table 3-3), the
standardized factor loading was 1.10 and the residual variance was -0.22. Removal of this item
resulted in similar model fit: CFI = 0.971, TLI = 0.970, RMSEA = 0.059 (95% CI: 0.053, 0.064)
and minimal impact to total HRQOL and physical functioning scores; the mean change in overall
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HRQOL and physical functioning was 0.21 (95% CI: 0.08, 0.35) and 0.90 (95% CI :0.28, 1.51),
respectively. Because of the minimal impact, results with this item retained are included in Table
3-2.
3.3.1.2 QOLCE-16
Results of the confirmatory factor analysis for the QOLCE-16, representing the higherorder structure are presented in Table 3-2. The model showed adequate fit: CFI = 0.966, TLI =
0.959, and RMSEA = 0.141 (95% CI: 0.126, 0.157). The standardized parameter estimates for
the first-order items are presented in Table 3-3; all items loaded significantly onto their
respective first-order factors (p < 0.001). Higher order factor loadings were strong, ranging from
λ = 0.76 to 0.90 (p < 0.001).
For one item in the physical functioning sub-domain (item #48 in Table 3-3) the
standardized factor loading was 1.05 (residual variance: -0.09). As was found in QOLCE-55,
removal of this item resulted in similar model fit: CFI = 0.977, TLI = 0.972, RMSEA = 0.124
(95% CI: 0.107, 0.141), and minimal impact on total HRQOL and physical functioning scores;
difference in scores was -0.25 (95% CI: -0.62, 0.12) and -1.37 (95% CI: -2.67, -0.07),
respectively. Because of the minimal impact, results with this item retained are included in Table
3-2.

3.3.2 Internal Consistency and Convergent Validity
3.3.2.1 QOLCE-55
The internal consistency/reliability of the QOLCE-55 was excellent for overall HRQOL
and good to excellent for each subscale; alpha/glb values were: 0.97/0.99 for overall HRQOL,
0.98/0.99 for cognitive, 0.92/0.96 for emotional, 0.94/0.95 for social, and 0.89/0.95 for physical
functioning. Convergent validity was examined via ICC comparing similar domains from the
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parent-proxy -reported QOLCE-55 and the self-reported QOLIE-31-P. Of primary interest, the
correlation between overall HRQOL as reported by parents on the QOLCE-55 and young adults
on the QOLIE-31-P was good (ICC=0.76; 95% CI 0.64 - 0.85; n = 65). The correlations were
moderate to good between the parent-proxy reported QOLCE-55 and the self-reported QOLIE31-P on the domains of cognitive (ICC=0.61; 95% CI 0.44 - 0.74; n = 65), emotional (ICC=0.59;
95% CI 0.40 - 0.73; n = 65), and social functioning (ICC=0.78; 95% CI 0.65 - 0.86; n = 56).

3.3.2.2 QOLCE-16
The internal consistency/reliability of the QOLCE-16 was excellent for overall HRQOL
and good to excellent for each subscale; alpha/glb values were: 0.93/0.98 for overall HRQOL,
0.93/0.95 for cognitive, 0.87/0.88 for emotional, 0.95/0.95 for social, and 0.78/0.87 for physical
functioning. With respect to convergent validity of the QOLCE-16, the correlation between
overall HRQOL as reported by parents on the QOLCE-16 and young adults on the QOLIE-31-P
was good (ICC=0.72; 95% CI 0.59 - 0.82; n = 72). The correlations were moderate to good
between the parent-proxy reported QOLCE-16 and the self-reported QOLIE-31-P on the
domains of cognitive (ICC=0.51; 95% CI 0.31 - 0.66; n = 72), emotional (ICC=0.55; 95% CI
0.37 - 0.69; n = 71), and social functioning (ICC=0.68; 95% CI 0.51 - 0.79; n = 60).

3.4 Discussion
The current study aimed to validate the QOLCE for young adults with epilepsy to allow
for reliable assessments of HRQOL over time, from early childhood through emerging
adulthood. Overall, the results suggest that the QOLCE-55 and QOLCE-16 are reliable and valid
instruments that can be used to reliably evaluate HRQOL over time and into adulthood.
Validated prospective accounts of HRQOL by parents, in conjunction with AYA’s self-report
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provides a comprehensive account of HRQOL at disease onset and over the long-term, allowing
for the identification of early predictors of HRQOL trajectories.
The higher-order factor structure of both the QOLCE-55 and QOLCE-16 was confirmed
in a sample of young adults with a history of childhood-onset epilepsy. All items on the
questionnaires loaded significantly onto their respective domains. The same single item on both
the QOLCE-55 and QOLCE-16 (‘Needs more supervision than other children his/her age?’) was
found to have a standardized factor loading greater than 1 (and a negative residual variance).
However, we do not believe that this undermines the validity of the QOLCE-55 and QOLCE-16
for young adults for several reasons. The factors in the QOLCE-55 and QOLCE-16 are
correlated with each other. Past research has shown that models with correlated factors can
produce, in certain situations, item factor loadings having values greater than one, without being
indicative of a model or structural issue [31]. Given that this single item in the QOLCE does not
impact the model fit or estimation of loadings for the overall higher-order structure, we suggest
that the higher standardized factor loading is not a concern for the overall validity of the
measure. Furthermore, individual item scores from the QOLCE are not used in evaluating
outcomes and removal of the item resulted in negligible changes in the model and overall
HRQOL and physical functioning scores.
It is important to note that the aim of this study was not to suggest that parent-proxy
reports of HRQOL in adults should be routinely used, but rather to present a valid method of
measuring HRQOL longitudinally from early childhood with a consistent method and informant.
Although the QOLCE-55 and QOLCE-16 may also be utilized by cross-sectional studies of
young adults, it is important that self-reported HRQOL is also obtained whenever possible.
Parents and their children have unique perspectives on well-being, and children’s and AYA’s
reports are not interchangeable with those of their parents, who typically report poorer HRQOL
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relative to self-reports [2,4,5]. The use of multiple informants to capture varying relevant
perspectives is therefore ideal and recommended [2].
We also evaluated internal consistency, which were acceptable for overall HRQOL and
each subscale of the QOLCE-55 and QOLCE-16. Convergent validity of the QOLCE-55 and
QOLCE-16 were also assessed, comparing parents’ reports with young adult’s self-reports on the
QOLIE-31-P. Overall, results were acceptable, showing moderate to high correlations, for
overall HRQOL, as well as the domains of cognitive, emotional and social functioning. In line
with past studies, we also found greater agreement between parents and their children with
respect to more externalized domains, such as social functioning, relative to more internalized
domains, such as emotional functioning [2,4,5].
Several limitations of this study should be considered. Although we aimed to increase
sample size and generalizability by including a wide array of young adults with childhood-onset
epilepsy, the resulting sample size may be considered small for confirmatory factor analysis
research. In addition, we did not have data to evaluate test-retest reliability, and a subset of the
sample was used to evaluate construct validity. Therefore, further evaluation of the validity of
the QOLCE-55 and QOLCE-16 is encouraged for other studies with larger samples of young
adults with a history of childhood-onset epilepsy. Given the relatively small number of patients
from each data source, we could not evaluate whether model fit was different among the four
data sources, although model fit of the largest sample alone (the HERQULES data) yielded
similar results (data not shown). In addition, limited demographic and clinical characteristics
were consistently available in each of the datasets combined for analyses, thus precluding a more
detailed description of our sample on characteristics such as the presence of comorbidities. In
addition, we did not have information pertaining to the young adults’ living arrangements and
whether they resided with their parents. Though this is an important topic for future research, the
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results of the present study provide the first step in validating a tool to be used by the clinician’s
and/or researchers’ discretion and best used to supplement young adults’ self-reported HRQOL.
Lastly, a potential criticism of the QOLCE is that it is focused on function, as opposed to
satisfaction in different domains [2]. The focus on function may help parents more accurately
rate items as they believe their child would rate them. Additionally, reports from multiple
informants are ideal and provide an opportunity to better understand clinical problems, their
course, their impact, and response to treatments [2]. In conclusion, the present findings support
the use of the QOLCE-55 and QOLCE-16 as a reliable and valid parent-proxy reported
instruments for young adults with a history of childhood-onset epilepsy. This capability may
facilitate the evaluation of long-term trajectories of HRQOL from childhood into emerging
adulthood employing measurement by a consistent informant. Self-reported measures of
HRQOL remain an integral part of evaluating young adults’ HRQOL, and reports from multiple
informants may be further valuable in providing varying perspectives. Furthermore, there is a
need to develop self-reported epilepsy-specific HRQOL measures that can be adapted for use as
children mature through childhood, adolescents, and adulthood.
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Figure 3-1. Summary of the established factor structure of the Quality of Lifein Childhood
Epilepsy Questionnaire (QOLCE-55).

HRQOL: Health-related quality of life.
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Table 3-1. Participant characteristics of young adults with data available for the QOLCE-55 and
QOLCE-16.
Data Source
Surgery
PEPSQOL Outcomes
Study

Complete
Sample

HERQULES

Clinic
Sample

Sample size
Age at epilepsy onset, years a
Age, years
Sex, female b
Underwent epilepsy surgery
Seizure-free > 1-year c

123
9.1 (3.6)
20.2 (2.0)
59 (50%)
38 (31%)
79 (68%)

69
9.9 (1.4)
20.3 (1.5)
32 (46%)
0 (0%)
57 (86%)

25
8.9 (5.0)
18.7 (0.8)
12 (48%)
14 (56%)
13 (56%)

17
5.6 (4.5)
22.9 (2.9)
11 (64%)
12 (71%)
5 (29%)

12
9.9 (5.0)
18.7 (0.4)
4 (50%)
12 (100%)
4 (36%)

QOLCE-16
Sample size
Age at epilepsy onset, years a
Age, years
Sex, female b
Underwent epilepsy surgery
Seizure-free > 1-year c

134
9.1 (3.6)
20.1 (2.0)
64 (50%)
41 (31%)
87 (68%)

76
9.9 (1.4)
20.3 (1.5)
36 (47%)
0 (0%)
63 (86%)

25
8.9 (5.0)
18.7 (0.8)
12 (48%)
14 (56%)
13 (56%)

18
6.0 (4.8)
22.8 (2.9)
12 (67%)
13 (72%)
6 (33%)

15
8.9 (5.0)
18.6 (0.4)
4 (40%)
14 (93%)
5 (36%)

QOLCE-55

Missing data for a1 patient, b5 patients, c6 patients.
Mean (SD) or n (%) are presented.
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Table 3-2. Summary of the higher-order summary factor model of the QOLCE-55 and QOLCE-16.
For simplicity, first-order items were not included.
QOLCE-55

QOLCE-16

Factor
loading (SE)

R2 (SE)

Residual
error

Factor
loading (SE)

R2 (SE)

Residual
error

Cognitive
Functioning

0.86 (0.03)

0.77 (0.06)

0.26

0.78 (0.05)

0.60 (0.08)

0.40

Emotional
Functioning

0.88 (0.04)

0.69 (0.07)

0.22

0.83 (0.05)

0.69 (0.77)

0.31

Social
Functioning

0.85 (0.04)

0.82 (0.03)

0.28

0.90 (0.04)

0.80 (0.07)

0.20

Physical
Functioning

0.71 (0.05)

0.43 (0.08)

0.50

0.76 (0.05)

0.58 (0.07)

0.42

Standardized factor loading are shown and all were significant at p < 0.001. SE: Standard Error
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Table 3-3. Standardized parameter estimates for first-order items.
QOLCE-55
Factor
R2 (SE)
loading (SE)

QOLCE-16
Factor
R2 (SE)
loading (SE)

Cognitive Functioning
1. Had trouble understanding directions?
2. Had difficulty following complex instructions?
3. Had trouble understanding or following what others were saying?
4. Had difficulty following simple instructions?
5. Had trouble remembering things people told him/her?
6. Had trouble finding the correct words?
7. Found it hard remembering things?
8. Had trouble concentrating on a task?
9. Had trouble remembering things s/he read hours or days before?
10. Had difficulty doing one thing at a time?
11. Had difficulty reasoning or solving problems?
12. Had trouble understanding what s/he read?
13. Reacted slowly to things being said and done?
14. Had difficulty keeping track of conversations?
15. Had trouble remembering names of people?
16. Had trouble remembering where s/he put things?
17. Had difficulty concentrating on reading?
18. Planned to do something than forgot?
19. Had difficulty making plans or decisions?
20. Had trouble writing?
21. Had trouble talking?
22. Had difficulty attending to an activity

0.92 (0.02)
0.94 (0.01)
0.94 (0.01)
0.90 (0.02)
0.88 (0.02)
0.89 (0.02)
0.89 (0.02)
0.88 (0.02)
0.92 (0.02)
0.77 (0.04)
0.91 (0.02)
0.93 (0.02)
0.88 (0.03)
0.94 (0.02)
0.81 (0.03)
0.75 (0.04)
0.90 (0.02)
0.78 (0.04)
0.90 (0.02)
0.76 (0.04)
0.83 (0.03)
0.84 (0.03)

0.84 (0.03)
0.88 (0.03)
0.89 (0.03)
0.81 (0.04)
0.77 (0.04)
0.79 (0.04)
0.78 (0.04)
0.78 (0.04)
0.85 (0.03)
0.59 (0.06)
0.82 (0.04)
0.86 (0.03)
0.78 (0.05)
0.88 (0.03)
0.66 (0.06)
0.57 (0.06)
0.80 (0.04)
0.61 (0.06)
0.80 (0.04)
0.58 (0.06)
0.69 (0.05)
0.71 (0.06)

0.84 (0.04)
0.62 (0.08)
0.89 (0.03)
0.73 (0.05)
0.59 (0.10)
0.77 (0.04)
0.78 (0.04)
0.42 (0.09)
0.83 (0.04)
0.84 (0.05)

0.71 (0.07)
0.38 (0.10)
0.80 (0.05)
0.53 (0.08)
0.35 (0.12)
0.59 (0.06)
0.61 (0.06)
0.18 (0.08)
0.68 (0.07)
0.71 (0.08)

0.85 (0.05)

0.72 (0.09)

0.80 (0.04)
0.70 (0.05)
0.46 (0.06)
0.64 (0.06)
0.78 (0.04)
0.81 (0.04)

0.64 (0.06)
0.49 (0.07)
0.21 (0.06)
0.41 (0.07)
0.60 (0.06)
0.66 (0.06)

0.90 (0.03)
0.74 (0.06)
0.98 (0.02)
0.47 (0.08)
0.56 (0.09)
0.81 (0.06)
0.74 (0.07)

0.81 (0.05)
0.54 (0.08)
0.96 (0.05)
0.23 (0.08)
0.32 (0.10)
0.65 (0.09)
0.54 (0.10)

0.95 (0.01)
0.97 (0.01)

0.91 (0.03)
0.94 (0.03)

0.95 (0.01)
0.84 (0.03)

0.91 (0.03)
0.71 (0.05)

0.89 (0.03)

0.80 (0.05)

0.79 (0.03)

0.62 (0.05)

0.84 (0.05)

0.70 (0.08)

0.84 (0.04)

0.70 (0.08)

0.60 (0.07)

0.35 (0.08)

0.77 (0.05)
0.83 (0.05)

0.60 (0.08)
0.69 (0.09)

Emotional Functioning
23. Felt no one cared?
24. Wished s/he was dead?
25. Felt nobody understood him/her?
26. Angered easily
27. Hit or attacked people
28. Felt happy?
29. Felt down or depressed?
30. Swore in public
31. Felt frustrated?
32. Demanded a lot of attention?
33. Was socially inappropriate (said or did something out of place in a
social situation)?
34. Felt valued?
35. Worried a lot?
36. Was obedient?
37. Felt pleased about achieving something?
38. Felt excited or interested in something?
39. Felt confident?

Physical Functioning
40. Gone to parties without you or without supervision?
41. Stayed out overnight (with friends or family)?
42. Played with friends away from you or your home?
43. Played freely in the house like other children his/her age?
44. Participated in sports activities (other than swimming)?
45. Been able to do the physical activities other children his/her age do?
46. Played freely outside the house like other children his/her age?
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47. Gone swimming? (i.e., swam independently)
48. Needs more supervision than other children his/her age?

0.32 (0.12)
1.10 (0.05)

0.10 (0.08)
-

0.91 (0.04)

0.82 (0.06)

0.74 (0.06)

0.55 (0.08)

0.91 (0.03)
0.93 (0.03)
0.97 (0.02)
0.94 (0.02)
0.90 (0.04)

1.05 (0.04)

-

0.84 (0.05)

0.91 (0.03)

0.83 (0.05)

0.86 (0.05)
0.93 (0.03)
0.89 (0.04)
0.81 (0.08)

0.92 (0.02)
0.98 (0.01)
0.95 (0.02)

0.85 (0.04)
0.95 (0.03)
0.90 (0.04)

Social Functioning
49. Limited his/her social activities (visiting friends, close relatives, or
neighbors)?
50. Limited his/her leisure activities (hobbies or interests)?
51. How limited are your child’s social activities compared with others
his/her age?
52. Affected his/her social interactions at school or work?
53. Isolated him/her from others?
54. Made it difficult for him/her to keep friends
55. Frightened other people?

All p-values were significant at p < 0.001 (except QOLCE-55 item #47, where p = 0.01); SE: Standard error
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Chapter 4: Long-term quality of life trajectories among individuals diagnosed with
epilepsy in childhood 1

4.1 Introduction
The majority of children with epilepsy face cognitive, psychiatric, and/or behavioral
comorbidities that often to go under-recognized and untreated[1-4]. Furthermore, although
seizures often resolve over the long-term, epilepsy continues to impact social outcomes in
adulthood (e.g. education, employment, romantic relationships)[5]. Understandably, healthrelated quality of life (HRQOL) is a key outcome for individuals with epilepsy and is critical for
understanding the impact of epilepsy and its treatment. In one of the first comprehensive
prospective studies of HRQOL, our group showed that children with epilepsy have poorer
HRQOL in comparison to their similarly-aged peers at the time of diagnosis, and show some
improvements over the following two years that plateaus with time[6]. Further work by our
group demonstrated that children with epilepsy are heterogenous and experience several distinct
trajectories of HRQOL, which generally improve over time or remain stable over the first two
years after diagnosis[7,8]. These findings were important in providing a comprehensive
evaluation of HRQOL and its determinants over the first two years after an epilepsy diagnosis in
childhood, but describing a relatively short, two-year window leaves unanswered questions for
clinicians and families about what the longer-term future holds for these children. Therefore, in
the current study, we present the results from an extended 10-year follow-up of this same cohort
of children.

1

A version of this chapter has been published: Puka K, Ferro MA, Camfield CS, Levin SD, Smith ML, Wiebe S,
Zou G, Anderson KK, Speechley KN (2020). Trajectories of quality of life 10 years following a diagnosis of
epilepsy in childhood. Epilepsia 61, 1453-1463. DOI: 10.1111/epi.16579
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A major limitation of previous prospective studies of children’s HRQOL has been their
relatively short follow-up of 24 to 28-months[6-11]. Virtually no information is available on
HRQOL over the long-term, including whose HRQOL will likely improve, remain the same or
decline over time and for what reasons, especially as these children become adolescents and
young adults (AYAs). Only two studies have investigated long-term HRQOL[12-14].
Conclusions to be made from these studies are limited by cross-sectional study designs,
precluding the investigation of risk factors and their limited focus on characteristics associated
with HRQOL; these studies have focused on clinical and demographic characteristics which are
not associated with short-term HRQOL and mental health outcomes, with the exception of
seizure-control [15-17]. There have been no long-term investigations including other categories
of known risk factors for HRQOL such as families’ resources to deal with a child’s chronic
illness, other stressors in their lives, child-family interactions and relationships, and parent
mental health. As well, there is no information regarding the stability of predictors at observable
at diagnosis on long-term HRQOL. Lastly, adolescence is a time of tremendous physical, mental,
and social change and adolescents with epilepsy may be at particular risk for compromised
HRQOL as they mature towards adulthood. Therefore, there is a tremendous need to better
understand trajectories of HRQOL for children diagnosed with epilepsy as they develop into
AYAs and the clinical, parent, and family factors that are key risk and protective factors.
Prospectively delineating the course of children’s long-term HRQOL and its determinants would
also allow for the early identification of children at risk of poor outcomes across the life course
as potential targets for resources aimed at positively altering trajectories.
The objective of this study was to describe the long-term course (10-year follow-up) of
HRQOL among children with newly diagnosed epilepsy and identify key characteristics at
diagnosis associated with the trajectories of HRQOL. Specifically, we aimed to evaluate 1)
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whether the improvement in HRQOL scores observed over the first two years after diagnosis
continues as children mature into young adults, 2) whether the individual and family-level
characteristics that predicted short-term HRQOL (i.e. child cognitive problems, maternal
depression, and high family demands) have longer term prognostic power or whether other
factors have more prominence later in the course of the illness. These questions have not been
previously investigated for any patient-reported outcome, such as HRQOL, for children with
epilepsy and the answers are important for clinicians, patients, and families to better understand
the long-term course of pediatric epilepsy, beyond seizure control.

4.2 Methods
4.2.1 Participants and Study Design
Participants came from a population-based study of children with newly-diagnosed
epilepsy, the Health-Related Quality of Life in Children with Epilepsy Study (HERQULES) [6].
Participants were recruited by pediatric neurologists across Canada between April 2004 and
April 2007. Participating neurologists were asked to consecutively recruit all patients meeting
study inclusion criteria: children aged 4 to 12 years with newly diagnosed epilepsy (≥2
unprovoked seizures) and seen for the first time by a participating pediatric neurologist. The
lower age limit was chosen because there were no epilepsy-specific HRQOL measures available
for children under the age of 4 years. Exclusion criteria included a diagnosis of other progressive
or degenerative neurological disorders, or other major comorbid non-neurological health
condition likely to have an impact on HRQOL (e.g., asthma requiring daily medication, renal
failure). Ethics approval was obtained from relevant research ethics boards, and parents provided
written consent.
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A total of 456 eligible children were identified, and the parents of 373 (82%) returned
baseline questionnaires mailed to them. All measures described below were completed at the
time of epilepsy diagnosis (baseline) and at 0.5, 1, 2, 8, and 10-year follow-ups by the primary
caregiving parent or the child’s neurologist.

4.2.2 Measures
4.2.2.1 Children’s Health-related Quality of Life
Children’s HRQOL was evaluated using the parent-reported, Quality of Life in
Childhood Epilepsy Questionnaire (QOLCE). Scores on the 55-item QOLCE are reported given
that it has been validated for use by parents for children/adolescents [18-20] and young adults
[21] with epilepsy. The QOLCE-55 generates an overall HRQOL score ranging from 0 to 100,
with higher scores indicative of better HRQOL. In this study, the internal consistency of the
QOLCE-55, measured using Cronbach’s alpha ranged from 0.96 to 0.97.

4.2.2.2 Demographic and Clinical Characteristics
Parents reported on their child’s age and sex, and at the 8- and 10-year follow-up were
asked about their child’s most recent seizure and if their child was ever diagnosed with cognitive
problems (developmental delay or learning disability), behavioral problems (conduct disorder,
oppositional defiant disorder, or attention deficit hyperactivity disorder), emotional problems
(anxiety or depression), or autism spectrum disorder. Pediatric neurologists reported on
epilepsy/syndrome classification, severity of epilepsy, and the presence of behavioral, cognitive,
or motor problems. Severity of epilepsy was measured using the Global Assessment of Severity
of Epilepsy (GASE), a validated single item 7-point scale shown to have moderate/strong
correlations with several key clinical aspects of epilepsy [22,23]. In this report, GASE scores
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range from 1 (“extremely severe”) to 7 (“not at all severe”). Presence of comorbidities at
baseline was determined by physician report to three questions asking, “Does the patient have
behavioural/cognitive/ motor problems”.

4.2.2.3 Parent and Family Characteristics
Parents reported on their age, sex, educational attainment, employment status, whether
they live with a partner, and household income. Parents also completed a standardized measure
of depressive symptoms and three standardized scales of family environment. Depressive
symptoms were measured using the 20-item Center for Epidemiological Studies Depression
Scale (CES-D) [24,25]. The CES-D uses a 4-point Likert scale, with scores ranging from 0 to 60
and higher scores indicative of greater depressive symptoms; internal consistency was α= 0.91.
Family demands were measured using the 71-item Family Inventory of Life Events and Changes
(FILE) [26]. The FILE uses yes/no questions to evaluate the accumulation of normal and nonnormal life events and changes in life events in the previous year. Scores range from 0 to 71,
with higher scores indicative of greater demands; internal consistency was α= 0.83. Family
functioning was measured using the 5-item Family Adaptability, Partnership, Growth, Affection
and Resolve (Family APGAR) [27]. The APGAR uses a 5-point Likert scale, with a total score
ranging from 0 to 20 and higher scores indicative of greater satisfaction with family
relationships; internal consistency was α= 0.87. Lastly, level of family resources was measured
using the Family Inventory of Resources for Management (FIRM; specifically, the family
mastery and health subscale, and the extended family social support subscale) [26]. The 24 items
in these subscales use a 4-point Likert scale with the total score ranging from 0 to 72. Higher
scores indicate a more supportive, organized family environment with few disruptions in daily
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routines and interactions, and greater extended family social support; internal consistency was α=
0.89.

4.2.3 Data Analysis
Analyses were conducted using SAS 9.4 (SAS Institute Inc. Cary, NC, USA). Mean and
standard deviation (SD) were used to describe continuous variables, and proportions and
percentages were used to describe categorical variables. To assess attrition bias, baseline
characteristics of families that completed the 10-year follow-up to were compared with those
who did not using univariable logistic regressions.
Distinct subgroups of children following a similar HRQOL trajectory over time were
identified using latent class growth models (LCGM) with the Proc Traj macro [28]. The number
of trajectory groups was guided by a priori expectations, overall model fit as assessed by the
Bayesian Information Criterion (BIC), posterior probability, odds of correct classification, and
proportion of individuals in each group [29]. Models with a different number of groups were
compared using an estimate of the log Bayes Factor, which is approximately equal to two times
the difference in the BIC values for the two models being compared; values ranging from 0 to 2
are interpreted as weak evidence for the more complex model (the model with the additional
group), values ranging from 2 to 6 are interpreted as moderate evidence, values ranging from 6 to
10 are interpreted as strong evidence, and values greater than 10 are interpreted as very strong
evidence for the more complex model [28]. Cubic trajectories were first specified for one group
then additional groups were added until the model worsened [28]. Next, non-significant cubic or
quadratic terms were removed to ensure model parsimony [31]. Results were consistent when a
different set of start values were used. A probability of belonging to each group is assigned to
each participant, and the participant is assigned to the group based on the highest probability
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value. A censored normal model and an extension for LCGM to account for non-random attrition
were used [32]. The extension for non-random attrition allows for the joint estimation of
HRQOL trajectories and probability of dropping out; therefore, attrition was also used to inform
the probability of group membership. The extension uses a logistic model of dropout probability
included for each time point, and does not assume (as typically assumed with LCGM) that the
probability of group membership and attrition are independent [32].
Once the groups were finalized, baseline child, parent, and family characteristics of the
children in each trajectory group were compared. Analysis of variance and post hoc Tukey
correction was used for continuous variables, and chi-square or Fishers’ exact test was used for
categorical data. Multinomial logistic regression was used to identify independent factors
associated with each trajectory group. Only variables significant at p < 0.20 in the bivariate
comparisons were included in a multivariable model [33]. Listwise deletion was used for missing
data, as only 6% of the sample (n=23) were missing data on the variables of interest. The GASE
and household income (each with ≥6 categories) were treated as continuous variables to obtain a
more parsimonious model (results were similar when treated as categorical variables). Given that
each comorbidity (cognitive, behavioral, and motor) was associated with the trajectory group,
and given the overlap in comorbidities and sample size, having ‘at least one comorbidity’ was
entered in the multivariable model. As a sensitivity analyses, the multivariable model was
repeated after replacing ‘have at least one comorbidity’ with each type of comorbidity (cognitive,
behavioral, and motor).
Lastly, we estimated the proportion of children with clinically significant changes in
HRQOL in the long-term. In the absence of established thresholds for clinical significance, we
utilized distribution-based methods focusing on the standard error of measurement (SEM)
[34,35]. SEM was calculated from the baseline HRQOL assessment as: SEM = (SD) x √(1 –
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[Cronbach’s alpha]). To provide a conservative estimate, SEM was used to calculate the minimal
detectable change (MDC) at alpha = 0.05 – the minimal magnitude of change required to be 95%
confident that the observed change is a true change and not measurement error; MDC was
calculated as (1.96) x (SEM) x √(2) [34,35].

4.3 Results
Families of 367 children completed HRQOL questionnaires and were included in this
study. Table 4-1 presents a summary of the child, parent, and family characteristics. On average,
children were 7.9 years of age at the time of diagnosis (standard deviation [SD]: 2.3, range: 3.8
to 12.6), and 17.9 years at the last follow-up (SD 2.6, range: 12.9 to 23.9). At the time of
diagnosis, 61% had focal seizures, 26% had a cognitive, behavioral, and/or motor comorbidity,
and the majority had “somewhat severe” (23%), or “a little severe” (35%) epilepsy, as indicated
on the GASE. A detailed description of epilepsy/syndrome classification is presented in Table 42. At the 10-year follow-up, 85% had been seizure-free for the past year, and 66% had been
seizure-free for the past 5 years. In addition, the majority (70%) had not received any epilepsyrelated care from a doctor in the past year; an implication of this fact is unavailability of
physician reports (e.g. on severity of epilepsy) at the 10-year follow-up.
Of the initial sample, 154 families participated in the sixth and final follow-up
approximately 10 years after their child’s diagnosis of epilepsy. It is important to note however,
that the trajectory analysis utilises data from the full sample of 367 and accounts for any nonrandom loss to follow-up [32]. In addition, given that we focused on evaluating children’s
characteristics at the time of their diagnosis as potential as predictors of HRQOL, data from the
full initial sample are included in these analyses. Nonetheless, we compared the baseline
characteristics of children whose families did and did not complete the 10-year follow-up; results
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are presented in Table 4-3. The HRQOL of children whose families completed the 10-year
follow-up was similar at the time of diagnosis to those whose families did not (mean difference:
1.87, SD: 14.3, p = .23). Children in those families that did not complete the 10-year follow-up
were more likely, at the time of diagnosis, to have cognitive problems, the participating parent
was less likely to be living with their partner and reported more depressive symptoms and a
poorer family environment (i.e. poorer household income, and family resources, demands and
functioning).

4.3.1 Trajectories of health-related quality of life
The mean difference between baseline and 10-year follow-up HRQOL scores was an
improvement of 6.8 points (95% CI 4.6 to 9.0; t149=6.06, p<.0001), as indicated by a pairedsamples t-test. Sample size, mean, and standard deviation of QOLCE-55 scores at each time
point are presented in Table 4-4. Latent class growth modeling suggested that the data were best
modeled as four subgroups of children with unique HRQOL trajectories (Table 4-5). Figure 4-1
presents the trajectories for each group and Figure 4-2 additionally shows the trajectory of each
participant. Tables 4-6 and 4-7 provide the details of the model fit and scores at each time point,
respectively. The first group, labeled ‘Low-stable’ was composed of 11% of the sample who had
relatively low HRQOL scores at the time of diagnosis and no significant change in scores over
the follow-up. The second group, ‘Intermediate-stable’ was composed of 18% of the sample who
had intermediate scores at the time of diagnosis that remained relatively stable over the followup. The remaining two groups, composed of 71% of the sample, showed cubic trajectories with
intermediate or high HRQOL at the time of diagnosis, initial improvements over the first two
years, and a plateau over the long-term.
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4.3.2 Factors Associated with Each Trajectory
Table 4-8 summarizes the child, parent, and family characteristics at the time of diagnosis
of participants in each trajectory group, and Table 4-2 presents a more detailed account of the
epilepsy/syndrome classification for each group. At the time of diagnosis, children with less
severe epilepsy and without comorbidities, those with parents who had higher education and
fewer depressive symptoms, and those with a better family environment (household income and
family resources, demands, and functioning) were more likely to have a better long-term
HRQOL trajectory. Given that each comorbidity (cognitive, behavioral, and motor) was
associated with the trajectory group, having ‘at least one comorbidity’ was entered in the
multivariable model, though results were similar when each comorbidity was entered
individually (see below). Overall, the multivariable model showed that greater epilepsy severity,
presence of comorbidities, and poorer satisfaction with family relationships at the time of
diagnosis were significantly associated with poorer long-term HRQOL trajectories (Table 4-9).
Greater family demands and poorer family mastery and less extended family support at the time
of diagnosis were also associated with poorer long-term HRQOL trajectories, though not
consistently.
As a sensitivity analyses, the multivariable model was repeated after replacing ‘have at
least one comorbidity’ with each type of comorbidity (cognitive, behavioral, and motor). Results
with respect to other variables in the model remained similar. With respect to the type of
comorbidity, each was significantly associated with HRQOL trajectories, with cognitive
problems showing the strongest association (Wald chi- square 38.11, p of overall effect <.0001),
followed by behavioral (Wald chi- square: 20.47, p of overall effect <.0001) and motor problems
(Wald chi-square 8.29, p of overall effect =.040). The Wald chi-square for ‘at least one
comorbidity’ in the original model was 44.93, p of overall effect <.0001.
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4.3.3 Individual Change
To estimate the proportion of children with a meaningful change in HRQOL, we
calculated the minimal detectable change for overall HRQOL to be 8.16 points on the QOLCE55. Among the 150 children with scores available both at baseline and 10-year follow-up, 43%
showed an improvement and 13% showed a deterioration. Figure 4-3 presents the proportion of
children with improved and deteriorated scores for each trajectory group. The more favorable
trajectories (groups 3 and 4) had a larger proportion of children with improved scores, relative to
the less favorable trajectories (groups 1 and 2).

4.4 Discussion
To our knowledge, this is the first study to prospectively evaluate, from the time of
diagnosis, any aspect of long-term well-being of individuals with childhood-onset epilepsy. The
results are novel in showing that changes in HRQOL observed over the first two years after
diagnosis remain stable and are sustained over the long-term. Additionally, the results show, for
the first time, that individual and family-level characteristics (epilepsy severity, child
comorbidities and family environment at diagnosis) that predicted short-term HRQOL have
longer term prognostic power and continue to predict long-term HRQOL trajectories. These
results are important in identifying early in the course of epilepsy those children and families
who are more likely to continue to experience problems in the long-term. Importantly, given that
changes in HRQOL observed in the initial two years are sustained over the long-term, the initial
period after diagnosis may be critical in determining how the children and families cope and may
also set the stage for long-term outcomes, in which case, early intervention would be essential.
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We found that one-third of children maintained a relatively poor level of HRQOL over
the long-term, with the remainder showing initial improvements over the first two years that
were sustained over the long-term. The proportion of children with poorer HRQOL trajectories
may be underestimated, as discussed below. Results were heterogenous at the individual level as
well, with 43% of children showing meaningful improvements and13% showing meaningful
deteriorations. Initial improvements following diagnosis are not surprising and may occur as
seizure control improves and the individual and family learn to cope with the daily limitations
and accept the diagnosis, with help from their support system. Of course, it would be interesting
to determine whether the level of improved and plateaued HRQOL observed at long-term
follow-up is similar to the level of HRQOL prior to the diagnosis of epilepsy, if it were feasible
in the future to design the type of study necessary to obtain this information from the phase prior
to diagnosis.
Children with more severe epilepsy, with comorbidities (cognitive, behavioral and/or
motor), and with a poorer family environment (specifically, lower satisfaction with family
relationships, poorer family mastery, and greater family demands) at the time of epilepsy
diagnosis were more likely to have poorer long-term HRQOL trajectories. These findings align
with our group’s previous report of the two-year trajectories for this patient group [6-8] and other
studies of HRQOL trajectories 24 to 28 months post-diagnosis [9-11]. Epilepsy/syndrome
classification was not associated with HRQOL trajectories, which aligns with the extant
literature showing that epilepsy characteristics are not associated with HRQOL[15-17]. Notably,
as the identified clinical factors remain largely unmodifiable, the impact of family environment
is highlighted as a potential target for future interventions. We found that AYAs who had
achieved seizure control at last follow-up were more likely to have a more favorable HRQOL
trajectory, which is consistent with studies that have cross-sectionally evaluated HRQOL of
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young adults with a history of childhood-onset epilepsy [12-14] or pediatric epilepsy surgery[3639]. These studies have also identified that psychiatric disorders – particularly internalizing
disorders – are strongly associated with HRQOL, perhaps more so than seizure control
[12,13,38]. Other research has further shown that parent and family environment may have a
greater impact on children’s HRQOL and overall well-being, relative to epilepsy-specific factors
[40,41]. Therefore, involving families in interventions and understanding the impact of epilepsy
on the family and parents is important for the well-being of children with epilepsy and their
family. Interventions targeting the family as a unit are warranted, and healthcare providers
should be aware of the interrelationships among epilepsy, family environment, and the children’s
health and well-being [42]. These recommendations echo those proposed previously when we
reported on the two-year HRQOL trajectories of this patient group [6,7]. Furthermore, the
importance of family environment and these recommendations would not be limited to children
with epilepsy, and are applicable to other chronic conditions.
Findings from the current study should be considered in the context of its limitations.
First, the identified trajectories represent an approximation of a more complex reality and not
necessarily distinct entities, as is the case with any LCGM analysis (Figure 4-2). Second, as with
any long-term prospective study, attrition was inevitable because of loss of contact; we retained
72% and 42% of our sample by the 2-year and 10-year follow-up, respectively. Other studies that
have evaluated the long-term HRQOL of childhood-onset epilepsy have similarly retained 37%
[14] and 45% [12,13] of their sample. Notably, our study has a distinct advantage over past
cross-sectional studies because we retained 100% of our sample in analyses; latent class growth
curve modelling is a likelihood-based technique that utilizes data from the full sample (missing
values are predicted based on those in the study and the characteristics of those who dropped out)
and our evaluation of predictors of HRQOL trajectories utilized data from baseline which was
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available for all participants. We also used an extension of latent class growth curve modeling
that accounts for any non-random attrition by explicitly modeling the probability of dropping out
and does not assume that the probability of group membership and attrition are independent[32].
Our study is also unique because we could identify the characteristics of participants lost to
follow-up and estimate the impact of attrition on study results. We found that children lost to
follow-up were more likely to have cognitive problems, and the participating parent was less
likely to be living with their partner, reported more depressive symptoms, and reported a poorer
family environment (i.e. poorer household income, and family resources, demands and
functioning). These differences suggest that our results may underestimate the proportion of
children with poorer HRQOL trajectories, and that results may not be generalizable to families
facing greater adversities at the time of epilepsy diagnosis. However, with respect to HRQOL,
age, sex, epilepsy/syndrome classification, epilepsy severity, and parent education employment,
and living arrangement at the time of diagnosis, AYAs who did not complete the 10-year followup were similar to those who did complete the study at the time of diagnosis.
Third, children included in our cohort were also diagnosed with epilepsy between the
ages of 4 and 12 years, and the results may not be generalizable to children diagnosed with
epilepsy in early life, which is often associated with a more severe etiology. Children with
progressive or degenerative neurological disorders were excluded from our cohort.
Fourth, an established threshold of a minimal clinically important difference was not
available for the QOLCE as a measure of HRQOL. To deal with this limitation, we calculated
minimal detectable change. A review by Norman et al. [43] has previously shown that estimates
of a threshold of important change are consistently close to approximately one half of the
standard deviation of baseline HRQOL. The identified threshold in this study is consistent with
this estimate, finding that the identified threshold was 0.57 times of the standard deviation.
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Nonetheless, it will be important for future studies to identify the minimal clinically important
difference for the QOLCE.
Lastly, we evaluated children’s and AYA’s HRQOL as measured by a validated parentreported measure (the QOLCE-55), and understand that self and parent reports may
differ[44,45]. We were unable to obtain self-reported HRQOL across the stages of
developmental from childhood to emerging adulthood given the lack of consistent and age
appropriate self-reported HRQOL measures for children with epilepsy in the age range of this
cohort [21]. Though our results are valid from the parents’ perspective, it will be important for
future studies to prospectively evaluate self-reported HRQOL trajectories over the long-term. In
contrast to parents’ reports, self-reports may be more optimistic given that parents report poorer
HRQOL for their children compared with children’s self-reports [44,45].
Overall, this study delineated the long-term trajectory of children’s HRQOL after an
epilepsy diagnosis, and identified the child, parent, and family characteristics at the time of
diagnosis that continue to have a persistent effect in the long-term. The results are novel in
showing that HRQOL improves for the majority of children in the first two years after diagnosis,
and that these improvements are sustained over the long-term. There may be a critical period
early in the course of the disorder during which interventions may be most effective. Family
environment may be an optimal target for interventions, as it was the only modifiable factor
independently associated with long-term HRQOL trajectories. These results are important in
identifying prognosis beyond seizure control, and to allow for the identification of groups at risk
of persistent problems over the long-term who may benefit from early interventions targeting
children and their family.
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Figure 4-1. Children’s health-related quality of life over the first 10 years after their diagnosis of
epilepsy. Band around each trajectory represents the 95% confidence interval.
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Figure 4-2. Trajectories for children’s health-related quality of life during the first 10 years after
the diagnosis of epilepsy.

Note: Thick solid lines and band depict predicted trajectories and 95% confidence interval of the
entire group. Light lines depict the observed trajectory for each individual.
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Figure 4-3. Proportion of children who showed improved and declined health-related quality of
life scores at the 10-year follow-up, relative to baseline.
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Table 4-1. Child, parent, and family characteristics at diagnosis (n=367) and at the 10-year
follow-up (n=154).
At Diagnosis
10-Year Follow-up
Characteristics
Mean (SD) or n (%) Mean (SD) or n (%)
Child
Sex, # female
178 (49%)
68 (44%)
Age, years
7.9 (2.3)
17.9 (2.6)
Seizure classification a, 5
Focal seizures
219 (61%)
–
Generalized seizures
143 (39%)
–
Epilepsy severity, GASE a, 4
5.4 (1.2)
–
Seizure free >1 year 5
–
127 (85%)
Seizure free >5 years 5
–
99 (66%)
Comorbidities a
Cognitive
68 (19%)
–
Behavioral
51 (14%)
–
Motor
23 (6%)
–
At least one of the above
96 (26%)
–
Ever diagnosed with:
Cognitive problems
–
60 (39%)
Behavioral problems
–
33 (21%)
Emotional problems
–
40 (26%)
Autism spectrum disorder
–
12 (8%)
At least one of the above
81 (53%)
Parent
Sex, # female
342 (93%)
143 (93%)
Age, years 1
38.1 (6.1)
48.9 (5.3)
College/university education
198 (54%)
104 (68%)
Works full or part time 3
244 (67%)
119 (78%)
Living with partner
321 (87%)
135 (88%)
3
Depressive symptoms, CES-D
14.2 (10.3)
9.3 (8.9)
Family
Annual Household Income 10
< $20,000
27 (8%)
2 (1%)
$20,000 - $39,999
50 (14%)
15 (10%)
$40,000 - $59,999
77 (22%)
13 (9%)
$60,000 - $79,999
69 (19%)
19 (13%)
$80,000 - $99,999
50 (14%)
17 (12%)
$100,000 - $149,999
33 (23%)
84 (23%)
≥ $150,000
47 (32%)
Resources, FIRM 5
50.3 (10.9)
52.6 (11.5)
Demands, FILE 4
9.4 (6.3)
8.0 (5.7)
Functioning, APGAR 1
13.9 (3.7)
15.0 (3.9)
Superscript numbers indicate the number of children with missing/unknown data at diagnosis.
a
Data reported by children’s neurologist; not available at last follow-up because the majority of
adolescents and young adults had not received any epilepsy-related care from a physician in the
12 months prior to last follow-up. All other data is reported by parents.
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Table 4-2. Seizure/syndrome classification at the time of diagnosis.
Group 2

Group 3

Group 4

Intermediate Stable

Intermediate Increasing

HighIncreasing

(n = 67)

(n = 127)

(n = 132)

8 (20%)

10 (15%)

13 (10%)

14 (11%)

97 (26%)

8 (20%)

15 (22%)

38 (30%)

36 (27%)

Focal

99 (27%)

13 (32%)

21 (31%)

35 (28%)

30 (23%)

BECRS

45 (12%)

1 (2%)

5 (7%)

18 (14%)

21 (16%)

Focal to bilateral tonic-clonic

44 (12%)

7 (17%)

10 (15%)

12 (9%)

15 (11%)

BECRS + focal to bilateral
tonic-clonic

29 (8%)

2 (5%)

5 (7%)

9 (7%)

13 (10%)

Undetermined

8 (2%)

2 (5%)

1 (1%)

2 (2%)

3 (2%)

Complete
Cohort
(n=367)

Low-Stable

Generalized

45 (12%)

Absence

Group 1
(n = 41)

BECRS: Benign epilepsy of childhood with rolandic spikes.
Note: At the two-year follow-up, neurologist reported the same epilepsy / syndrome type among 84%
of children
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Table 4-3. Baseline characteristics of participants who completed (n=154) the 10-year follow-up
compared to those who did not (n=213).
Baseline characteristics
Child
Health-related quality of life,
QOLCE
Sex, # female
Age, years
Focal seizures (ref=generalized) b
Epilepsy severity, GASE b
Comorbidities b
Cognitive
Behavioral
Motor
At least one of the above
Parent
Sex, # female
Age, years
Living with partner
Works full or part time
College/university education
Depressive symptoms, CESD

Completed 10-year
Did not complete
follow-up
10-year follow-up
Mean (SD) or n (%) Mean (SD) or n (%)

Odds Ratio
(95% CI) a

72.3 (15.4)

70.4 (13.3)

68 (44%)
7.8 (2.4)
94 (61%)
5.5 (1.2)

110 (52%)
8.0 (2.3)
125 (60%)
5.3 (1.2)

0.99 (0.98, 1.01)
1.35 (0.89, 2.05)
1.04 (0.95, 1.13)
0.93 (0.61, 1.43)
0.91 (0.77, 1.09)

15 (10%)
19 (12%)
7 (5%)
28 (18%)

53 (25%)
32 (15%)
16 (8%)
68 (32%)

3.07 (1.66, 5.69)
1.26 (0.68, 2.31)
1.71 (0.68, 4.25)
2.11 (1.28, 3.48)

144 (94%)
38.8 (5.3)
142 (92%)
105 (68%)
90 (58%)
11.9 (9.9)

198 (93%)
37.6 (6.6)
179 (84%)
139 (66%)
108 (51%)
15.8 (10.2)

0.92 (0.40, 2.10)
0.97 (0.94, 1.00)
0.45 (0.22, 0.89)
0.91 (0.59, 1.42)
0.73 (0.48, 1.11)
1.04 (1.02, 1.07)

Family
Annual Household Income
0.78 (0.68, 0.90)
< $20,000
5 (3%)
22 (11%)
$20,000 - $39,999
14 (9%)
36 (18%)
$40,000 - $59,999
35 (23%)
42 (20%)
$60,000 - $79,999
27 (18%)
42 (20%)
$80,000 - $99,999
28 (18%)
22 (11%)
≥$100,000
43 (28%)
41 (20%)
Resources, FIRM
52.9 (11.0)
48.4 (10.4)
0.96 (0.94, 0.98)
Demands, FILE
8.4 (5.9)
10.2 (6.5)
1.05 (1.01, 1.09)
Functioning, APGAR
14.8 (3.8)
13.3 (3.6)
0.89 (0.84, 0.95)
a
Odds ratio (95% confidence interval) of dropping out of the study.
b
Data presented are parent reported, except for those denoted by superscript b which are physician
reported.
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Table 4-4. Sample size, mean, and standard deviation (SD) of QOLCE-55 scores at each time
point.
Participants with baseline and
follow-up scores *
n
Mean (SD)
n
Mean (SD)
Diagnosis
350
71.2 (14.3)
150
72.3 (15.4)
6-month follow-up
315
74.3 (13.5)
150
75.1 (14.3)
1-year follow-up
287
75.4 (13.9)
150
76.5 (14.3)
2-year follow-up
265
76.8 (14.5)
150
77.2 (15.2)
8-year follow-up
178
77.4 (16.6)
150
77.0 (17.4)
10-year follow-up
154
78.6 (16.3)
150
79.1 (15.5)
* Given the inevitable attrition of long-term follow-up, we also evaluated HRQOL scores for the
sub-sample of children with HRQOL scores at baseline and the 10-year follow-up.
All Participants
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Table 4-5. Model fit indices when different numbers of groups were specified.
Number
of groups

BIC

Logged Bayes
factor a

Overall Posterior
Probability (Min, Max)

Proportion of patients
in each group

2

-6475.88

-

0.955 (0.937, 0.961)

29%, 71%

3

-6391.65

168.46

0.904 (0.870, 0.924)

16%, 35%, 49%

4

-6389.04

5.22

0.841 (0.787, 0.908)

11%, 19%, 34%, 36%

5

-6397.77

-17.46

0.827 (0.757, 0.886)

12%, 15%, 19%, 42% 12%

6

-6522.51

-249.48

0.798 (0.742, 0.921)

7%, 10%, 11%, 9%, 30%, 32%

Calculated as 2*(BIC[complex] – BIC[null]); where the more complex model is the one with the greater number of groups. Values
ranging from 0 to 2 are interpreted as weak evidence for the more complex model, values ranging from 2 to 6 are interpreted as
moderate evidence, values ranging from 6 to 10 are interpreted as strong evidence, and values greater than 10 are interpreted as
very strong evidence for the more complex model [28].
BIC: Bayesian information criterion
a
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Table 4-6. Estimates of health-related quality of life trajectory parameters.
Sample
size

%
Sample

Posterior
Probability a

OCC b

1. Low-Stable

41

11.2%

.889

64.9

2. IntermediateStable

67

18.3%

.808

17.7

3. IntermediateIncreasingPlateau

127

34.6%

.780

7.1

4. HighIncreasingPlateau

132

36.0%

.894

14.6

Group

a

Parameter

β (Standard
Error)

p-value

Intercept
Linear
Intercept
Linear
Intercept
Linear
Quadratic
Cubic
Intercept
Linear
Quadratic
Cubic

48.98 (1.10)
-0.02 (0.21)
63.16 (1.16)
0.37 (0.20)
71.46 (1.07)
6.22 (1.10)
-1.14 (0.25)
0.06 (0.02)
83.55 (0.83)
2.92 (0.93)
-0.49 (0.21)
0.03 (0.01)

<.0001
.94
<.0001
.059
<.0001
<.0001
<.0001
.0002
<.0001
.0017
.021
.045

Values greater than 0.70 are deemed acceptable and indicative of high assignment accuracy
OCC: Odds of Correct Classification, values greater than 5.0 suggest that the model has high
assignment accuracy
b
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Table 4-7. Estimated mean health-related quality of life scores (95% confidence interval) at each time
point for each trajectory group.
At Diagnosis

6 Months
Follow-up

1 Year
Follow-up

2 Years
Follow-up

8 Years
Follow-up

10 Years
Follow-up

Time a

0.00 (0.00)

0.43 (0.09)

0.97 (0.12)

1.98 (0.12)

7.61 (0.81)

10.13 (0.82)

1. Low-Stable

49.0
(46.8, 51.1)

49.0
(46.9, 51)

49.0
(47.0, 50.9)

48.9
(47.2, 50.7)

48.9
(46.3, 51.4)

48.8
(45.4, 52.2)

2. Intermediate-Stable

63.2
(60.9, 65.4)

63.3
(61.1, 65.5)

63.5
(61.4, 65.6)

63.9
(61.9, 65.9)

66.0
(63.3, 68.7)

66.9
(63.5, 70.4)

3. IntermediateIncreasing-Plateau

71.5
(69.3, 73.6)

74.0
(72.2, 75.7)

76.5
(74.7, 78.2)

79.7
(77.4, 82.0)

78.5
(75.6, 81.5)

78.3
(75.2, 81.5)

4. High-Increasing83.5
84.6
85.8
87.3
Plateau
(81.5, 85.4)
(83.1, 86.2)
(84.2, 87.3)
(85.2, 89.5)
a
Mean time (in years) since children’s epilepsy diagnosis (standard deviation)

88.6
(85.7, 91.5)

89.8
(87.0, 92.6)

Group
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Table 4-8. Baseline characteristics of children in each trajectory group.
Group 2
Group 3
Group 4
Group 1

F/χ2
(p-value)

Intermediate
-Stable

Intermediate
-Increasing

HighIncreasing

(n = 67)

(n = 127)

(n = 132)

22 (54%)
7.9 (2.5)
23 (60%)
5.0 (1.4)

23 (34%)
7.7 (2.3)
42 (63%)
5.0 (1.3)

70 (55%)
7.9 (2.3)
75 (60%)
5.6 (1.0)

63 (48%)
8.1 (2.4)
79 (61%)
5.5 (1.2)

8.1 (.044)
0.5 (.69)
0.2 (.97)
5.2 (.0017)

3 > 1,2

22 (54%)
16 (39%)
6 (15%)

25 (37%)
17 (25%)
8 (12%)

18 (14%)
13 (10%)
8 (6%)

3 (2%)
5 (4%)
1 (1%)

73.9 (<.0001)
41.7 (<.0001)
(.0004) b

1,2>3,4; 3>4
1,2>3,4; 3>4
1,2,3>4

26 (63%)

33 (49%)

30 (24%)

7 (5%)

78.1 (<.0001)

1,2>3,4; 3>4

9 (56%)
2 (13%)

22 (85%)
15 (58%)

45 (85%)
34 (65%)

69 (95%)
63 (86%)

(.0016) b
35.4 (<.0001)

3,4>1
2,3>1; 4>1,2,3

40 (98%)

64 (96%)

119 (94%)

Age, years
Living with partner

38.1 (7.5)

37.6 (5.9)

35 (85%)

56 (84%)

Works full or part time
College/university
Depressive symptoms

28 (68%)
13 (32%)
20.1
(10.7)

41 (62%)
29 (43%)
17.5
(10.8)

Baseline Characteristics
Child
Sex, # female
Age, years
Focal seizures
Epilepsy severity, GASE
Comorbidities
Cognitive
Behavioral
Motor
At least one of the
above
Seizure free >1-year c
Seizure free >5-years c
Parent
Sex, # female

Family
Annual Household
Income
< $20,000
$20,000 - $39,999
$40,000 - $59,999
$60,000 - $79,999
$80,000 - $99,999
>$100,000
Resources, FIRM

Low-Stable

(n = 41)

Contrasts a

–

119
(90%)
37.6 (6.0) 38.9 (5.8)
122
108 (85%)
(92%)
82 (65%) 93 (71%)
73 (57%) 83 (63%)

1.9 (.59)
16.1 (.0011)

3>1; 4>2,1

14.0 (9.2)

12.7 (<.0001)

1>3; 1,2,3>4

4.6 (.004)

4>1

10.8 (9.5)

(.36) b
1.31 (.27)
4.7 (.19)

8 (20%)
8 (12%)
5 (4%)
6 (5%)
3 (8%)
10 (15%) 27 (22%)
10 (8%)
14 (35%) 12 (18%) 28 (23%) 23 (18%)
6 (15%)
10 (175)
18 (15%) 35 (27%)
6 (15%)
7 (11%)
16 (13%) 21 (16%)
3 (8%)
18 (28%) 29 (24%) 34 (26%)
43.8
46.7
19.4 (<.0001)
4 > 3,2,1; 3>1
49.0 (9.8) 55.3 (9.7)
(12.3)
(10.2)
11.9 (<.0001)
1,2,3 > 4
Demands, FILE
12.9 (7.4) 10.4 (5.3) 10.1 (6.9) 7.1 (5.0)
11.7 (<.0001)
4 > 1,2; 3>1
Functioning, APGAR
11.8 (4.3) 12.8 (3.6) 14.0 (3.4) 15.1 (3.5)
Mean (Standard Deviation) or n (%) are presented.
a
Denotes significant pairwise contrasts (at p<.05), e.g. 2,3>1 indicates that Group 2 and 3 are
significantly larger (or have higher scores) than Group 1;
b
p-value of Fisher’s exact test;
c
Provided as a descriptive statistic, is based on the data from the 10-year follow-up visit and therefore
was not considered in multivariable regression; data available for 168 adolescents and young adults.
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Table 4-9. Odds of belonging to each group trajectory relative to Group 4 (High-Increasing-Plateau).
Baseline Characteristics

p-value
of overall
effect

1. Low-Stable
OR (95% CI)

2. IntermediateStable
OR (95% CI)

3. IntermediateIncreasing-Plateau
OR (95% CI)

Child
1.67 (0.66, 4.21)
0.60 (0.29, 1.22)
1.28 (0.74, 2.21)
Sex (ref=female)
.07
0.69 (0.48, 0.99)
0.80 (0.61, 1.06)
1.19 (0.94, 1.51)
Epilepsy severity, GASE
.006
<.0001
35.72 (11.35, 112.47)
13.42 (5.11, 35.21)
4.44 (1.78, 11.04)
Any comorbidity
Parent
.24
2.52 (0.53, 12.08)
0.77 (0.22, 2.64)
0.63 (0.23, 1.71)
Living with partner
.19
0.43 (0.16, 1.14)
0.58 (0.28, 1.21)
1.00 (0.56, 1.79)
College/university education
.22
1.04 (0.99, 1.09)
1.04 (1.00, 1.08)
1.01 (0.97, 1.04)
Depressive symptoms
Family
.61
0.83 (0.60, 1.15)
1.03 (0.8, 1.33)
0.97 (0.79, 1.19)
Household Income
d
.12
0.98 (0.92, 1.03)
0.97 (0.92, 1.01)
0.96 (0.92, 0.99)
Resources, FIRM
e
.08
1.10 (1.01, 1.19)
1.04 (0.97, 1.12)
1.07 (1.01, 1.13)
Demands, FILE
f
.030
0.83 (0.72, 0.96)
0.91 (0.81, 1.03)
1.00 (0.91, 1.11)
Functioning, APGAR
OR odds ratio; CI confidence interval. Bolded items highlight statistical significance.
d
Higher scores are indicative of greater of more supportive, organized family environment with few
disruptions in daily routines and interactions, and greater extended family social support
e
Higher scores are indicative of greater family demands and stress
f
Higher scores are indicative of greater satisfaction with family relationships
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Chapter 5: Systematic review of quality of life in parents of children with epilepsy 1

5.1. Introduction
Childhood-onset epilepsy extends beyond seizures, with children experiencing a wide
range of cognitive, psychiatric, and behavioral comorbidities that often go under-recognized and
untreated [1-3]. In addition, families of children with epilepsy (CWE) have been found to
experience greater stress, poorer quality of parent-child relationships, lower parenting
confidence, and more problems in family functioning, adaptation, and relationships, relative to
other families [4]. Recent systematic reviews of parents of CWE report that up to 58% score in
the clinical range for anxiety symptoms [5], and up to 50% of mothers are at risk for clinical
depression [6]. Importantly, psychosocial factors, family environment, and parental well-being
often have a greater impact on children’s health-related quality of life (QOL), depression,
anxiety, and behavioral problems than epilepsy-related factors [4-10]. This finding is echoed in
other childhood chronic conditions, where the most important factors for adaptation and wellbeing are individual and family characteristics, rather than illness characteristics [11]. However,
epilepsy-related characteristics remain important in understanding parental outcomes. The
Caregiving Process Model adapted for CWE [12,13] aids in the conceptualization of the complex
interplay between epilepsy, individual, and family characteristics, and ultimately the
manifestation of parental outcomes, namely QOL. In this model, the first domain consists of
child/clinical characteristics (e.g. illness severity, time since diagnosis, comorbidities), family
environment (e.g. financial status, education, employment), parents’ psychosocial factors (e.g.
caregiver strain, stress response to children’s illness), and the interactions between these factors.

1

A version of this chapter has been published: Puka K, Tavares PT, Anderson KK, Ferro MA, Speechley KN
(2018). A systematic review of quality of life in parents of children with epilepsy. Epilepsy & Behavior 82, 35-45.
DOI: 10.1016/j.yebeh.2018.03.008
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These factors impact the second domain, coping resources (e.g. self-efficacy, social support),
followed by management behaviors (e.g. treatment plan management, lifestyle behaviors,
interactions with healthcare providers), and ultimately lead to caregiver outcomes (e.g. QOL,
physical symptoms, psychological symptoms, functional status).
Although the majority of past studies and systematic reviews have focused on symptoms
of anxiety and depression in parents of CWE, little is known about their QOL. Health-related
QOL is a multidimensional construct encompassing the individual’s subjective perception of
their physical health, psychological well-being, social functioning, and independence [14].
Although symptoms of depression and anxiety may impact health-related QOL, instruments
developed to measure health-related QOL reflect individual perceptions of the influence of
disease and treatment on function, and are not interchangeable with instruments that measure
symptoms or impairments, such as measures of anxiety and depression [15,16]. Health-related
QOL is an important construct in understanding how parents respond, adapt, and cope with the
challenges of childhood-onset epilepsy and other stressors, as conceptualized by the Caregiving
Process Model, and may provide targets for potential interventions. To date, there have been no
reviews evaluating the QOL of parents of CWE.
The current study aimed to provide a succinct review of the literature evaluating the QOL
of parents of children with epilepsy; an area of research that has been neglected and warrants
further research. Specifically, the primary aim was to systematically review the literature to
describe QOL for parents of children with childhood-onset epilepsy. Our secondary aims were to
identify factors associated with parental QOL, and to evaluate the association between parents’
QOL and their children’s psychological well-being, namely QOL, depression and anxiety. We
hypothesized that 1) parents of children with epilepsy will have poorer QOL relative to healthy
controls, 2) that the most proximal factors to parental outcome, as outlined in the Caregiving
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Process Model, would have the largest impact on parental QOL, and 3) parents’ QOL will be
strongly correlated with their children’s psychological well-being.

5.2. Methods
5.2.1 Definition of Quality of Life
As mentioned, health-related QOL is a broad construct that encompasses many domains
of life, including physical health, psychological well-being, social functioning, and
independence. Health-related QOL is thought to be encompassed within the larger construct of
QOL, which reflects individuals’ perception of their position in life, within the context of culture
and value systems in which they live and in relation to their goals, expectations, standards, and
concerns [17]. In contrast, health-related QOL is focused on the impact of illness and treatments
on a person’s life, and does not pertain to aspects of life that cannot be influenced by healthcare
intervention, such as environmental quality and political stability [18]. The current review was
inclusive of studies evaluating health-related QOL specifically, or QOL more generally.

5.2.2 Search Strategy and Study Selection
We conducted a comprehensive search of MEDLINE (Ovid), EMBASE (Ovid), and
PsycINFO on May 5, 2017, using a combination of subject headings and keywords relating to 1)
quality of life, 2) epilepsy, and 3) parents. Specifically, we searched for (exp "Quality of Life"/
or quality of life) and (exp Epilepsy/ or epilepsy) and (exp Parents/ or parent* or mother or
maternal or father or paternal), and restricted the search to studies in humans and published in
English. There were no date restrictions. To ensure no records were omitted from the search
strategy, reference lists of all included studies were manually searched (backward citation
tracking), and Web of Science, Scopus, and Google Scholar were used to identify articles citing
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these studies (forward citation tracking). In addition, alerts were set on Google Scholar to
identify studies published after the search date using the terms: (quality of life) and (epilepsy)
and (parent* or mother or maternal or father or paternal). This alert was discontinued on
December 31, 2017.
Articles were included if they quantitatively reported on the QOL of parents (or
guardians) of individuals with childhood-onset (<18 years of age) epilepsy. Review articles,
case-studies, and conference abstracts were excluded; we contacted authors of abstracts of
unpublished studies to determine whether the studies had been published subsequently in a peerreviewed journal, though no eligible studies were identified using this method. Among the
conference abstracts excluded, no information on parents’ QOL was available to be extracted.
All identified articles were screened by two independent reviewers (KP & TPT). First, title and
abstracts were checked and studies reporting, or thought to potentially report, on the QOL of
parents of individuals with childhood-onset epilepsy were retained; inter-rater reliability was κ =
0.46. Second, the full text of each article was checked and studies meeting inclusion criteria were
retained; inter-rater reliability was κ = 0.85. Any disagreements between reviewers were
discussed among the two reviewers and resolved by consensus.

5.2.3 Quality Check
All included studies were evaluated by two independent reviewers using a modified
version of the Downs and Black Quality Index [19]. Items specific to intervention studies, such
as randomization and blinding, were removed, reducing the Quality Index to 15 items. The
modified index is presented on Table 5-1, and has been used by past systematic reviews on
similar topics [6]. The Quality Index is composed of four subscales: reporting quality, external
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validity, internal validity, and statistical power. Each checklist item was scored as 0 (no/unable
to determine) or 1 (yes), where higher scores reflect higher methodologic quality.

5.2.4 Data Extraction and Synthesis
Data relevant to describing patient and parent characteristics, parental QOL, and factors
associated with parental QOL were extracted by one reviewer (KP), and verified by a second
independent reviewer (TPT). When methodological questions arose or if more detailed data were
required, corresponding authors were contacted; of the 12 corresponding authors contacted, 7
responded, though the requested information was not always available. Although the Short-Form
health survey (SF-36 or SF-12) was employed by eight studies to evaluate parental QOL, the
available data, the heterogeneity in patient samples, and the subscales reported did not allow for
a meta-analysis. Similarly, in evaluating factors associated with parental QOL, operationalization
of the factors, analyses used, and data reported varied among studies which did not allow for a
meta-analysis. Results of univariable and multivariable analyses were reported for each study.
Results of univariable analyses were combined and presented for the factors that were examined
in at least two studies. Similar methods have been utilized by prior systematic reviews and metaanalyses evaluating risk factors [20].

5.3. Results
5.3.1 Search results
PRISMA reporting guidelines were followed [21]. The search strategy identified 709
records, of which 62 underwent full-text screening, and 11 met the inclusion criteria (Figure 51). Forward citation tracking identified one additional article, and the automated alerts of studies
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published after the search date identified three articles. Therefore, 15 articles were included in
this systematic review [22-36].
Some articles reported on different aspects of the same study, utilizing the same parent
sample. In these cases, we aimed to include as much information as possible from all articles,
while avoiding data duplication. Articles reporting on the same parent sample were: 1) Moreira
et al. [31] and Carona et al. [32], we primarily focused on the results of Moreira et al. [31], which
presented parental QOL relative to a control group; 2) Mori et al. [27] and [28], we primarily
focused on Mori et al. [27], which examined parents of CWE; 3) Reilly et al. [22] and [23], we
presented results from both studies because they were conducted at different time points; and, 4)
Soria et al. [35] and [36], we primarily focused on Soria et al. [35], which examined parents of
CWE.

5.3.2 Study and participant characteristics
The included studies were published between 2009 and 2018. The characteristics of these
studies are presented in Table 5-2. The majority were conducted in Europe [22,23,26,30,31,3335] and others in North America [24], and Asia [25]; two recruited participants from multiple
countries [27,29]. Of note, most studies recruited participants through outpatient hospital visits
(77%), and were multicentred (69%). Three studies excluded patients with intellectual disability
or other comorbidities [25,31,33], and three studies excluded patients with progressive
neurodegenerative disorders [24-26]. Two other studies focused on patients with specific
syndromes: Mori et al. [27] studied patients with CDKL5, a rare X-linked genetic disorder
associated with epilepsy and severe developmental delays; and Gallop et al. [29] studied patients
with Lennox-Gastaut Syndrome, a syndrome associated with seizures that are difficult to control
and require life-long treatment and usually, but not always, accompanied by impaired intellectual
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development. One study examined patients with moderate to severe developmental delay who
were starting the ketogenetic diet [34]. Ten studies reported cross-sectional data on parents’
QOL, and three evaluated parents’ QOL at two time points; one reported parents’ QOL at
baseline and two years after epilepsy surgery [23], one reported baseline and after one year on
the ketogenic diet [34], and another at baseline and five to seven months after a sleep monitoring
intervention [30].
Child and parental characteristics are presented in Table 5-3. Of note, the included
studies predominantly evaluated QOL in mothers, with only three studies reporting QOL in
fathers [22,23,36] (two of these studies reported on the same parent group [22,23]). In addition,
the majority of studies concentrated on children with active epilepsy, with only one reporting on
long-term outcomes with the majority of patients seizure-free [24].
Table 5-4 presents a summary of the modified Downs and Black quality assessment.
Reporting quality was good, with 9 of the 12 studies meeting 6 or 7 of 7 criteria. External and
internal validity were good, with 10 out of 12 studies meeting 2 or 3 of 3 criteria for external
validity, and 10 studies of 12 meeting 3 or 4 of the 4 criteria for internal validity. Only one study
reported a sample size calculation. Study results were synthesized through a comprehensive
narrative review and generally showed the same trend across studies. When differences in study
findings were apparent, these are discussed and appear to be a result of differences in QOL
measures and patient populations, as opposed to differences in study quality.

5.3.3 Parental QOL
Our first objective was to describe QOL in parents of children with childhood-onset
epilepsy. A summary of results from each study is presented in Table 5-5, and Table 5-6 presents
a summary of the QOL measures utilized. QOL was predominantly evaluated using the Short-
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Form health survey (SF-36 or SF-12; evaluating HRQOL) [22-27,29,30]; other measures
evaluated QOL using the WHOQOL-BREF [32], the EUROHIS-QOL-8 [31,33], a single item
QOL measure [34], and the Parental QOL Difficulties Questionnaire [35]. The SF-36 and SF-12
generates eight subscales and two composite scales relating to mental health-related QOL and
physical health-related QOL. Seven (out of eight) studies employing the SF-36 or SF-12 found
that parents of CWE had poorer mental health-related QOL relative to population norms or
control groups [22,23,25-27,29,30], and one study reported similar mental health-related QOL
[24]. This latter study was unique in evaluating long-term outcomes (10 years after diagnosis)
where the majority of children were seizure-free [24]. Six studies reported that parents of CWE
had similar or marginally better physical health-related QOL relative to controls [2224,26,27,29]; however, two studies reported poorer scores on some subscales relating to physical
health-related QOL [22,23]. The two studies utilizing the EUROHIS-QOL-8 reported a similar
overall QOL relative to controls [31,33].
Three studies compared the QOL of parents of CWE and parents of children with other
chronic conditions. Moreira et al. [31] found that the QOL of parents of CWE was better relative
to parents of children with obesity and similar to parents of children asthma, diabetes, and
cerebral palsy. Soria et al. [36] found similar QOL among parents of CWE and children with
brain tumours. Mori et al. [28] found that parents of CWE (those with CDKL5) had poor mental
health-related QOL, and better- physical health-related QOL, relative to parents of children with
Down syndrome and Rett syndrome.

5.3.4 Factors associated with parental QOL
Our second objective was to identify the factors associated with parental QOL. Few
studies reported on the factors associated with parental QOL, often with different variables of
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interest. Table 5-7 presents a summary of the factors evaluated by at least two studies and the
bivariate relationship between each factor and parental QOL. Studies consistently found that
better QOL in children [31,33], greater parental anxiety [22,25] and depressive symptoms
[22,24,25], and lower socioeconomic status were associated with poorer parental QOL
[24,25,27,33]. Although studies have predominantly focused on mothers (with few exceptions
[22,23,36]), mothers of CWE were found to have lower QOL relative to fathers in three
European studies [22,33,36], but no significant relationship was found in one Asian study [25].
Two studies found that seizure control was associated with better parental QOL [24,25], and two
studies found no significant relationship [27,33]. Parents’ education [24,25,27], and children’s
age [24,25,27,31,33], age of seizure onset [24,25], and number of antiepileptic drug [24,25] have
not been associated with parental QOL. Inconsistent results have been reported in terms of
family size, patients’ sex, and parents’ age and employment [24,25,27,33]. Table 5-5 presents a
summary of multivariable and other study findings, and highlights the association between
family environment and psychosocial factors with parents’ QOL.

5.3.5 Parental QOL and their children’s well-being
Our third objective was to evaluate the association between parents’ QOL and their
children’s psychological well-being, namely QOL, depressive symptoms, and anxiety. Only two
studies addressed this question, with bivariate analyses showing that better parental QOL was
associated with better QOL in their children [31,33]. One of the studies evaluated this
relationship in a multivariable model, finding no significant relationship when adjusting for child
internalizing and externalizing problems [31].
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5.4. Discussion
This review adds to the literature by providing a comprehensive evaluation of the QOL of
parents of CWE relative to healthy controls and parents of children with other chronic
conditions, and identifying key factors associated with parental QOL. This review also evaluated
the association between the QOL of parents and their children, and identified a number of
limitations in the literature evaluating parental QOL. Specifically, we found that parents of CWE
had poorer QOL relative to healthy controls and population norms, but similar QOL to parents of
children with other chronic conditions. Although clinical factors are a major stressor for poor
QOL, the results of this review highlight the role of family environment and psychosocial factors
in determining parents’ QOL.
Our first objective was to describe the QOL of parents of CWE, finding that their QOL
(particularly their mental health-related QOL) was poorer relative to healthy controls, and similar
to parents of children with other chronic conditions or disabilities. Not surprisingly, greater child
care needs have been associated with greater parental burden and poorer parental QOL in
epilepsy and other chronic conditions, likely associated with symptoms of burnout and restricted
social contacts and family interactions [26,37]. Consequently, children with the greatest needs
may be cared for by parents with poor mental and physical health-related QOL. Two studies
included in this review found that QOL in parents of CWE was similar to that of controls at the
group level using the EUROHIS-QOL-8 scale [31,33]. Four studies utilizing the SF-36 or SF-12
reported better physical health-related QOL [23,24,27] in parents of CWE, though this result
should be interpreted with caution. Researchers have expressed concern of artificially inflated
physical health-related QOL scores among individuals with substantially lower mental healthrelated QOL, and vise-versa [38-42]. This concern originates from the orthogonal-factor analytic
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model used to generate the mental and physical health-related QOL composite scores, which
forces these scores to be uncorrelated.
Our secondary objective was to identify the factors associated with parental QOL.
Child/clinical characteristics, family environment, and caregiver psychosocial factors were
predominantly evaluated; the impact of coping resources and management behaviors (the second
and third domain of the Caregiving Process Model) have received limited investigation. Family
environment and psychosocial factors were found to be more robust determinants of parent QOL
than child/clinical characteristics. Results were similar among the three studies that focused on
children with more severe syndromes [27,29,34]. We found that parental QOL was consistently
associated with, and often most impacted by, parental anxiety and depressive symptoms, and
poorer socioeconomic status [22,24,25,33]. Seizure control was not consistently associated with
parental QOL [24,25,27,33]. Patients’ sex, age, age at seizure onset, use of antiepileptic drugs,
and parents’ age and education, were not associated with parental QOL. Mothers had poorer
QOL relative to fathers [22,33,36], with similar results previously reported for symptoms of
anxiety, depression and stress in epilepsy and other conditions [5,43]. However, it is important to
note that this presents an area of future research, as the majority of studies on parental QOL (as
well as anxiety, depression, and stress) are primarily focused on mothers. We cannot identify
whether this result is specifically attributed to sex differences, or whether it is associated with
being a primary caregiver. Though mothers are often the primary caregiver, epilepsy affects the
entire family and the impact on fathers remains poorly understood [44-46].
The results of this systematic review, and research in other chronic conditions, highlight
the integral role of family environment and psychosocial factors, which may mitigate the impact
of the severity of childhood illness on parental psychological well-being, in line with the
Caregiving Process Model [24,32,33,37,47]. However, these studies generally utilize simple
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study designs evaluating cross-sectional results; only one study has utilized more complex
design/analysis. Carona et al. [32] found that the impact of caregiver burden on the QOL of
parents with CWE is indeed mediated by the parents’ coping strategies. Similarly, among parents
of children with other chronic conditions, the association between parental QOL and burden of
care is diminished when controlling for social support, coping skills, financial burden, and
whether the parents feel that they need more help in the household [37,48]. These results suggest
that although the severity of the epilepsy and other disease-specific factors may be a major
stressor for poorer QOL, family environment, psychosocial factors, coping resources, and
management behaviors are important intermediaries in the manifestation of parental outcomes,
and may be targeted for intervention. However, there is a need for more studies utilizing
complex study designs and evaluating mediating and moderating effects between factors.
Our third objective was to evaluate the relationship between parental QOL and their
child’s psychological well-being, namely children’s QOL, depression and anxiety symptoms.
Only the association between parent and child QOL was evaluated by the included studies,
showing significant correlations [31,33]. This aligns with past research showing that family
environment and psychosocial factors are strongly associated with children’s QOL and
psychopathology [4-10].
A limitation of the literature evaluating QOL in parents of CWE is the cross-sectional
nature of the studies. Though three studies evaluated parents at two time points [23,30,34], their
aim was to evaluate an intervention. Only one study focused on patients with new-onset epilepsy,
but aimed to evaluate the impact of a sleep monitoring intervention, without an evaluation of the
impact of child factors, family environment and psychosocial factors on parental QOL.
Consequently, a causal relationship cannot be determined for the strong correlations among
parental QOL with coping, social support, family environment, and their child’s QOL.
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Furthermore, the natural course of parental QOL throughout their child’s epilepsy management
is unknown, and presents an area for future research; work with focus groups has shown that the
needs and concerns of parents of CWE change over time [13]. In addition, almost all studies
recruited patients through outpatient hospital clinics, limiting the generalizability of results to
parents of children primarily seen by community physicians. The majority of studies relied on
population-based norms in describing the QOL of parents and only three studies directly
compared the QOL of parents of CWE and those with other chronic conditions. This presents an
area of future research and would help identify the impact of epilepsy-specific factors on parental
well-being, above and beyond the challenges and social limitations associated with rearing
children with chronic conditions. In addition, only two studies used matched healthy controls;
reliance on population norms has been found to bias estimates in other psychological constructs,
and future studies should aim to carefully control for important sociodemographic variables and
avoid relying on normative data [49]. Lastly, the objectives of the included studies varied, and
the few studies evaluating predictors of parental QOL did not consistently report univariable and
multivariable relationships.
The lack of consistent reporting by the studies included in this review prevented a metaanalysis of results and estimation of effect sizes. We were unable to provide estimates of the
proportion of parents at risk of compromised QOL. We were also unable to rule out the
possibility of publication bias. We would expect, however, that studies evaluating parental QOL
would be publishable irrespective of ‘positive’ or ‘negative’ results.
There is clear evidence that parental psychological well-being and family environment
are closely linked with children’s QOL and mental-health [4-10]. Parents of CWE report unmet
psychosocial care needs [50], with social and financial burden contributing to parents’ feelings of
being unable to manage their child’s specific needs [37]. These parents report a need for ongoing
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emotional support and education regarding the emotional and psychological impact epilepsy may
have on their child, as well as difficulty with changes in family roles, unpredictability of
seizures, and not knowing the long-term prognosis [51]. Education programs for CWE and their
parents have been shown to improve self-management and communication skills, and reduced
epilepsy-related concerns [52]. However, there is a severe lack of controlled trials of
psychological treatments for children with epilepsy and their families [53]. Some programs have
been recently developed, but await replication with larger samples in randomized controlled
trials [54]. Interventions targeting the family as a unit are warranted, and healthcare providers
should be aware of the interrelationships among epilepsy, family environment and the child’s
health and well-being. Beyond the implementation of family-centered care in the management of
patients, there is evidence that problem solving therapy and parenting programs are effective and
an important element in the management of chronic childhood illnesses for the health and wellbeing of the child and parent [11,55]. Parenting programs should focus on enhancing parent
illness management skills, positive parenting skills, and reducing family stress [11]. Key
elements of effective parenting programs include increasing positive interactions between parent
and child, developing skills in communicating about emotions, increasing consistency and
quality of parenting [11]. At a more fundamental level, acknowledgment of the impact that
epilepsy has on parents may help to alleviate feelings of isolation. Connecting families with
community support services, and instructing parents how to recognize the signs and symptoms of
poor psychological well-being and where to access assistance for these issues may also be
helpful. If parents are reminded of the importance of their own psychological well-being and can
successfully identify these symptoms, they may be empowered to seek the appropriate resources,
and improve their own well-being and that of their children.
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Overall, this systematic review highlights the compromised QOL of parents of CWE, and
the importance of psychosocial factors, which may have a larger impact on parental QOL
relative to epilepsy-related factors. The majority of studies in this review found that parents of
CWE have poorer scores across most domains of QOL, especially with regard to mental healthrelated QOL. We identified factors associated with parental QOL and highlighted a need for
further research evaluating the potential causal relationship between parental QOL and family
environment, psychosocial factors, coping strategies, management behaviors, and their child’s
QOL. Nonetheless, there is clear evidence that parental psychological well-being and family
environment are closely linked with children’s QOL and mental health. In managing chronic
childhood illness, it is important to recognize the impact on the family, and the impact the family
environment has on the health and well-being of the child.
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Figure 5-1. Flow chart of study selection.
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Table 5-1. Modified Downs & Black Quality Index

Reporting
1.
Is the hypothesis/objective of the study clearly described?
2.
Are the main outcomes to be measured clearly described in the
Introduction or Methods section?
3.
Are the characteristics of the patients included in the study clearly
described?
4.
Are the main findings of the study clearly described?
5.
Does the study provide estimates of the random variability in the data for
the main outcome?
6.
Have actual probability values [or confidence intervals] been reported for
the main outcomes except where the probability value is less than 0.001?
7.
Is the response rate clearly described?
External Validity
8.
Were the patients asked to participate in the study representative of the
entire population from which they were recruited?
9.
Were patients who were prepared to participate representative of the entire
population from which they were recruited?
10. Were the staff, places, and facilities where the patients were studied,
representative of the treatment the majority of patients receive?
Interval Validity
11. If any of the results of the study were based on “data dredging,” was this
made clear?
12. Were the statistical tests used to assess the main outcomes appropriate?
13. Were the main outcome measures used valid and reliable?
14. Was there adequate adjustment in the analyses from which the main
results were drawn
Power
15. Did the study provide a sample size or power calculation to detect
important effects where the probability value for a difference being due to
chance is less than 0.05?

Yes

No

Unclear

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1
1

0
0

0
0

1

0

0

1

0

0

Note: The original 27-item Quality Index was modified to exclude assessment of items related
specifically to intervention studies, including randomization, blinding, withdrawals and dropouts, and intervention integrity, reducing it to 15 items
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Table 5-2. Characteristics of studies reviewed.
Study

Study
location

Study
design

Reilly
2015 [22]

Sweden

CS

Reilly
2017 [23]

Sweden

PR

Canada

CS

China

CS

Greece

CS

Puka 2018
[24]
Lv
2009 [25]
Bompori
2014 [26]
Mori 2017
[27-28]

Various

CS

Gallop
2010 [29]

US, UK,
Italy

CS

Borusiak
2016 [30]

Germany

PR

Portugal

Moreira
2013[31],
Carona
2014 [32]
Mendes
2017 [33]
Bruce
2017 [34]
Soria
2012, [35]
2008 [36]

Source of
recruitment
Multicentre;
Hospitals
Multicentre;
Hospitals
Multicentre;
Community
Single centre;
Hospital
Single centre;
Hospital
International
CDKL5
Disorder
Database
Clinics,
support groups,
websites

Inclusion criteria/ patient
sample

Comparison group
for this review

Surgical candidates

Population norms

Surgical patients

Population norms

CWE w/o PNDD or major
non-neurological disorder
CWE w/o ID, PNDD,
diseases other than epilepsy
CWE w/o PNDD, NCD and
patients seen because of
seizure exacerbation

Population norms
Matched controls
Matched controls

Patients with CDKL5
mutation

Population norms

Patients with LennoxGastaut Syndrome

Population norms

Single centre;
Hospital

New-onset epilepsy;
excluded CWE w/ other
disorders

Population norms

CS

Multicentre;
Hospitals

CWE w/o comorbidities

Healthy controls

Portugal

CS

Multicentre;
Hospitals

CWE w/o ID or other nonneurological condition

Other*

UK

PR

Single centre;
Hospital

Intractable epilepsy; CWE
starting the ketogenic diet

None

France

CS

Multicentre;
Hospitals

All patients; excluded CWE
with “occasional seizures”

None

* Normative data obtained from another study of controls from various European countries [56];
CS: cross-sectional; CWE: Children with epilepsy; ID: Intellectual disability; N/A: not available;
NCD neurocutaneous disorders (eg. tuberous sclerosis); PNDD: Progressive neurodegenerative
disorder; PR: prospective; UK: United Kingdom; US: United States; w/o: without.
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Table 5-3. Summary of parent and patient characteristics.

Study
Reilly 2015
[22]

Parent factors
Mothers,
n
Age
n (%)
117 mothers
n/a
102 fathers

Reilly 2017
[23]
Puka
2018 [24]

50 mothers
44 fathers

Child factors
Age at
Duration
sz onset
of sz

Females,
n (%)

Age

n/a

< 18 years

n/a

n/a

Intractable epilepsy

n/a

27 (54%)

< 20 years

3
[0 – 14]

n/a

25 (50%) sz free
86% sz free ≥ 1 year
69% sz free ≥5years
37% newly diagnosed
28% poorly controlled
35% well controlled

Current sz status

159

159 (100%)

49.2 (5.5)
[35.6-69.4]

75 (47%)

18.1 (2.5)
[12.9 – 23.9]

7.9 (2.3)
[3.8 – 12.6]

10.2 (0.8)
[8.6–11.6]

Lv 2009 [25] 263

200 (76%)

39.5 (5.0)

96 (37%)

12.76 (4.0)

8.2 (4.4)

4.6 (3.9)

Bompori
2014 [26]

100

72 (72%)

n/a

42 (42%)

11 (2.6)
[8 - 16]

6.0 (3.6)
[0.1 - 14.5]

5.0 (3.2)
[0.5–16]

74% Sz controlled

Mori
2017 [27]

158

141 (89%)

~ Median: 38.5
[24.6–63.7]

~ 85%

~ Median: 5.2
[0.2–34.1]

< 18 years*

n/a

~64% daily sz; 17% weekly sz;
~10% monthly/year sz;
~9% no sz

Gallop
2010 [29]

40

36 (90%)

43.0
[23–69]

15 (37%)

Median: 12
[4 - 43]

2.5
[0.1 – 7.5]

n/a

n/a

Borusiak
2016 [30]

36

n/a

n/a

16 (44%)

9.0 (4.2)
[1 – 16]

9.0 (4.2)
[1 – 16]

New-onset

n/a

Moreira
2013[31]

68

60 (88%)

42.4 (7.2)

33 (48%)

12.6 (2.9)
[8 - 18]

< 18 years

5.6 (4.0)

On average sample was ‘a little
to somewhat severe’

Mendes
2017 [33]

192

163 (85%)

41.5 (5.7)
[29 – 58]

96 (50%)

11.9 (3.1)
[8-18]

7.5 (3.6)

4.4 (3.4)
[0.75 - n/a]

66% had no sz in past 9 months

Bruce 2017
[34]

12

n/a

n/a

n/a

Median: 3.5
[0.3 – 17]

n/a

n/a

n/a

Soria 2012
[35]

219

unclear

n/a

94 (43%)

10.5 (3.3)
[3 – 16]

3.3 (2.9)

n/a

62% had ≤ 1 sz every 3 months
3.3% had ≥1 sz per day

Unless otherwise noted, all ages and durations are presented as mean years (standard deviation) [range]; n: sample size; sz: seizure; n/a: not
available; *not stated explicitly; ~ denotes approximate value (data of entire cohort are presented, data from the subgroup with outcomes of
interest are not available)
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Table 5-4. Summary of the modified Downs & Black quality assessment.
Total score
(max = 15)

Reporting Quality
(max = 7)

External Validity
(max = 3)

Internal Validity
(max = 4)

Power Calculation
(max = 1)

Reilly 2015 [22]

12

6

2

4

0

Reilly 2017 [23]

14

7

3

4

0

Puka 2018 [24]

13

7

2

4

0

Lv 2009 [25]

14

7

3

4

0

Bompori 2014 [26]

12

5

3

4

0

Mori 2017 [27]

13

7

2

4

0

Gallop 2010 [29]

5

3

0

2

0

Borusiak 2016 [30]

13

7

2

3

1

Moreira 2013 [31]

12

6

2

4

0

Mendes 2017 [33]

14

7

3

4

0

Bruce 2017 [34]

7

5

0

2

0

Soria 2012 [35]

13

7

2

4

0

11.7
2.7

6.2
1.2

1.8
1.1

3.6
0.7

0.1
0.3

Study

Mean:
Standard Deviation:
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Table 5-5. Summary of study results.
Study
Reilly
2015 [22]

QOL
measure
SF-36
(Swedish norms)

Reilly
SF-36
2017 [23]* (Swedish norms)
Puka
2018 [24]
Lv 2009
[25]
Bompori
2014 [26]

SF-12v2
(US norms)

SF-36
(Chinese norms)

SF-12
(US norms)

Mori
2017 [27]

SF-12v2

Gallop
2010 [29]

SF-36v2

(US norms)

(US norms)

Scores relative to comparison group
Poorer
Similar
Better
MCS, MH, RE,
SF, VT, GHM, RPM

PF, BP,
GHF, RPF

PCS

MCS, VT, SF,
MHF, RE;

PCS, RP,
GH, BPM,
MHM, PFM

BPF, PFF

–

MCSM

PCSM

PF, RP, BP GH,
VT, SF, RE, MH

–

–

Multivariable analyses: parental anxiety, parental depression and poor
seizure control had strongest impact on parental QOL

MCS

PCS

–

MCS

–

PCS

MCS (NTS)

–

PCS
(NTS)

Parents of CWE with a mild clinical presentation and no neurodevelopmental
comorbidities had similar PCS and MCS relative to matched controls
Multivariable analyses: MCS --child’s sleep disturbances, financial hardship
and oral feeding (relative to enteral feeding) associated with poorer MCS;
PCS-- oral feeding associated with better PCS.
Qualitative data, highlighted social, physical, emotional, and financial impact
on parents’ QOL and the protective role of social support

MCS (NTS)

–

–

Borusiak
2016 [30]

(US norms)

Moreira
2013[31]

EUROHISQOL-8

–

Overall
QOL

–

Mendes
EUROHIS2017 [33]
QOL-8

–

Overall
QOL

–

Bruce
Single item
2017 [34] (scale 0-10)

–

–

–

–

–

–

SF-12

QOL

Soria 2012
Difficulties
[35]
Questionnaire

Highlight of other study findings
Parental anxiety and depression associated with MCS
MCS significantly improved for mothers and fathers post-surgery; PCS
remained similar. Fathers had greater improvements in MCS relative to
mothers. Improved PCS associated with reduced medications post-surgery.
Multivariable analyses: poorer QOL associated with poorer family
environment, and greater maternal depressive symptoms/perception of stress

Evaluated a sleep monitoring intervention, finding no significant change in
parental QOL 5-7 months after baseline
Carona et al.[32]: Mediation model: parents’ caregiving burden had a direct
and indirect (through poor coping strategies [specifically, behavioral
disengagement]) negative impact on QOL
Mediation model: family cohesion had a direct positive effect on parents’
QOL; indirect effect (through perception of stigma) was not significant
Rating of 3.3 (SD 1.3; range 2 – 5) at baseline and 6.6 (SD 1.3; range 4 – 8)
12 months after ketogenic diet
Multivariable analyses: idiopathic epilepsy associated with better parental
QOL; age, age at seizure onset, seizure frequency, number of medications,
and school type were not significant.

PCS: physical component summary scale; MCS: mental component summary scale; PF: Physical functioning; RP: role limitation-physical;
BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role limitation-emotional; MH: mental health; NTS: not tested
statistically; QOL: quality of life; M mothers only; F fathers only; * Scores at follow-up.
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Table 5-6. Quality of life measures utilized by included studies
Scale
SF-36: Short-form health
survey

36-item scale.
Generates 8 scales: Physical functioning, role limitation-physical, bodily
pain, general health, vitality, social functioning, role limitation-emotional,
and mental health.
In addition, generates 2 composite scores relating to mental and physical
health-related quality of life.

SF-12: Short-form health
survey

12-item scale.
Shortened version of the SF-36, which provides comparable composite
scores.
Generates 2 composite scores relating to mental and physical healthrelated quality of life. Although scores for the 8 scales can be calculated, it
is recommended that they are not used.

WHOQOL-BREF: World 26-item scale.
Health Organization
Quality of Life
Generates a physical, psychosocial, environmental, and social summary
Instrument-Abbreviated
score.
Version
EUROHIS-QOL-8

8-item scale.
Shortened version of the WHOQOL-BREF.
Generates an overall score, and social, psychological, physical, and
environmental subscale scores.

Parental QOL Difficulties
Questionnaire

13-item scale.
Generates a total QOL score.

Single item measure

1-item scale.
“How does living with epilepsy and seizures affect your quality of life?”
Scale of 0 to 10.
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Table 5-7. Summary of bivariate relationships between parental quality of life and factors
evaluated in at least two studies.
Reilly
[22]

Puka
[24]
+

Lv
[25]

Age of seizure onset

X

x

Patient’s age
Seizure control

X
+

X
+

Number of AMSs

x

X

Parent’s age

X

X
–

Greater parent education
Parent full-time employment

X
+

X
–

Higher income/SES

+

+

–

x
–

Patient’s sex (ref=female)

Parent’s sex (ref=female)

+

Family size / # of siblings
Parental depressive symptoms

–

Parental anxiety symptoms

–

Child’s quality of life

Mori
[27]
x
x

Moreira Mendes
[31]
[33]
x
x

x

Soria
[36]

x
x
+
x

+
x
x
+

+

+

–
+

+

+ significant positive relationship; – significant negative relationship; x no significant
relationship (p>.05)
SES: socioeconomic status; ASMs: antiseizure medications

+
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Chapter 6: Health-related quality of life in mothers of children with epilepsy: 10 years after
diagnosis 1

6.1 Introduction
For the majority of individuals with childhood-onset epilepsy, the long-term prognosis
for seizure control is generally favorable [1]. However, it is well recognized that the impact of
epilepsy extends far beyond seizures, and the majority of children with epilepsy (CWE) have
cognitive or psychiatric problems that may persist after seizure control [2,3]. Notably, such
impairments may be particularly deleterious in childhood where they may interfere with the
attainment of other cognitive, behavioral or social skills. Social outcomes in adulthood, such as
education, employment, income, and independence, may be poor and are associated with
cognitive and psychiatric comorbidities [4]. In terms of health related quality of life (HRQOL),
the trajectory and long-term outcomes show improvements with time and are also associated
with cognitive and psychiatric problems, as well as poor seizure control, continued use of
antiseizure medications (ASM) and poorer family environment [5-7].
Although past research has evaluated multiple long-term outcomes following childhoodonset epilepsy, very little is known about parental outcomes. Relative to control groups, families
of CWE fare worse on a range of factors, including the quality of the parent-child relationship,
parenting confidence, family relationships, functioning and stress, and parental psychopathology
[8]. In turn, these factors often have a greater negative influence on the child’s HRQOL and
psychopathology compared to epilepsy-related factors [8-12]. Although a number of crosssectional studies have evaluated symptoms of depression and anxiety in parents of CWE [10,11],

1

A version of this chapter has been published: Puka K, Ferro MA, Anderson KK, Speechley KN (2018). Health
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few have evaluated HRQOL. Studies evaluating parental HRQOL early in the course of the
disorder have found poor HRQOL relative to population norms or control groups [13-17],
although one study reported similar parental HRQOL [18]. Mothers in particular have been
found to have poorer HRQOL relative to fathers of CWE [15]. Although a number of studies
have evaluated the impact of childhood-onset epilepsy on parents, no studies, to our knowledge,
have evaluated long-term outcomes [10,11].
Our first objective was (a) to describe the long-term HRQOL in mothers of CWE, and (b)
to characterise the variation in observed HRQOL in relation to child, maternal, and family
factors assessed at the ten-year follow-up. Our second objective was to evaluate the baseline
child, maternal, and family factors predictive of maternal HRQOL ten years later. Mothers are
often the primary caregiver, and understanding the determinants of maternal HRQOL is essential
in identifying at-risk mothers and providing preventive interventions. Addressing the impact of
childhood epilepsy on mothers is also essential for the well-being of the child because parental
and family factors are thought to have a greater negative influence on the child’s HRQOL and
psychopathology compared to epilepsy-related factors [8-12].

6.2 Methods
6.2.1 Participants
Data come from a multicenter, prospective cohort of children with newly-diagnosed
epilepsy, the Health-Related Quality of Life in Children with Epilepsy Study (HERQULES). The
study protocol was approved by the research ethics boards at all participating sites. CWE were
prospectively followed for a mean of ten years post-diagnosis. The details of the study design
have been previously described [7]. Briefly, pediatric neurologists across Canada recruited
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consecutive CWE meeting study inclusion criteria. Eligible children were aged four to twelve
years with newly-diagnosed epilepsy (≥2 unprovoked seizures) and seen for the first time by a
pediatric neurologist. Children were not eligible if they also had a diagnosis of other progressive
or degenerative neurological disorder, or other major co-morbid non-neurological physical
disorder likely to have an impact on quality of life (e.g., asthma requiring daily medication, renal
failure). A total of 456 eligible children were identified; 373 (82%) primary care-giving parents,
346 of whom were mothers, participated by completing baseline evaluations. Data collection
occurred at the time of diagnosis and 0.5, 1, 2, 8, and 10 years later. At the 10-year follow-up,
173 parents completed questionnaires. Since so few fathers were primary caregivers, we report
baseline and 10-year follow-up data for the 159 mothers who completed the HRQOL
questionnaire at follow-up.

6.2.2 Study Measures
The primary caregiver was asked to complete a mailed questionnaire at each time-point.
Maternal HRQOL was measured using the second edition of the Short Form Health Survey (SF12v2), a 12-item self-reported measure evaluating physical and mental health components of
HRQOL over the past four weeks [19]. The psychometric properties of the SF-12v2 are wellestablished [19] and in this study, the internal consistency (as measured by Cronbach’s alpha)
was 0.90. Normative data from the United States (US) were used to calculate the T-score (mean
50, standard deviation 10) for the physical and mental health components of HRQOL. Difference
scores were calculated by subtracting participants’ scores from the US population mean of
similarly aged women. These difference scores are used for all analyses; a positive difference
score indicates that the participant rated their HRQOL as better relative to population norms.
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6.2.2.1 Child and epilepsy factors
At baseline, mothers completed a questionnaire pertaining to their child’s age and sex. At
the 10-year follow-up mothers also reported on seizure status and whether their child was ever
diagnosed with cognitive problems (developmental delay or learning disability), behavioral
problems (conduct disorder, oppositional defiant disorder, or attention deficit hyperactivity
disorder), emotional problems (anxiety or depression), or autism spectrum disorder. At the 10year follow-up CWE, now aged 12.9 – 23.9 years, reported on whether they were currently
taking ASMs. At baseline, neurologists completed a brief questionnaire providing information on
the child’s type and frequency of seizures, and comorbidities. Neurologists also completed the
Global Assessment of Severity of Epilepsy (GASE) scale [20,21], a single item, 7-point Likert
response scale providing an overall measure of the severity of epilepsy. The GASE has been
shown to detect within-patient changes in severity of epilepsy and has moderate/strong
correlations with several key clinical aspects of epilepsy [21]. Lower scores are indicative of
greater severity; scores range from 1 (extremely severe) to 7 (not at all severe).

6.2.2.2 Maternal and family factors
At baseline and follow-up, mothers also completed a questionnaire inquiring about their
age, sex, education, employment status, living arrangement, annual household income, and three
self-reported measures of family environment. Family resources were evaluated using two
subscales from the Family Inventory of Resources for Management (FIRM)[22] – specifically
the family mastery and health subscale and extended family social support subscale. The 24
items in these scales use a four-point Likert scale with higher scores reflecting a more
supportive, organized family environment with few disruptions in daily routines and interactions,
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and greater extended family social support (scores range from 0 to 72). The FIRM has
demonstrated adequate reliability and validity [22], and in this study, the internal consistency
was α=0.90 at both baseline and follow-up. Family demands were evaluated using the Family
Inventory of Life Events and Changes (FILE) scale [23]. This 71-item scale uses yes/no
questions to evaluate the accumulation of normal and non-normal life events and changes in life
events in the previous year. Scores range from 0 to 71, with higher scores reflecting greater
demands. The FILE has well-established reliability and validity [23], and in this study, the
internal consistency was α=0.81 and α=0.80 at baseline and follow-up, respectively. Lastly,
satisfaction with family relationships was evaluated using the Family Adaptability, Partnership,
Growth, Affection and Resolve (Family APGAR) scale [24]. This 5-item scale uses a five-point
Likert scale with higher scores reflective of grater satisfaction with family relationships (scores
range from 0 to 20). The APGAR has been found to be reliable and valid in clinical and research
settings [24], and in this study, the internal consistency was α=0.89 and α=0.88 at baseline and
follow-up, respectively.

6.2.2.3 Maternal psychosocial factors.
Mothers also completed the Center for Epidemiological Studies Depressive Scale (CESD)[25] at baseline and follow-up, and the Perceived Stress Scale (PSS)[26] at follow-up. The
CES-D is a 20-item self-reported measure of depressive symptoms over the past four weeks and
uses a four-point Likert scale; total scores range from 0 to 60 with higher scores indicative of
greater depressive symptoms. In this study, the internal consistency of the CES-D was α=0.91
and α=0.90 at baseline and follow-up, respectively. The PSS is a 10-item self-reported measure
of perceived stress over the past four weeks using a five-point Likert scale; total scores range
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from 0 to 40 with higher scores indicative of greater perceived stress. In this study, the internal
consistency of the PSS was α=0.91.

6.2.3 Statistical Analyses
Analyses were conducted using SAS 9.4 (SAS Institute Inc. Cary, NC, USA) and SPSS
23.0 (IBM Corporation, Armonk, NY, USA). Prior to analyses, data were screened for missing
values. Among the variables evaluated at follow-up, household income, whether the child was
seizure-free in the past 5 years, and parental depressive symptoms had 4.7%, 2.3% and 0.6%
missing data, respectively. Little’s MCAR test indicated that the data were missing completely at
random, χ2(5) =3.67, p=.60. Among the variables evaluated at the time of diagnosis, household
income, epilepsy severity, maternal depressive symptoms, and family demands had 4.4%, 3.1%,
0.6%, and 0.6% missing data, respectively. Little’s MCAR test indicated that data were missing
completely at random, χ2(11) =16.16, p=.14. Multiple imputation, using the fully conditional
specification method and five imputations, was used to account for missing data. The pooled R2
and estimates from the five imputations are reported. Study findings were the similar when
multiple imputation or complete case analyses were used.
Descriptive statistics computed for the sample included means and standard deviations
(SD) for continuous variables, and frequencies and percentages for categorical variables.
Independent samples t-tests or chi-squared analyses were used to compare the baseline
characteristics of families that did and did not participate at the ten-year follow-up. To evaluate
objective 1a (describing maternal HRQOL in the long-term), one-sample t-tests were used to
evaluate whether the mean difference score of mothers’ HRQOL relative to population norms
was statistically different from 0. Next, we aimed to cross-sectionally evaluate the child
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(including epilepsy syndrome), maternal, and family factors at follow-up (listed in Table 6-1)
associated with mothers’ HRQOL. A series of univariable simple linear regressions were used,
and factors significant at p<.20 (selected a priori [27]) were entered into a three-stage blockwise linear regression. Stage 1 included child and epilepsy variables, as constructs considered to
be the most distal to mothers’ HRQOL. Stage 2 included maternal and family variables, and
stage 3 included maternal psychosocial variables, considered to be the most proximal constructs
to mothers’ HRQOL. Since the maternal psychosocial factors may be considered closely related
to HRQOL, a block-wise regression allowed for an evaluation of the impact of family factors on
HRQOL, independent of maternal psychosocial variables. A similar set of analyses as those
utilized for objective 1b were used to evaluate our second objective, to evaluate the baseline
child, maternal, and family factors (listed in Table 6-1) predictive of mothers’ HRQOL ten years
later. The unstandardized regression coefficient (B) and the 95% confidence interval (CI) are
presented; the omission of zero from the CI indicates a statistically significant effect at p<.05.

6.3 Results
Forty-six percent of the original sample of mothers (n=159) were included in this
analysis. Children of these mothers had been diagnosed with epilepsy 10.2 years ago (SD: 0.8;
range: 8.6 to 11.6). Mothers (94% were biological parent) had a mean age of 49.2 years (SD 5.5;
range 35.6 to 69.4). At follow-up, 137 (86%) children had been seizure-free for at least one year,
and 104 (69%) had been seizure free for at least five years. Child, maternal, and family
characteristics at diagnosis and 10-year follow-up are presented in Table 6-1. We compared the
baseline characteristics of families who were lost to follow-up with families who completed the
10-year follow-up. Families lost to follow-up fared worse on a number of factors at the time of
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diagnosis; children had more comorbidities, and the mothers were younger, were less likely to
live with their partner, had more depressive symptoms, and reported a poorer family
environment (Table 6-2).
On average, scores on the physical and mental health components of mothers’ HRQOL
were 53.0 (SD 7.6; 95% CI 51.8, 54.2) and 49.5 (SD 9.3; 95%CI 48.0, 50.9), respectively.
Relative to US population norms of women of the same age, the mean scores on physical and
mental health component of mothers’ HRQOL were 4.38 (SD 7.63; 95% CI 3.18, 5.58) and 0.16
(SD 9.33; 95%CI -1.29, 1.63) points higher (t158= 7.24, p<.001 and t158=0.23, p = .82),
respectively. In our sample of mothers, 10 (6%) scored more than one standard deviation (SD)
below population means on the physical health component of HRQOL, and 25 (16%) scored
more than one SD on the mental health component of HRQOL. In comparison, in the population
from which the norms are derived, 16% score more than one SD below the mean.
Results of univariable regressions are presented in Table 6-3. Block-wise linear
regression models were used to evaluate the impact of child and epilepsy variables (Stage 1),
maternal and family variables (Stage 2), and maternal psychosocial variables (Stage 3) on
mothers’ HRQOL (Table 6-4). The final model explained 10% of the variation in scores of the
physical health component of HRQOL, and showed that better family resources was associated
with higher (better) scores (B=0.20; 95%CI 0.03, 0.36). In terms of the mental health component
of HRQOL, child and epilepsy variables (Stage 1) accounted for 8% of the variation in scores.
Introducing maternal and family variables (Stage 2) accounted for 51% of the variation and
introducing maternal psychosocial variables (Stage 3) accounted for 76% of the variation in
scores. Higher household income, better family resources, better family functioning, and fewer
family demands were all independent predictors of the mental health component of HRQOL.
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Once parental depressive symptoms and perception of stress were introduced into the model,
having a child without anxiety/depression (B=2.11; 95%CI 0.22, 3.99), better family functioning
(B=0.34; 95%CI 0.06, 0.62), fewer depressive symptoms (B=0.33; 95%CI 0.20, 0.47), and
perception of less stress (B=0.70; 95%CI 0.52, 0.88) were associated with better scores on the
mental health component of HRQOL. In the final model, perception of stress was the strongest
independent predictor of the mental health component of HRQOL.
A secondary objective of this study was to identify the baseline characteristics associated
with maternal HRQOL 10-years after diagnosis. Univariable analyses are presented in Table 6-5.
Results of the block-wise linear regression are presented in Table 6-6; only maternal depressive
symptoms at baseline (B=0.35; 95%CI 0.16, 0.51) remained significantly associated with the
mental health component of HRQOL ten years after diagnosis. Other variables were not
significantly associated with HRQOL.

6.3.1 Sensitivity Analysis
Since the majority (86%) of CWE in our sample had been seizure–free for at least one
year, we sought to investigate whether the relationships found above were similar for CWE who
had experienced seizures in the past year. Due to the small sample size(n=22), only univariate
associations were evaluated using simple linear regressions. Comparing mothers of children with
and without seizures in the past year, the physical health scores (52.65 (SD 8.81) vs. 53.02
(7.38), p=.77, respectively) and mental health scores (45.88 (10.71) vs. 50.03 (9.00), p=.058,
respectively) were similar. Overall, factors associated with HRQOL were similar in the subgroup that experienced seizures in the past year. Better family functioning (B=2.43; 95%CI 1.54,
3.32), fewer family demands (B=0.84; 95%CI 0.08, 1.61), child having been diagnosed with
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behavioral problems (B=12.92; 95%CI 3.68, 22.23), fewer maternal depressive symptoms
(B=0.86; 95%CI 0.63, 1.10), and maternal perception of less stress (B=1.15; 95%CI 0.70, 1.60)
at the 10-year follow-up were associated with higher (better) scores on the mental health
component of mother’s HRQOL. There were no significant associations with the physical health
component of mother’s HRQOL.

6.4 Discussion
Although numerous studies have evaluated the long-term outcomes of children with
epilepsy, there have been no studies, to our knowledge, evaluating the long-term impact on
parents. Evaluating parental well-being is particularly important because epilepsy is known to
negatively impact parental and family well-being, which in turn negatively impact the child’s
HRQOL and psychopathology [8-12]. The primary objective of this study was to describe the
long-term impact of childhood epilepsy on mothers. We utilized a large population-based sample
of CWE followed prospectively from diagnosis for ten years and evaluated mothers’ HRQOL.
Ten years after their child’s diagnosis of epilepsy, the physical health component of mothers’
HRQOL was significantly, though marginally, better compared to population norms of women of
a similar age, whereas the mental health component of HRQOL was similar. As well, at the
individual level, the proportion of mothers with scores lower than one standard deviation was
smaller or similar than population norms. Family environment and maternal psychopathology
were the most robust factors affecting mothers’ HRQOL; child and epilepsy factors had little
impact. These findings highlight the importance of addressing caregiver and family factors,
which appear to have a greater impact on mothers’ well-being, and consequently child wellbeing [8-12], than epilepsy factors.
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Finding that mothers’ physical and mental health component of HRQOL were the same
or better compared to population norms ten years after diagnosis is encouraging given that nearly
all studies evaluating CWE early in the course of the disorder find poorer parental HRQOL
compared to the general population [13-17]. Changes in one’s ratings of HRQOL may result
from an improved health status or from one’s adaptation to the disease [28]. Such an adaptation,
known as response shift, is common and occurs when one’s internal standards, values or
conceptualization of HRQOL change as one adapts to the new health state [28]. In the current
study, better ratings of the physical component HRQOL are likely associated with response shift
as well as improved health status since the majority of children in our study had been free of
seizures for more than five years.
Past studies have evaluated parental HRQOL early in the course of the disorder and have
found that better parental HRQOL is commonly associated with seizure severity [13,14],
duration of epilepsy [13], status epilepticus [13], the family’s economic situation [13,29,30],
family cohesion [30], perceived stigma [30], parental anxiety and depressive symptoms [13,15],
parental coping behaviours [29,31], and parental burden and stress [31]. Though various studies
have evaluated the role of child, parental or family factors, few studies have evaluated these
factors simultaneously and in a comprehensive manner. The present study is therefore unique in
evaluating HRQOL in the long-term and by evaluating multiple aspects of the family
environment and maternal psychosocial functioning. We found that better family resources
(family mastery and extended family social support) were predictive of better physical health
related quality of life. All aspects of family environment assessed were significant predictors of
the mental health component of HRQOL. When maternal psychosocial factors were added into
the model, family functioning and maternal depressive symptoms and perception of stress
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remained significant predictors. These findings are in keeping with other reports of parents’
HRQOL early in the course of the disorder [13,15,29-31]. We found that mothers’ perception of
stress, as opposed to depressive symptoms, was the strongest predictor of poor mental health
related quality of life. This may not be surprising given that perception of stress may encompass
a number of factors evaluated in our model. In CWE, parental perception of stress has been
associated with the child’s functional status, social support, family cohesion, parental depression
and coping behaviour [32]. In addition, parents of children with chronic conditions are
commonly found to have higher levels of stress relative to parents of healthy children [33,34],
and the use of more stress management strategies has been associated with better psychological
health of caregivers [33]. Coping strategies may mediate the association between increased
caregiving burden and impaired parental HRQOL [31]. These findings suggest that addressing
caregiver burden may be a target for intervention in order to promote effective adaptation
outcomes for parents and, subsequently, their children.
The second objective of this study was to evaluate the association between mothers’
HRQOL in the long-term with child, maternal and family factors at the time of epilepsy
diagnosis. We found that mothers’ depressive symptoms at baseline were associated with
mothers’ HRQOL ten years later. This finding extends previous research reporting associations
between parental depressive symptoms and HRQOL [13,15], and suggests that parental
psychopathology at the time of diagnosis has long-term consequences. A substantial number of
parents of CWE have unmet psychosocial care needs [35] and studies evaluating parents’ needs
report a desire for information regarding the effects of seizures and medications on their child’s
development, what to do when their child has a seizure, available support services, the
opportunity to talk with other parents of CWE, emotional support and improved access to
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healthcare providers [36,37]. Parents report that the most difficult aspects of parenting a child
with epilepsy include changes in family roles, unpredictability of seizures, not having a longterm prognosis, need for ongoing emotional support, and need for education regarding the
emotional and psychological impact epilepsy may have on their child [37]. In addressing these
needs and difficulties, CWE and their families may benefit from family-centered care, in which
care is planned around the entire family, with family members recognised as care recipients
[38,39]. Family-centered care is associated with improved child and parental outcomes and can
help families better manage the medical and non-medical aspects of their child’s chronic
condition, and thereby reduce commonly experienced challenges [39].
The findings of this study should be considered in light of the study’s strengths and
limitations. This is the first study, to our knowledge, to evaluate parental well-being in the longterm following a child’s diagnosis of epilepsy. Mothers’ HRQOL was measured using the shortform health survey (SF-12v2), a well-validated, reliable, and commonly utilized HRQOL
instrument; nonetheless, this measure contains only 12 items and does not provide reliable
subscale scores to evaluate other domains of HRQOL. In addition, HRQOL was only measured
at the ten-year follow-up and not at baseline. As expected with any long-term study, attrition bias
may have been introduced as a result of families being lost to follow-up. Similar trends are
observed in other studies [40]. The majority of mothers (75%) were retained in the study through
the four data collection points over the first two years of follow-up but, as one might expect
given the lengthy follow-up period, attrition was higher (54%) by the final data collection 10
years after diagnosis. Of the families lost after the initial two years, we were unable to contact
52% of them, 17% had agreed to continue participating when contacted but did not return
completed questionnaires, 8% indicated they were not interested any longer, and 7% offered
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family issues as their reason for discontinuing. Families followed over the ten-year period had a
better family environment and fewer maternal depressive symptoms at the time of diagnosis, and
had children with fewer comorbidities, relative to mothers lost to follow-up. Thus, the current
study may underestimate the proportion of mothers with poor HRQOL and limits the external
validity of results. In addition, it is important to note that, at follow-up, the majority of youth in
our study had been seizure-free for more than five years, which is representative of the course of
epilepsy [1]. Although seizure-status was not associated with mothers’ HRQOL in the current
study, it will be important to evaluate whether these findings generalize to children with
intractable epilepsy or continued seizures. It was the case in the current study, however, that
results among the patients with continued seizures were similar to those without seizures and
highlighted the impact of family environment and maternal depressive symptoms and perception
of stress. In this subgroup, mothers of children who had been diagnosed with behavioral
problems, had better mental health related quality of life. This finding may be attributable to the
small sample size (6 out of 22 patients had behavioral problems) or it may be that, as a result of
receiving a diagnosis of behaviour problems, these families have benefitted from interventions
such as prescription medications for behavioral problems and/or receipt of more support through
community services. Lastly, child comorbidities were not evaluated based on standardized
measures.
Overall, the results of this study indicate that the long-term HRQOL for mothers of CWE
is comparable to women of a similar age in the general population, and associated with family
environment and maternal psychosocial factors. Epilepsy-related factors had little impact on
mothers’ HRQOL in the long-term. The results of this study are encouraging in showing
favorable maternal HRQOL outcomes in the long-term and highlighting the important role of
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modifiable factors on maternal HRQOL. Adopting family-centered care practises and addressing
caregiver stress and burden may aid in proving vulnerable children and families with the support
required to improve and maintain child and family well-being.
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Table 6-1. Parent reported child, maternal and family characteristics of participants at the time
of diagnosis and at the 10-year follow-up.
Child variables
Sex, n female
Age, years
Aged <18 years
Epilepsy syndrome a
Focal
Generalized
Seizure severity (GASE Score) a, b
Comorbidities at baseline a, c
Cognitive problems
Behavior problems
Motor problems
At least one of the above
Ever diagnosed with
Cognitive problems
Behavioural problems
Emotional problems
Autism spectrum disorder
At least one of the above
Seizure free >1 year
Seizure free >5 years
Not taking anti-epileptic medications
Maternal and family variables
Age, years
Has college/university level education
Works full time
Lives with partner
Household annual income
<$50,000
$50,000-$99,999
$100,000-$149,999
>$150,000
Family resources (FIRM)
Family demands (FILE)
Family functioning (APGAR)
Maternal psychosocial variables
Depression Scale (CES-D)
Perceived Stress Scale
a

At diagnosis

At follow-up

mean (SD) or n (%)
75 (47%)
7.9 (2.3)
159 (100%)

mean (SD) or n (%)
75 (47%)
18.1 (2.5)
83 (52%)

94 (59%)
65 (41%)
5.5 (1.2)

–
–
–

18 (11%)
17 (11%)
6 (4%)
29 (18%)

–
–
–

–
–
–
–
–
–
–

62 (39%)
33 (21%)
39 (25%)
11 (7%)
84 (53%)
137 (86%)
107 (69%)
79 (72%)

39.0 (5.3)
96 (60%)
113 (71%)
147 (92%)

49.2 (5.4)
113 (71%)
93 (58%)
140 (88%)

36 (24%)
70 (46%)

53.2 (10.6)
8.4 (5.9)
14.5 (3.7)

22 (15%)
46 (30%)
37 (25%)
46 (30%)
52. (11.4)
8.1 (5.6)
14.8 (3.8)

11.9 (9.8)
–

9.8 (9.0)
13.0 (7.3)

46 (30%)

Physician reported; b Lower scores reflect greater severity; score of 5 corresponds to ‘somewhat severe’
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Table 6-2. Baseline child, maternal and family characteristics of participants who did and did not participate at
the ten-year follow-up.

Child variables at baseline
Sex, n female
Age of first seizure, years
Seizure severity (GASE)a
Epilepsy syndrome, n
Focal
Generalized
Physician reported:
Cognitive problems
Behavior problems
Motor problems
At least one of the above

Lost to followup
mean (SD)
or n (%)
103 (48%)
6.92 (2.5)
5.34 (1.2)

Participated at
10-yr follow-up
mean (SD)
or n (%)
75 (47%)
6.82 (2.5)
5.47 (1.2)

114 (60%)
80 (39%)

90 (59%)
64 (41%)

56 (27%)
39 (18%)
19 (9%)
73 (35%)

18 (11%)
17 (11%)
6 (4%)
29 (18%)

<.001
.04
.05
<.001

38.97 (5.4)
96 (60%)
109 (69%)
147 (92%)

.02
.02
.47
.004
<.001

Maternal and family variables at baseline
Age at baseline, years
37.55 (6.5)
College/university level education, n
103 (48%)
Works full time, n
139 (65%)
Lives with spouse, n
176 (82%)
Household annual income, n
<$50,000
85 (43%)
$50,000-$99,999
79 (40%)
≥$100,000
34 (17%)
Family resources (FIRM)
47.67 (11.0)
Family demands (FILE)
10.29 (6.9)
Family functioning (APGAR)
13.28 (3.7)

36 (24%)
70 (46%)
46 (30%)
53.24 (10.6)
8.44 (5.9)
14.75 (3.7)

p value
.85
.70
.30
.75

<.001
.006
<.001

Maternal psychosocial variables at baseline
Depression Scale (CES-D)
16.04 (10.3)
11.94 (9.8)
<.001
a
Physician reported scale, lower scores are of indicative of greater seizure severity; 5
corresponds to ‘somewhat severe’ (scores range from 1 to 7).
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Table 6-3. Univariable linear regression results evaluating the relationship between child,
maternal, and family factors at follow-up with maternal HRQOL.
Mental Health
B (95% CI)
p-value
-3.97 (-6.84, -1.10)
.007
-0.12 (-0.71, 0.46)
.68
-1.45 (-4.45, 1.55)
.34

Physical Health
B (95% CI)
p-value
-0.50 (-2.90, 1.91)
.68
-0.13 (-0.61, 0.35)
.58
0.47 (-1.98, 2.93)
.70

-2.59 (-5.57, 0.39)
1.11 (-2.5, 4.72)
-3.34 (-6.71, 0.03)
-0.81 (-6.48, 4.87)
-1.19 (-4.13, 1.74)
4.07 (-0.13, 8.27)
3.55 (0.40, 6.70)
-2.28 (-5.98, 1.41)

.09
.54
.052
.78
.42
.058
.027
.22

-0.51 (-2.97, 1.95)
0.94 (-2.01, 3.9)
1.66 (-1.11, 4.44)
-1.84 (-6.25, 2.58)
-0.36 (-2.76, 2.05)
0.52 (-2.95, 4.00)
1.64 (-0.97, 4.26)
-1.78 (-4.99, 1.43)

.68
.53
.24
.41
.77
.77
.22
.27

Maternal and family variables at follow-up
Age
-0.10 (-0.37, 0.17)
Has college/university level education
1.44 (-1.79, 4.67)
Works full time
2.99 (0.06, 5.93)
Lives with partner
-4.62 (-9.09, -0.16)
Household annual income
2.73 (1.38, 4.09)
Family resources (FIRM)
0.50 (0.39, 0.60)
Family demands (FILE)
-0.86 (-1.09, -0.64)
Family functioning (APGAR)
1.45 (1.14, 1.76)

.46
.39
.046
.042
.0001
<.0001
<.0001
<.0001

0.1 (-0.12, 0.32)
1.16 (-1.48, 3.8)
1.05 (-1.37, 3.48)
-1.6 (-5.29, 2.09)
1.14 (-0.01, 2.28)
0.19 (0.09, 0.29)
-0.28 (-0.49, -0.07)
0.25 (-0.06, 0.56)

.38
.39
.39
.39
.051
.0002
.010
.12

Maternal psychosocial variables at follow-up
Depression Scale (CES-D)
-0.80 (-0.90, -0.69)
Perceived Stress Scale
-1.05 (-1.16, -0.93)

<.0001
<.0001

-0.19 (-0.32, -0.06)
-0.19 (-0.35, -0.03)

.004
.019

Child variables at follow-up
Sex, (ref=male)
Age
Focal seizures (ref=generalized)
Ever diagnosed with
Cognitive problems
Behavioural problems
Emotional problems
Autism spectrum disorder
At least one of the above
Seizure free >1 year*
Seizure free >5 years
Not taking anti-epileptic medications

*In the multivariable model, seizure-freedom ≥ 1 year was not included because of its high
correlation with seizure-freedom ≥ 5 years.
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Table 6-4. Summary of block-wise linear regression evaluating the association between the
physical and mental health components of mothers’ HRQOL with patient and epilepsy factors
(stage 1), maternal and family factors (stage 2) and maternal psychosocial functioning (stage 3).
Unstandardized regression coefficients (B) and the 95% confidence interval (CI) are presented.
PATIENT AND FAMILY
CHARACTERISTICS AT FOLLOW-UP:
Physical health HRQOL

Stage 1
B (95% CI)

Stage 2
B (95% CI)

n/a

R2=.096, p=.004

Household annual income
Family resources (FIRM)
Family demands (FILE)
Family functioning (APGAR)
Maternal depressive symptoms
Maternal perception of stress
Mental health HRQOL
Patient’s sex (ref= male)
Seizure-free >5 years
Has cognitive problems
Has emotional problems
Mother employed
Mother lives with partner
Household annual income
Family resources (FIRM)
Family demands (FILE)
Family functioning (APGAR)
Maternal depressive symptoms
Maternal perception of stress
* highlights significant values

0.45 (-0.75, 1.66)
0.20 (0.05, 0.36) *
-0.09 (-0.34, 0.17)
-0.22 (-0.62, 0.17)

R2=.084, p=.009
-3.59 (-6.43, -0.76) *
2.34 (-1.00, 5.67)
-1.43 (-4.49, 1.63)
-1.7 (-5.22, 1.83)

R2=.505, p<.001
= .422, p<.001
-1.06 (-3.26, 1.14)
-0.45 (-2.98, 2.08)
0.89 (-1.46, 3.23)
-1.65 (-4.30, 1.01)
1.36 (-0.87, 3.59)
-1.96 (-5.60, 1.69)
1.36 (0.19, 2.54) *
0.17 (0.03, 0.32) *
-0.39 (-0.63, -0.16) *
0.80 (0.42, 1.19) *

R2change

Stage 3
B (95% CI)
R2=.103, p=.01
R2change = .008, p=.54
0.40 (-0.84, 1.64)
0.20 (0.03, 0.36) *
-0.08 (-0.35, 0.19)
-0.24 (-0.65, 0.18)
-0.11 (-0.32, 0.10)
0.11 (-0.17, 0.38)
R2=.757, p<.001
= .252, p<.001
-0.71 (-2.26, 0.85)
0.78 (-1.08, 2.64)
1.63 (-0.04, 3.29)
-2.11 (-3.99, -0.22) *
0.50 (-1.09, 2.10)
-0.07 (-2.66, 2.52)
0.27 (-0.58, 1.12)
-0.08 (-0.19, 0.03)
-0.02 (-0.19, 0.16)
0.34 (0.06, 0.62) *
-0.33 (-0.47, -0.20) *
-0.70 (-0.88, -0.52) *

R2change
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Table 6-5. Univariable linear regression results evaluating the relationship between child,
maternal, and family factors at baseline with maternal HRQOL at follow-up.
Mental Health
B (95% CI)
p-value
0.25 (-0.40, 0.89)
.45
-0.59 (-1.86, 0.68)
.36

Physical Health
B (95% CI)
p-value
0.13 (-0.37, 0.63)
.61
0.83 (-0.22, 1.89)
.12

-0.76 (-5.39, 3.87)
1.73 (-3.02, 6.48)
-4.27 (-11.94, 3.40)
-0.55 (-4.35, 3.25)

.75
.47
.27
.77

-0.17 (-3.95, 3.62)
1.84 (-2.05, 5.72)
-1.92 (-8.21, 4.36)
.44 (-2.66, 3.55)

.93
.35
.54
.78

Maternal and family variables at baseline
Age
-0.05 (-0.33, 0.22)
Has college/university level education
2.48 (-0.49, 5.46)
Works full time
2.17 (-0.97, 5.31)
Lives with partner
0.13 (-5.43, 5.68)
Household annual income
2.52 (0.49, 4.55)
Family resources (FIRM)
0.25 (0.12, 0.39)
Family demands (FILE)
-0.45 (-0.69, -0.21)
Family functioning (APGAR)
0.48 (0.10, 0.87)

.71
.10
.18
.96
.015
.0002
.0003
.015

0.15 (-0.07, 0.36)
2.71 (0.29, 5.12)
-0.54 (-3.12, 2.04)
-1.78 (-6.31, 2.75)
2.42 (0.78, 4.05)
0.1 (-0.01, 0.22)
-0.06 (-0.27, 0.14)
0.19 (-0.13, 0.52)

.18
.028
.68
.44
.004
.07
.54
.24

Maternal psychosocial variables at baseline
Depression Scale (CES-D)
-0.41 (-0.54, -0.27)

<.0001

-0.03 (-0.15, 0.09)

.65

Child variables at baseline
Age
Seizure severity (GASE Score)
Comorbidities at baseline
Cognitive problems
Behavior problems
Motor problems
At least one of the above
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Table 6-6: Summary of block-wise linear regression evaluating the relationship between the physical and
mental health component of mothers’ HRQOL with baseline patient and epilepsy factors (stage 1),

maternal and family factors (stage 2) and maternal psychosocial functioning (stage 3).
Unstandardized regression coefficients (B), and the 95% confidence interval (CI) are presented.
PATIENT AND FAMILY
CHARACTERISTICS AT BASELINE:
Physical health HRQOL
Seizure severity
Mother’s age
Mother’s education
Household annual income
Family resources (FIRM)
Mental health HRQOL
Mother’s education
Mother employed
Household annual income
Family resources (FIRM)
Family demands (FILE)
Family functioning (APGAR)
Maternal depressive symptoms
* highlights significant values

Stage 1
B (95% CI)

0.84 (-0.18, 1.87)

Stage 2
B (95% CI)
2
R =.0.084, p=.02
R2change = 0.053, p<.03
0.64 (-0.38, 1.66)
0.09 (-0.13, 0.31)
1.85 (-0.61, 4.31)
1.68 (-0.14, 3.50)
0.04 (-0.08, 0.16)

n/a

R2=.135, p=.001

R2=.017, p=.11

1.17 (-1.82, 4.16)
2.70 (-0.39, 5.80)
0.87 (-1.31, 3.06)
0.18 (-0.03, 0.38)
-0.29 (-0.58, 0.00)
-0.14 (-0.64, 0.37)

Stage 3
B (95% CI)
n/a

R2=.212, p<.001
= .082, p<.001
0.97 (-1.89, 3.84)
2.40 (-0.56, 5.36)
0.88 (-1.26, 3.02)
0.07 (-0.13, 0.27)
-0.21 (-0.49, 0.07)
-0.35 (-0.84, 0.15)
-0.34 (-0.51, -0.16) *

R2change
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Chapter 7: Prevalence and trajectories of depressive symptoms among mothers of children
with newly diagnosed epilepsy: A longitudinal 10‐year study 1

7.1 Introduction
It has become increasingly recognized that comorbidities associated with pediatric
epilepsy are apparent very early in the course of the illness, with cognitive and psychiatric
comorbidities evident before the first recognised seizure or the initiation of antiepileptic drugs[13]. Unsurprisingly, the elevated risk of comorbid disorders and poorer social outcomes last well
into adulthood, and may remain even if seizures remit or are well controlled by medications[4-6].
Beyond the impact on patients, families of children with epilepsy (CWE) fare worse on a range
of family factors relative to controls, including problems with family functioning and mental
health problems among parents[7,8]. Recent systematic reviews have shown that parents of CWE
have poorer quality of life relative to controls[9], and a significant proportion score above the
clinical cut-off for major depressive disorder (up to 50% of mothers)[10] and anxiety (up to 58%
of parents)[11]. Relative to fathers, mothers of CWE have also been found to have poorer quality
of life, and more symptoms of anxiety, depression, and stress; however, it is unclear whether
these differences are the result of sex differences or associated with being a primary
caregiver[9,11-14]. Importantly, the literature to date indicates that poor family environment and
parental mental health often have a greater impact on children’s quality of life and health
outcomes, relative to epilepsy-related factors[7,9-11,15-17]. Some studies have also found that
various aspects of family environment act as mediators or moderators in the relationship between
parents’ mental health and children’s quality of life[17]. Similarly, parents of children with

1

A version of this chapter has been published: Puka K, Ferro MA, Anderson KK, Speechley KN (2019). Prevalence
and trajectories of depressive symptoms among mothers of children with newly diagnosed epilepsy: a longitudinal
10-year study. Epilepsia 60, 358-366. DOI: 10.1111/epi.14638
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developmental disabilities and non-neurological chronic conditions, such as asthma, are also at
elevated risk for symptoms of depression and anxiety, with family and parent characteristics
identified as robust factors associated with child well-being, rather than illness
characteristics[18-20]. Therefore, understanding the impact of childhood illness on parents is
important for the well-being of both children and parents.
Although the literature evaluating the family environment and parental well-being in
families with CWE is growing, few studies have evaluated parental outcomes prospectively and
very little is known about long-term outcomes. Past research evaluating these outcomes has
come from the Health-Related Quality of Life in Children with Epilepsy Study
(HERQULES)[16], which is also unique in that it focused on family environment. Family
environment was described by household income and three standardized scales evaluating i)
family demands/stressful events, ii) satisfaction with family relationships, and iii) family mastery
and extended family social support. Mothers’ depressive symptoms were prospectively evaluated
at four time points over the first two years after their children’s epilepsy diagnosis, and findings
suggest that 30-38% of mothers scored in the at-risk range for major depressive disorder[21].
Mothers were a heterogeneous group, showing four distinct trajectories of depressive symptoms
over time, which were associated with family environment, child cognitive problems and quality
of life, and maternal age and education[21]. In addition, cross-sectional outcomes 10-years after
diagnosis were recently published, finding that the quality of life for mothers of CWE was
similar to population norms and associated with family environment and not epilepsy-related
factors[22]. Notably, there have been no studies that have prospectively followed families of
CWE over the long-term and evaluated any aspect of parental mental health or quality of life.
Using data from HERQULES, we aimed to address this knowledge gap. The objectives of this
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paper were to 1) identify the prevalence of depressive symptoms among mothers of CWE at the
time of diagnosis, and 0.5, 1, 2, 8, and 10 years later, 2) identify trajectories of mothers’
depressive symptoms, and 3) identify the baseline child, maternal, and family characteristics
associated with depressive symptom trajectories.

7.2 Methods
7.2.1 Participants
Data presented here were collected as part of the HERQULES study, a prospective cohort
of children with newly diagnosed epilepsy. Ethics approval was obtained from relevant research
ethics boards, and parents provided written consent. Details of the study design have been
described previously[16]. Briefly, pediatric neurologists across Canada recruited consecutive
patients meeting inclusion criteria: children aged 4-12 years of age with newly diagnosed
epilepsy (≥2 unprovoked seizures) and seen for the first time by a pediatric neurologist. Children
were not eligible if they also had a diagnosis of other progressive or degenerative neurological
disorder, or other major comorbid non-neurological physical disorder likely to have an impact on
quality of life (e.g., asthma requiring daily medication, renal failure).
A total of 456 eligible children were identified, and 373 (82%) participated in the study.
The parent primarily responsible for the child’s daily care and the child’s neurologist were asked
to complete questionnaires at six-time points: at the time of epilepsy diagnosis (baseline), and
0.5, 1, 2, 8, and 10 years later. Because few fathers completed the survey at multiple time points
(n=12), only surveys completed by mothers (biological, adoptive, or foster; n=356) were
included in these analyses.
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7.2.2 Measures
The primary outcome of interest was mothers’ depressive symptoms, as measured by the
Center for Epidemiological Studies Depression Scale (CES-D)[23,24]. The CES-D is a 20-item
self-reported measure that assesses mood, somatic complaints, interactions with others, and
motor functioning over the past week. The scale uses a 4-point Likert scale (0-3) with total
scores ranging from 0 to 60. Higher scores are indicative of greater depressive symptoms, and
scores of 16 or higher are indicative of being at-risk for major depressive disorder. In this study
the internal consistency of the CES-D ranged from 0.90 to 0.92 across the six time points.

6.2.2.1 Child Characteristics
Mothers reported on their child’s age and sex, and the child’s neurologist reported the
type of seizures (focal vs generalized), severity of epilepsy, and the presence of behavioral,
cognitive, or motor problems. Severity of epilepsy was measured using the Global Assessment of
Severity of Epilepsy (GASE) scale, a single item, 7-point Likert response scale[25,26]. The
GASE has been shown to detect within-patient changes in severity of epilepsy and has
moderate/strong correlations with several key clinical aspects of epilepsy[25,26]. In these
analyses, the GASE was reverse coded, such that lower scores are indicative of greater severity.
Scores on the GASE ranged from 1 to 7, corresponding to “extremely severe”, “very severe”,
“quite severe”, “moderately severe”, “somewhat severe”, “a little severe”, and “not at all severe”,
respectively.
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7.2.2.2 Parent and Family Characteristics
Mothers reported on their age, educational background, employment status, and whether
they were living with a partner. Family environment was evaluated using mothers’ report of their
household income and three standardized scales. The Family Inventory of Life Events and
Changes (FILE) was used to evaluate family demands[27]. The FILE is composed of 71 yes/no
questions evaluating the accumulation of normal and non-normal life events and changes in life
events in the previous year. Scores range from 0 to 71 with higher scores indicative of greater
demands. In this study the internal consistency of the FILE was α = 0.84. The Family
Adaptability, Partnership, Growth, Affection and Resolve (Family APGAR) scale was used to
evaluate family functioning[28]. The Family APGAR is composed of 5 items using a 5-point
Likert scale, with higher scores indicative of greater satisfaction with family relationships.
Scores range from 0 to 20, and in this study the internal consistency of the Family APGAR was α
= 0.87. Lastly, the Family Inventory of Resources for Management (FIRM; specifically, the
family mastery and health subscale, and the extended family social support subscale) was used to
evaluate family support resources[29]. The 24 items in these subscales use a 4-point Likert scale
with higher scores indicative of more supportive, organized family environment with few
disruptions in daily routines and interactions, and greater extended family social support. Scores
range from 0 to 72, and in this study the internal consistency of the FIRM was α = 0.90.

7.2.3 Statistical Analyses
All analyses were conducted using SAS 9.4 (SAS Institute Inc. Cary, NC, USA).
Descriptive statistics computed for the sample included means and standard deviations (SD) for
continuous variables, and frequencies and percentages for categorical variables. The GASE and
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household income (each with ≥6 categories) were treated as continuous variables to obtain a
more parsimonious model (results were similar when treated as categorical variables).
Univariable logistic regression models were used to compare the baseline characteristics of
families that completed the 10-year follow-up with those who did not.
Trajectories of mothers’ depressive symptoms over the 10-year period were investigated
using latent class growth modeling, using the Proc Traj macro [30]. This semi-parametric
approach identifies distinct subgroups of individuals following a similar pattern on an outcome
over time, in this case depressive symptoms. The number of trajectory groups is guided by a
priori expectations, overall model fit as assessed by the Bayesian Information Criterion (BIC),
posterior probability, odds of correct classification, and proportion of individuals in each group
[31]. Models with a different number of groups were compared using an estimate of the log
Bayes Factor, which is approximately equal to two times the difference in the BIC values for the
two models being compared; values ranging from 0 to 2 are interpreted as weak evidence for the
more complex model (the model with the additional group), values ranging from 2 to 6 are
interpreted as moderate evidence, values ranging from 6 to 10 are interpreted as strong evidence,
and values greater than 10 are interpreted as very strong evidence for the more complex model
[30]. First, cubic trajectories were specified for one group then additional groups were added
until the model worsened[30]. Once the number of groups was determined, non-significant cubic
or quadratic terms were removed to ensure model parsimony. Results were consistent when a
different set of start values was used. We used a censored normal model and an extension to
account for non-random attrition, with intermittent missing data assumed to be missing at
random [32]. The extension for non-random attrition allows for the joint estimation of depressive
symptom trajectories and probability of dropping out. The probabilities of group membership
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and attrition are not assumed to be independent and the probability of dropout was allowed to
vary as a function of the prior observation [32].
Once the groups were finalized, we compared the baseline child, maternal, and family
characteristics of the mothers in each trajectory group. Analysis of variance and post hoc Tukey
correction was used for continuous variables. Categorical data were evaluated using the chisquare or Fishers’ exact test. A multinomial logistic regression model was used to identify
factors associated with each trajectory group. Only variables significant at p<0.20 in the bivariate
comparisons were included in a multivariable model. Listwise deletion was used for missing
data, as only 6% of the sample (n=22) were missing data on the variables of interest.

7.3 Results
A total of 356 mothers were included in this study. The CES-D was completed by 344
mothers at baseline, 316 at 6 months, 282 at 1 year, 259 at 2 years, 181 at 8 years, and 159 at 10year follow-up. Mothers (94% were biological parent) completed questionnaires. Table 7-1
presents a summary of the child, maternal, and family characteristics. On average, mothers were
38.1 years of age at diagnosis (SD 6.2; range 24 to 71), and 49.1 years at the 10-year follow-up
(SD 5.4; range 36 to 69). Their children had a mean age of 7.9 years at diagnosis (SD 2.4; range
4 to 12.8) and 18.1 years at the 10-year follow-up (SD 2.5; range 13 to 24). At the time of
diagnosis, the majority of children had a ‘somewhat severe’ (23%) or ‘a little severe’ (36%)
epilepsy severity score on the GASE, and 28% of children had cognitive, behavioral, or motor
problems. At the 10-year follow-up, 71% of children had not received epilepsy care from a
physician in the prior year and therefore, we could not obtain physicians’ report of clinical
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characteristics. At the 10-year follow-up, the majority of children (68%) had been seizure-free
for at least 5 years.
At the last follow-up, data were collected from 159 mothers, out of the total of 356. We
compared the baseline characteristics of families who were lost to follow-up with families who
completed the 10-year follow-up. Families lost to follow-up fared worse on a number of factors
at the time of diagnosis: children had more comorbidities, and the mothers, who were younger,
were less likely to be living with a partner, had poorer educational attainment, reported a poorer
family environment, and had more depressive symptoms (Table 7-2). Non-random attrition was
controlled for in modeling the trajectories of depressive symptoms over time[32].

7.3.1 Prevalence of Depressive Symptoms
Mothers’ mean CES-D score was 14.5 (SD 10.5) at baseline; 11.6 (SD 9.5) at 6 months;
12.2 (SD 9.7) at 1 year; 11.9 (SD 10) at 2 years; 11.2 (SD 9.6) at 8 years; and 9.8 (SD 9.0) at 10
years. The period prevalence of being in the at-risk range for major depressive disorder, as
defined by scoring ≥ 16 [23] in at least one of the six time points evaluated, was 57% (n=204).
At baseline, 38% of mothers scored in the at-risk range for major depressive disorder, which
changed to 29% at 6 months, 32% at 1 year, 29% at 2 years, 27% at 8 years, and 24% at 10
years. Because some mothers were lost to follow-up, we also evaluated the CES-D scores of
those mothers who were followed for the entire 10-year period. We found a similar trend, where
the mean CES-D was 12.3 (SD 9.9) at baseline, 9.7 (SD 8.8) at 6 months, 11.0 (SD 9.1) at 1
year, 10.5 (SD 9.2) at 2 years, 11.0 (SD 9.7) at 8 years, and 9.8 (SD 9.0) at 10 years. At baseline,
30% of this subsample scored in the at-risk range for major depressive disorder, which changed
to 23% at 6 months, 27% at 1 year, 23% at 2 years, 25% at 8 years, and 23% at 10 years.
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7.3.2 Trajectories of Depressive Symptoms Over Time
Depressive symptoms over time were best fitted by a four-class model with linear and
quadratic terms (Table 7-3). Figure 7-1 presents the trajectory of each group. In addition, Figure
7-2 presents each mothers’ trajectory, Table 7-4 presents the estimates of the trajectory
parameters, and Table 7-5 presents the estimated CES-D score at each time point. The first group
(29% of the sample; labeled Low-Stable) identified mothers with few depressive symptoms
(CES-D scores of ~ 6) throughout the 10-year period. The second group (46%; IntermediateStable) is composed of mothers with elevated depressive symptoms relative to the Low-Stable
group, with CES-D scores below the at risk range (scores of ~12), that remained stable over the
10-year period. The third group (20%; High-Stable) is composed of mothers with depressive
symptoms in the at-risk range for major depressive disorder (CES-D scores of ~23) that
remained stable over the 10-year period. Lastly, the fourth group (5%; High-Decreasing) is
composed of mothers with high CES-D scores at baseline (score of ~38) that declined over the
10-year period (CES-D scores of ~5 at the 10-year follow-up).

7.3.3 Factors Associated with Each Trajectory
Child, maternal, and family characteristics at the time of diagnosis were compared across
the four trajectory groups and results are summarised in Table 7-6. Mothers with a more positive
family environment (income, support resources, demands, and functioning), who were older,
lived with their partner, had a college/university education, and had a child without a cognitive
comorbidity at the time their child was diagnosed were more likely to have a better trajectory of
depressive symptoms over time. Table 7-7 presents the results of the multivariable model,
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presenting the odds ratio and using the Low-Stable group as the reference category. Better family
environment (namely, greater family resources [e.g. family mastery and social support], and
better family functioning [e.g. satisfaction with family relationships]) was consistently associated
with a better trajectory of depressive symptoms over time. In addition, the Intermediate-Stable
group was more likely to have children with focal seizures (relative to generalized) and cognitive
problems. The High-Stable group was more likely to have children with cognitive problems, and
mothers were younger and less likely to have a college or university level education.
7.4 Discussion
This was the first study, to our knowledge, to prospectively evaluate any aspect of mental
health or quality of life among parents of CWE in the long-term, and determine whether the
course of parental mental health in the long-term mirrors the favorable long-term course of
seizure control. Epilepsy is known to negatively impact parental mental health and the family
system, which in turn negatively impacts children’s mental health and well-being[7,9-11,15-17].
We found that 38% of mothers scored in the at-risk range for major depressive disorder at the
time of epilepsy diagnosis, compared to 24% at the 10-year follow-up. Mothers of CWE were
not a homogenous group; four subgroups with unique trajectories of depressive symptoms over a
ten-year period were identified. Better family environment (namely, greater satisfaction with
family relationships and greater family mastery and social support) at the time of diagnosis was
consistently associated with better long-term trajectories of depressive symptoms. Children’s
cognitive problems and type of seizures, and mothers’ age and education were also associated
with the trajectory of depressive symptoms. Notably, these child and maternal factors are largely
unmodifiable, lending more support for future interventions to focus on family environment.
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We found that almost all mothers showed a stable trajectory of depressive symptoms over
time, scoring similarly at the time of diagnosis and throughout the 10-year follow-up. This is
particularly interesting given that, at final follow-up, 68% of the adolescents and young adults
(AYA) had been seizure-free for more than five years. This indicates that the course of mothers’
depressive symptoms may not be associated with the course of seizure control. Considering the
needs of parents, this finding is not unexpected. Parents report unmet psychosocial care needs
[33] and a need for more information, ongoing emotional support, school support, and dealing
with changes in family roles [34,35]. Additionally, given that the trajectories were associated
with family environment at the time of diagnosis, these findings highlight the long-lasting and
persistent effects of the family system.
Evidence-based treatments for depression, such as cognitive behavioral therapy and
pharmacotherapy, are warranted to improve depressive symptom trajectories among parents of
CWE. However, beyond the implementation of established treatments, there is an opportunity for
psychobehavioral interventions that go beyond focusing on the individual and target children,
parents, and other family members. The severity of illness and child care needs are important
contributors to the mental health of parents of children with neurodevelopmental conditions,
however a number of important intermediaries may be targeted [36,37]. For example, the use of
stress management and coping strategies are associated with better parental mental health and
have been found to mitigate the impact of caregiving burden on parents’ mental health [38-40].
Notably, targeting the whole family system would additionally contribute to improving
children’s mental health. In children, family mastery and support resources have been found to
moderate the relationship between severity of epilepsy and the child’s emotional well-being [41].
Interventions (e.g. mindfulness-based or self-management interventions) that may be delivered
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by non-clinical staff, in groups, and in a community setting may be optimal in reducing costs and
allowing for wide-spread utilization. This effort may also be supported by collaboration with
community-based epilepsy support agencies well-equipped to provide support to patients and
with their families. Although there is some evidence of improved outcomes following familybased interventions [35,42,43], there is a need for larger, randomized controlled trials.
In evaluating the results of the current study, a number of limitations should be
considered. First, as with any latent class growth model, the four identified trajectories are an
approximation of a more complex reality, and do not necessarily represent distant entities. As
indicated in Figure 7-2, depressive symptoms fluctuate over the long-term, with some mothers
scoring above the cut-off for major depressive disorder, for the first time, years after their child’s
diagnosis of epilepsy. Indeed, we found that 10% and 9% of mothers had scored above cut-offs
for risk of major depressive disorder, for the first time, at the 8 and 10-year follow-up,
respectively (data not shown). Although these incidence proportions may not be associated with
epilepsy, this finding nonetheless emphasizes the importance of discussing the possibility of the
late emergence of mental health problems for parents of CWE. This is particularly because their
child may not be under regular review by their physician and there may not be an opportunity to
raise questions about the parents’ well-being. Second, although a strength of this study was the
prospective evaluation of mothers’ depressive symptoms into the long-term, the study was
inevitably affected by attrition; at the 10-year follow-up, 45% of the sample completed
questionnaires. The majority of mothers (75%) were retained in the study over the first 2 years of
follow-up, with the majority of attrition occurring at the 8- and 10-year follow-up. Of the
families lost after the initial 2 years, we were unable to contact 52% of them, 17% had agreed to
continue participating when contacted but did not return completed questionnaires, 8% indicated
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that they were not interested any longer, and 7% offered family issues as their reason for
discontinuing. We found that families lost to follow-up fared worse on a number of factors at the
time of diagnosis, including maternal depressive symptoms. This suggests that our report may
underestimate the proportion of mothers at risk for major depressive disorder. It is important to
note, however, that the analyses we used attempted to account for this non-random attrition. We
also had not collected information on whether mothers had received any treatments for mental
health problems; it may be possible that the High-Decreasing trajectory group received treatment
(as a result of endorsing many depressive symptoms at baseline) which subsequently resulted in
remission of depressive symptoms in the long-term. Third, the measure of depressive symptoms
utilized (the CES-D), is reliable and well-validated but, unlike the revised version (CESD-R
released after the initiation of this study), does not include the additional response option that
allows for the determination of whether individuals meet Diagnostic and Statistical Manual of
Mental Disorders (DSM) criteria for major depressive disorder. Future studies should evaluate
the proportion of mothers meeting DSM criteria for major depressive disorder and the factors
contributing to the maintenance of depressive symptoms in the long-term and whether family
factors act as mediators or moderators in the relationship between epilepsy-specific factors and
the mental health outcomes of parents. Lastly, the majority of AYA in our study had been
seizure-free for more than 5 years at final follow-up, which is representative of the reported
course of epilepsy[5]. It will be important for future studies to evaluate the trajectory of mothers’
depressive symptoms in samples with continued or refractory seizures.
This study delineated the prevalence and trajectories depressive symptoms among
mothers of CWE from diagnosis over a 10-year period. Although depressive symptoms
decreased over time as a group, the trajectory analyses showed that almost all mothers showed a

141

stable trajectory over time, scoring similarly at the time of diagnosis and throughout the 10-year
follow-up. The stability in depressive symptoms over the 10-year period, despite favorable
seizure outcomes, highlights the need for targeting parental mental health, possibly through
family-focused interventions. We found that better family environment, epilepsy-specific factors,
and maternal age and education at baseline were associated with depressive symptoms
trajectories over the 10-year period. Given the strong evidence that parental and child health and
well-being are closely linked, greater recognition of the impact of epilepsy on parents and the
family is needed.
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Figure 7-1. Estimated trajectories of mothers’ depressive symptoms during the first 10 years after
their child’s diagnosis of epilepsy.
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Figure 7-2. Trajectories of mothers’ depressive symptoms during the first 10 years after having a
child diagnosed with epilepsy.

Note: Thick solid lines and band depict predicted trajectories and 95% confidence interval. Light
lines depict observed trajectory for each individual.
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Table 7-1. Parent reported child, maternal and family characteristics at diagnosis (n=356) and at
the 10-year follow-up (n=159).
Characteristics

At Diagnosis
10-Year Follow-up
Mean (SD) or n (%) Mean (SD) or n (%)

Child
Sex, n female
171 (48%)
75 (47%)
Age, years
7.9 (2.4)
18.1 (2.5)
Focal seizures a, b
212 (61%)
–
a
Epilepsy severity, GASE
5.4 (1.2)
–
Seizure free >1 year
–
133 (86%)
Seizure free >5 years
–
106 (68%)
a
Comorbidities
Cognitive
71 (20%)
–
Behavioral
55 (15%)
–
Motor
23 (6%)
–
At least one of the above
98 (28%)
–
Maternal
Age, years
38.1 (6.2)
49.1 (5.4)
Living with partner
309 (86%)
138 (87%)
Works full or part time
236 (67%)
123 (78%)
College/university education
190 (53%)
113 (72%)
Family
Annual Household Income
< $20,000
9 (8%)
2 (1%)
$20,000 - $39,999
50 (14%)
15 (10%)
$40,000 - $59,999
74 (21%)
12 (8%)
$60,000 - $79,999
63 (18%)
19 (13%)
$80,000 - $99,999
49 (14%)
19 (13%)
$100,000 - $149,999
37 (25%)
82 (24%)
≥ $150,000
46 (31%)
Resources, FIRM
50.1 (11.1)
52.0 (11.5)
Demands, FILE
9.5 (6.6)
8.1 (5.6)
Functioning, APGAR
13.9 (3.8)
14.8 (3.9)
a
Physician reported
b
Unknown/undetermined for six children; reference category is generalized seizures
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Table 7-2. Baseline characteristics of participants that did (n=159) and did not (n=197) complete the
10-year follow-up.
Baseline characteristics
Child
Sex, n female
Age, years
Focal seizures b, c
Epilepsy severity, GASE b
Comorbidities b
Cognitive
Behavioral
Motor
At least one of the above
Maternal
Age, years
Living with partner
Works full or part time
College/university education
Depressive symptoms, CESD

Completed 10-year
Did not complete
follow-up
10-year follow-up
Mean (SD) or n (%) Mean (SD) or n (%)

Odds Ratio
(95% CI) a

75 (47%)
7.95 (2.3)
93 (59%)
5.49 (1.17)

96 (49%)
7.94 (2.4)
119 (62%)
5.33 (1.2)

1.07 (0.70, 1.62)
1.00 (0.91, 1.09)
1.14 (0.74, 1.75)
0.89 (0.74, 1.07)

17 (11%)
17 (11%)
5 (3%)
29 (18%)

54 (27%)
38 (19%)
18 (9%)
69 (35%)

3.15 (1.74, 5.70) *
2.00 (1.08, 3.69) *
3.10 (1.12, 8.54) *
2.42 (1.47, 3.98) *

38.99 (5.35)
147 (92%)
108 (68%)
98 (62%)
16.2 (10.62)

37.33 (6.65)
162 (82%)
128 (66%)
92 (47%)
12.26 (9.89)

0.96 (0.92, 0.99) *
0.38 (0.19, 0.76) *
0.92 (0.59, 1.43)
0.55 (0.36, 0.83) *
1.04 (1.02, 1.06) *

Family
Annual Household Income
< $20,000
4 (3%)
25 (13%)
$20,000 - $39,999
15 (10%)
35 (18%)
$40,000 - $59,999
34 (22%)
40 (21%)
$60,000 - $79,999
28 (18%)
35 (18%)
$80,000 - $99,999
29 (18%)
20 (11%)
≥$100,000
47 (30%)
35 (18%)
Resources, FIRM
53.18 (10.7)
47.55 (11.0)
Demands, FILE
8.43 (5.9)
10.45 (7.0)
Functioning, APGAR
14.74 (3.7)
13.28 (3.7)
a
Odds ratio (95% confidence interval) of dropping out of the study
b
Physician reported
c
Unknown/undetermined for six children; reference category = generalized
* Statistically significant (p <.05)

0.73 (0.63, 0.84) *

0.95 (0.93, 0.97) *
1.05 (1.02, 1.09) *
0.90 (0.85, 0.95) *
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Table 7-3. Model fit indices when different numbers of groups were specified.
Number
of groups
2
3
4
5
6

BIC
-5805.41
-5802.7
-5787.46
-5799.57
-5812.24

Logged Bayes
factor a
5.42
30.48
-24.22
-25.34

Overall Posterior
Probability (Min, Max)
0.956 (0.934, 0.963)
0.836 (0.758, 0.914)
0.818 (0.775, 0.875)
0.808 (0.792, 0.917)
0.781 (0.743, 0.844)

Proportion of patients
in each group
69%, 31%
45%, 34%, 21%
35%, 39%, 19%, 7%
23%, 44%, 19%, 4%, 10%
16%, 47%, 15%, 14%, 4%, 3%

Calculated as 2*(BIC[complex] – BIC[null]); where the more complex model is the one with the greater number of groups. Values
ranging from 0 to 2 are interpreted as weak evidence for the more complex model, values ranging from 2 to 6 are interpreted as
moderate evidence, values ranging from 6 to 10 are interpreted as strong evidence, and values greater than 10 are interpreted as
very strong evidence for the more complex model [30].
BIC: Bayesian information criterion
a

150

Table 7-4. Estimates of the trajectory parameters.
Sample
size
104

%
Sample
29.2

Posterior
Probability a

OCC b

Parameter

β (SE)

p-value

0.86

12.6

Intercept
Linear

5.04 (0.68)
-0.09 (0.10)

<.0001
.33

IntermediateStable

163

45.8

0.78

5.1

Intercept
Linear

11.88 (0.75)
-0.08 (0.10)

<.0001
.42

High-Stable

72

20.2

0.88

28.7

Intercept
Linear

22.68 (0.72)
0.13 (0.14)

<.0001
.37

HighDecreasing

17

4.8

0.85

108.7

Group

Low-Stable

Intercept 37.63 (1.88)
<.0001
Linear
-10.23 (1.67) <.0001
Quadratic 0.73 (0.16)
<.0001
a
Values greater than 0.70 are deemed acceptable and indicative of high assignment accuracy
b
OCC: Odds of Correct Classification, values greater than 5.0 suggest that the model has high
assignment accuracy
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Table 7-5. Estimated CES-D score (95% confidence interval) over time for each trajectory group.
Group

At Diagnosis

6 Month
Follow-up

1 Year
Follow-up

2 Year
Follow-up

8 Year
Follow-up

10 Year
Follow-up

Time a

0.00 (0.00)

0.44 (0.09)

0.97 (0.12)

1.98 (0.12)

7.63 (0.79)

10.14 (0.82)

5.97
(4.36, 7.58)

5.94
(4.38, 7.50)

5.91
(4.40, 7.42)

5.83
(4.41, 7.26)

5.55
(4.10, 7.00)

5.36
(3.64, 7.09)

11.53
(9.47, 13.60)

11.33
(8.84, 13.81)

Low-Stable

Intermediate12.00
11.96
11.93
11.85
Stable
(10.14, 13.85) (10.13, 13.80) (10.12, 13.74) (10.06, 13.64)

a

High-Stable

22.68
22.73
22.79
22.92
23.44
23.78
(21.25, 24.10) (21.36, 24.10) (21.47, 24.11) (21.67, 24.17) (21.86, 25.01) (21.66, 25.89)

HighDecreasing

37.63
33.44
29.00
20.77
(33.90, 41.35) (30.55, 36.34) (26.44, 31.57) (17.16, 24.37)

Mean time (in years) since child’s epilepsy diagnosis (standard deviation)

4.05
(0.00, 10.02)

4.98
(0.00, 11.30)
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Table 7-6. Baseline characteristics of each trajectory group.

Baseline Characteristics

Group 1
Low-Stable
(n = 104)

Group 2
IntermediateStable
(n = 163)

Group 3
High-Stable
(n = 72)

Group 4
High-Decreasing
(n = 17)

F/χ2
(p-value)

48 (46%)
8 (2.3)
53 (51%)
5.4 (1.1)

73 (45%)
7.9 (2.3)
103 (65%)
5.4 (1.3)

39 (54%)
7.9 (2.6)
45 (63%)
5.3 (1.1)

11 (65%)
8.7 (2.2)
11 (65%)
5.4 (1.0)

3.81 (.28)
0.70 (.55)
5.12 (.16)
0.44 (.73)

7 (7%)
10 (10%)
4 (4%)
14 (13%)
67 (88%)
57 (75%)

39 (24%)
26 (16%)
12 (7%)
51 (31%)
53 (87%)
38 (62%)

20 (28%)
15 (21%)
7 (10%)
28 (39%)
20 (83%)
15 (63%)

5 (29%)
4 (24%)
0 (0%)
5 (29%)
2 (67%)
2 (67%)

16.71 (.0008)
5.19 (.16)
(.33) c
16.16 (.001)
(.52) c
(.32) c

2,3,4>1

39.6 (5.1)
95 (91%)
71 (68%)
73 (70%)

38.3 (6.6)
145 (89%)
112 (70%)
86 (53%)

36 (6.1)
59 (82%)
45 (63%)
26 (36%)

35.4 (5.3)
10 (59%)
8 (47%)
5 (29%)

6.23 (.0004)
15.63 (.001)
4.02 (.26)

1>3,4; 2>3
1,2>4

2 (2%)
9 (9%)
20 (19%)
21 (20%)
17 (16%)
35 (34%)
57.8 (8.0)
6.7 (5.0)
16 (2.7)

10 (6%)
23 (14%)
37 (23%)
31 (20%)
25 (16%)
33 (21%)
49.5 (9.1)
9.1 (5.8)
13.9 (3.4)

11 (16%)
16 (24%)
13 (19%)
10 (15%)
5 (7%)
13 (19%)
43 (11.0)
12.8 (7.0)
12 (3.8)

6 (38%)
2 (13%)
4 (25%)
1 (6%)
2 (13%)
1 (6%)
36.4 (14)
16.5 (9.3)
9.6 (5.2)

Contrasts a

Child
Sex, n female
Age, years
Focal seizures b
Epilepsy severity, GASE b
Comorbidities b
Cognitive
Behavioral
Motor
At least one of the above

Seizure free >1 year d
Seizure free >5 years d
Maternal
Age, years
Living with partner
Works full or part time
College/university

24.39 (<.0001)

2,3>1

1>2; 1,2 >3,4

Family
Annual Household Income
< $20,000
$20,000 - $39,999
$40,000 - $59,999
$60,000 - $79,999
$80,000 - $99,999
>$100,000
Resources, FIRM
Demands, FILE
Functioning, APGAR

10.62 (<.0001)

1>2,3,4; 2>4

48.00 (<.001)
22.02 (<.0001)
29.84 (<.0001)

1>2,3,4; 2>3,4
3,4>1,2; 2>1
1>2,3,4; 2>3,4

Mean (Standard Deviation) or n (%) are presented.
a
Denotes significant (at p<.05) pairwise contrasts, e.g. 3>1 indicates that Group 3 is significantly larger
(or has higher scores) than Group 1;
b
Physician reported;
c
Fishers’ exact test;
d
Provided as a descriptive statistic, is based on the data from the 10-year follow-up visit and therefore
was not considered in multivariable regression
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Table 7-7. Summary of multinomial regression presenting the odds ratio (OR) and 95% confidence
interval (95% CI) for belonging in each trajectory relative to the Low-Stable trajectory.
Baseline Characteristics

p-value of
overall effect

Intermediate-Stable
OR (95% CI)

High-Stable
OR (95% CI)

High-Decreasing
OR (95% CI)

Child
2.19 (1.20, 3.98) a
2.07 (0.93, 4.63)
3.07 (0.77, 12.3)
.07
Focal seizures
a
a
3.97
(1.39,
11.38)
3.99
(1.16,
13.73)
2.41
(0.34, 17.21)
.07
Cognitive problems
0.58 (0.21, 1.65)
0.55 (0.15, 1.93)
0.36 (0.05, 2.83)
.70
Behavioural problems
Maternal
0.96 (0.91, 1.01)
0.89 (0.83, 0.96) b
0.89 (0.80, 1.01)
.020
Age
a
0.59 (0.32, 1.11)
0.42 (0.18, 0.96)
0.45 (0.10, 1.99)
.21
College/university education
1.30 (0.45, 3.79)
0.92 (0.25, 3.42)
0.72 (0.12, 4.44)
.84
Living with partner
Family
0.93 (0.74, 1.16)
0.95 (0.71, 1.29)
0.75 (0.45, 1.26)
.70
Household Income
c
c
d
0.93 (0.89, 0.97)
0.88 (0.84, 0.93)
0.86 (0.79, 0.92) c
<.0001
Resources, FIRM
1.04 (0.98, 1.11)
1.07 (1.00, 1.16)
1.09 (0.98, 1.21)
.27
Demands, FILE e
c
c
f
0.87 (0.78, 0.96)
0.79 (0.69, 0.90)
0.70 (0.58, 0.85) c
.0011
Functioning, APGAR
Bolded items highlight statistical significance; a p<.05; b p<.01; c p<.001
d
Higher scores are indicative of greater of more supportive, organized family environment with few
disruptions in daily routines and interactions, and greater extended family social support
e
Higher scores are indicative of greater family demands and stress
f
Higher scores are indicative of greater satisfaction with family relationships
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Chapter 8: Summary and Discussion

8.1 Introduction
Past research has emphasized the importance and prevalence of psychological
comorbidities among children with epilepsy and their parents. In fact, the definition of epilepsy
has been updated to include cognitive, psychological, and social consequences as characteristic
features of epilepsy [1]. In the long-term, the majority of children (66-80%) achieve seizurecontrol [2,3], but there has been a lack of research evaluating psychological comorbidities over
the long-term for children and their parents. This large gap in our understanding of long-term
outcomes, and the characteristics of children and parents likely to show optimal outcomes was
evaluated in this thesis research. This chapter summarizes the findings of this thesis research and
their implications within the context of the extant literature. Strengths and limitations of this
research, as well as suggestions for future research are also discussed.

8.2 Summary of Key Findings
8.2.1 Long-term outcomes for children
Children with newly diagnosed epilepsy were prospectively followed over 10 years to
delineate health-related quality of life (HRQOL) trajectories and their determinants. A key
finding was that changes in HRQOL observed within the first two years after the diagnosis of
epilepsy remained stable over the long-term. We also found that one third of children reported a
relatively poor HRQOL at the time of diagnosis, which remained stable and poor throughout the
10-year follow-up. These findings suggest that early interventions may be essential and that how
children and their families respond and cope with the illness during the initial period after
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diagnosis may be critical and have long-term effects. Severity of epilepsy, neuropsychological
comorbidities and family functioning at the time of epilepsy diagnosis were associated with
long-term HRQOL trajectories. This finding aligns with the Stress Process Model (Figure 2-1)
which suggests that although the clinical characteristics such as severity of illness are important
determinants of long-term outcomes, their impact may be mitigated by coping and supportive
factors, namely family environment.

8.2.2 Long-term outcomes for mothers
Mothers of children with newly diagnosed epilepsy were prospectively followed over 10
years to delineate their depressive symptom trajectories and their HRQOL at the 10-year followup. A key finding was that trajectories of depressive symptoms remained stable over the longterm for the majority of mothers, with 20% scoring in the at-risk range for clinical depression
throughout the 10-year follow-up. With respect to HRQOL, the mental health component of
mother’s HRQOL was similar to that of similarly aged women in the general population.
Importantly, we found that neuropsychological comorbidities and family environment at the time
of epilepsy diagnosis were significantly associated with long-term trajectories of depressive
symptoms in mothers, and that family environment was significantly associated with mothers’
HRQOL. Similar to the results reported earlier for children’s outcomes, these findings for
mothers also align with the Stress Process Model (Figure 2-1) in that coping and supportive
factors, namely family environment, are important determinants of mothers’ depressive
symptoms and HRQOL, and may mitigate the impact of clinical characteristics such as severity
of the illness.
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8.3 Strengths
This thesis research has several strengths that represent key contributions to the extant
literature on children’s and parents’ outcomes over the long-term after an epilepsy diagnosis.
First, data came from a population-based cohort study (HERQULES) of children with newly
diagnosed epilepsy recruited across Canada. HERQULES had a strong response rate (82%) and
one of the largest samples (n=373) of studies evaluating HRQOL and mental health outcomes
among children with epilepsy and their parents. The results of this thesis research can therefore
be considered highly generalizable.
Second, the study utilized a prospective design and evaluated outcomes at multiple time
points, allowing for the evaluation of long-term trajectories of children’s HRQOL and mothers’
depressive symptoms. Additionally, the focus on incident cases of epilepsy also allowed for the
identification of characteristics, available early in the course of the disorder, that are associated
with long-term outcomes. This is essential in delineating the long-term prognosis beyond seizure
control and allowing for the early identification of children and parents who are at risk for poor
long-term outcomes. The results of this thesis research are the first to prospectively evaluate any
aspect of mental health over the long-term for children with epilepsy and their parents and
identify baseline factors associated with long-term outcomes.
Third, HERQULES provided a robust and rich data source that evaluated multiple
clinical and family characteristics. Importantly, clinical characteristics were reported by the
child’s treating neurologists, and parents completed multiple measures of parent characteristics
and family environment. HERQULES was among the first studies to focus on characteristics
beyond seizure control, and allowed for the identification of modifiable factors, namely family
environment, that could represent targets of early interventions.
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8.4 Limitations
The results of this thesis research should be considered within the context of its
limitations. First, although this research is the first to prospectively evaluate long-term mental
health outcomes for children with new-onset epilepsy and their parents, attrition was inevitable
and primarily occurred because of loss of contact. We retained approximately 72% and 42% of
our sample to the 2- and 10-year follow-up, respectively. As mentioned in earlier chapters,
however, this research has a distinct advantage since it was possible to include all participants in
our prospective analyses of HRQOL and depressive symptoms because latent class growth curve
models utilize a likelihood-based technique to predict missing values. In addition, these models
explicitly modeled the probability of dropping out to account for non-random attrition.
Additionally, we focused on baseline predictors of trajectories that were available for all
participants. Nonetheless, given the characteristics of families lost to follow-up, our results may
have underestimated the proportion of children with poorer HRQOL trajectories and the
proportion of mothers with greater depressive symptoms.
Second, this research was focused on children aged 4-12 years at the time of epilepsy
diagnosis, and our results may be not generalizable to children with an earlier age of onset who
tend to have more catastrophic types of epilepsy. One reason for choosing the lower age limit
was because of the lack of standardized parent-reported HRQOL measures for children younger
than four years of age. The inclusion of young children also prevented self-reported HRQOL
assessments by children using a mailed survey; parents of young children would most likely have
aided their children with questionnaire completion at home and thereby potentially biased their
children’s report of their HRQOL. Additionally, children younger than eight years of age are
thought to lack the cognitive maturity and verbal comprehension skills required to provide
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reliable self-reports [4]. Notably, although child self-reports and parent proxy-reports of HRQOL
are not considered interchangeable given their unique perspectives and values, parents provide
reliable and consistent reports of their children’s HRQOL [4,5].
Third, this research was focused on mothers’ HRQOL and depressive symptoms and the
results are not generalizable to fathers. The primary caregiving parent was asked to complete the
questionnaires, with 356 mothers and only 12 fathers completing the survey at multiple times.
Given the small sample size of fathers, we focused on mothers to reduce heterogeneity.
Additionally, since mothers are most often the primary caregiver of children [6], it is reasonable
to assume that mothers may be particularly at risk for distress in response to their children’s
epilepsy. Lastly, we also did not have data on parents’ (and children’s) mental health care
utilization, which may be associated with trajectories of long-term depressive symptoms. This
remains an important area for future investigation.

8.5 Future research and potential implications
As noted above, one limitation of this thesis research was the focus on parents’
perceptions of their children’s outcomes, primarily as a consequence of the young age of the
children and given the data collection strategy of mailed questionnaires. In addressing this
limitation, AYA followed in the long-term were asked to complete a self-reported survey at the
8- and 10-year follow-up. The adult (QOLIE-31-P) and adolescent (QOLIE-AD-48) version of a
widely utilized epilepsy-specific HRQOL instrument were completed by young adults (aged 18
years or older) and adolescents (aged 11 to 17 years), respectively. A natural next step for future
research will be to evaluate AYA’s perceptions of their HRQOL in the long-term and compare
their reports with that of their parents’ proxy-reports. AYA and parents both provide valid,
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reliable assessments of AYA’s HRQOL, however given their unique perspectives and values
their reports are not considered interchangeable [4]. Therefore, it will be important to evaluate
long-term HRQOL outcomes as reported by AYA.
The current research was focused on evaluating long-term outcomes and trajectories of
children’s and parents’ HRQOL and mental health. Expanding on these results, a second line of
future research should aim to evaluate the moderating and mediating effects of coping and
support factors such as family environment, as described in the conceptual framework (Figure 21). The HERQULES study is uniquely suited to address this research given that multiple patient,
clinical, parent and family characteristics were evaluated at multiple time points over the 10-year
follow-up allowing for temporal separation of effects. Indeed, previous work using HERQULES
has shown that family stress and satisfaction with family relationships mediate – while family
mastery and extended family social support moderate – the negative impact of epilepsy severity
and parental psychopathology on children’s HRQOL and emotional well-being [7,8]. Expanding
this research to include long-term HRQOL and mental health outcomes, will enhance our
understanding of the complex interplay between these factors and identify whether family
environment has a long-term mediating and moderating effects. Similarly, future research may
also evaluate families’ responses over time to stress and the epilepsy diagnosis. For example,
HERQULES data could be used to calculate changes in scores from diagnosis to the six-month
follow-up and the association of any changes observed with the long-term outcomes evaluated
here.
Lastly, a third line of future research will be focused on applying the results of this study
to inform behavioral interventions. We found that a similar set of clinical, patient, parent, and
family characteristics at the time of epilepsy diagnosis were associated with better HRQOL and
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mental health outcomes over the long-term for children and their mothers. Specifically, the
severity of epilepsy and neuropsychological comorbidities, as well as the family environment at
the time of diagnosis were associated with better mental health outcomes. Given that epilepsy
severity and its comorbidities are already a focus of clinical care and taken together with the fact
that family environment may be modifiable, interventions targeting the family early in the course
of the disorder may be effective in improving children’s and parents’ long-term HRQOL and
mental health. Our group has begun implementing these findings by piloting a randomized
controlled trial of a mindfulness-based intervention targeting the family unit [9]. The
intervention, Making Mindfulness Matter (M3), was modelled after the school-based MindUP
program used by over 6 million children in over 12 countries [10-12], and was augmented for
provision online and to integrate a parent component. M3 is a concurrent parent and child
program delivered over an eight-week period with one 1.5-hour session per week for parents and
1-hour session per week for children. The program is standardised, with parents and children
learning the same core principles: how our brains work, stress and the brain, mindful breathing,
mindful sensing, mindful movement, perspective taking, optimism, and gratitude/acts of
kindness. Within the parent group, the emphasis is on applying the principles and skills directly
to parenting. Notably, a key feature of the intervention is its low cost, online group delivery, and
facilitation by non-clinician staff which would allow the program to be scalable to communities
across Canada and increases its likely sustainability. This ongoing pilot trial is scheduled to end
on September 2022 [9].
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8.6 Conclusions
Overall, this thesis research makes a significant contribution in delineating the long-term
course and factors associated with the health and well-being of children with epilepsy and their
parents, and by strengthening the methodological rigour of longitudinal studies for this patient
group. This research showed that changes in children’s HRQOL early in the course of the
disorder are maintained over the long-term and that optimal outcomes may be achieved through
interventions delivered early in the course of the disorder. Mothers’ course of depressive
symptoms remained relatively stable throughout the 10-year follow-up, with 20% of mothers
scoring in the at-risk range for clinical depression throughout the follow-up period. Importantly,
for both children and their mothers, severity of epilepsy, neuropsychological problems, and
family environment at the time of diagnosis were associated with their long-term HRQOL and
depressive symptom trajectories. These results are important in providing clinicians, children,
and their parents with prognostic information regarding potential long-term outcomes and show
that targeting the family environment early on may lead to optimal HRQOL and mental health
for children with epilepsy and their parents.
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Appendix A: Data Collection and Measurement

Data used in this dissertation came from the Health-related Quality of Life of Children
with Epilepsy Study (HERQULES). HERQULES recruited children aged 4-12 years with newlydiagnosed epilepsy and prospectively followed them over a ten-year period. HERQULES was
funded through two independent Canadian Institutes for Health Research (CIHR) grants, one to
evaluate the course of children’s HRQOL over the short-term (2-year follow-up), and a second to
follow the cohort over the long-term (10-year follow-up). The study design, recruitment, and
methods used by HERQULES are described below. Ethical approval for HERQULES was
obtained from the Research Ethics Board at Western University (REB # 10069E and 102819)
and all appropriate ethics boards across the country. Approval forms can be provided upon
request.

Recruitment
HERQULES utilized a two-stage clustered sample design, whereby pediatric neurologists
were recruited, who were then asked to consecutively recruit their patients meeting inclusion
criteria. In the first stage, the membership list of the Canadian Association of Child Neurology
(CACN) served as the sampling frame to identify all pediatric neurologists practising across
Canada. To ensure completeness, a small group of members from across the country reviewed
the list and added the names of a small number of pediatric neurologists who were not on the list
and removed members who were not currently practising. A total of 72 eligible pediatric
neurologists were identified who were subsequently contacted and agreed to participate.
Neurologists were provided with study materials including an overview of the study,
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inclusion/exclusion criteria, physicians’ questionnaires, study timelines, and a token of
appreciation. In the second stage of the clustered sampling design, participating neurologists and
their staff approached and recruited eligible parents of children with newly-diagnosed epilepsy.
The contact details of eligible and interested parents were sent to the HERQULES staff who
facilitated parents’ participation in the study (described below). Of the 72 neurologists identified,
a total of 53 (74%) were successful in recruiting participants into HERQULES.
Patient recruitment occurred between April 2004 and April 2007. HERQULES staff send
letters of information and contacted by phone interested parents to further address any questions
and finalize eligibility and participation. The Tailed Design Method was used to maximize
participation and response rates; this method outlines a systematic approach for providing
reminders, follow-ups, and dissemination of a study newsletter describing the study progress and
results in aggregate form. In addition, birthday and holiday cards were sent to patients and their
parents. A total of 455 eligible families identified, of whom 373 (82%) participated by
completing the baseline questionnaires. Of the 373 participating families, 282 (76%) completed
the two-year follow-up, and 173 (46%) completed the 10-year follow-up. A detailed participant
flow chart is presented in Figure A-1.

Inclusion and Exclusion Criteria
Study inclusion criteria included: 1) children aged 4 to 12 years, 2) case with newly
diagnosed epilepsy (≥2 unprovoked seizures) and seen for the first time by a participating
pediatric neurologist, and 3) the parent/caregiver was primarily responsible for the child's care
for at least six months and would be continuing for the at least two years (duration of the original
study). Additionally, children with newly diagnosed epilepsy but whom had a prior history of
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neonatal seizures were included if medication was removed by six weeks of age and seizures did
not reoccur. Exclusion criteria included 1) diagnosis of epilepsy was previously confirmed, 2)
diagnosis of other progressive or degenerative neurological disorders, or other major comorbid
non-neurological health condition likely to have an impact on HRQOL (e.g., asthma requiring
daily medication, renal failure), and 3) insufficient English language skills.

Measures and Data Collection
Questionnaires at the time of epilepsy diagnosis and 0.5, 1, 2, 8, and 10 years later were
completed by children, parents, and/or neurologists (described below). The time points chosen
were based on a priori considerations, as there were no known optimal time points for capturing
the variability of HRQOL overtime. Three assessments were completed in the first year on the
hypothesis that epilepsy and family factors would be most dynamic during the first-year postdiagnosis. One assessment was chosen during the second year on the hypothesis that family
dynamics and epilepsy factors would have become more stable. Lastly, the 8- and 10-year
follow-up was chosen to prospectively evaluate long-term outcomes. Each questionnaire is
presented in Appendix B.
At the 8- and 10-year follow-up children, who were now adolescents and young adults
(AYAs), reported on their HRQOL and seizure-status. Adolescents (aged 11 to 17 years)
completed the 48-item Quality of Life in Epilepsy Inventory for Adolescents (QOLIE-AD48)[1], and young adults (aged 18 years or older) completed the 31-item Patient-Weighted
Quality of Life in Epilepsy Questionnaire (QOLIE-31-P)[2]. Patients did not complete
questionnaires at earlier time points because there were no epilepsy-specific, self-reported
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HRQOL measures available for youth aged 4-12 years appropriate for use in a mailed
questionnaire.
Parents completed the questionnaires at the time of epilepsy diagnosis, and 0.5, 1, 2, 8,
and 10 years later. Parents reported on their child’s HRQOL using the 76-item Quality of Life in
Childhood Epilepsy Questionnaire (QOLCE)[3-6], and on their depressive symptoms using the
20-item Center for Epidemiological Studies Depression Scale (CES-D)[7]. Parents also reported
on demographic characteristics and completed three standardized measures of family
environment: 1) the Family Adaptability, Partnership, Growth, Affection and Resolve (Family
APGAR)[8], with higher scores indicative of greater satisfaction with family relations; 2) the
Family Inventory of Life Events and Changes (FILE)[9], with higher scores indicative of greater
family demands/stressors; and 3) Family Inventory of Resources for Management (FIRM)[10],
with higher scores indicative of a more supportive, organized family environment with few
disruptions in daily routines and interactions, and greater extended family social support. At the
10-year follow-up parents also reported on their HRQOL using the 12-item Short-Form Health
Survey (SF-12v2)[11].
Neurologists completed a one-page questionnaire at the time of epilepsy diagnosis, and
0.5, 1, 2, 8, and 10 years later. Neurologists reported on clinical characteristics and on the child’s
epilepsy severity using the single item Global Assessment of Severity of Epilepsy scale
(GASE)[12,13]. Neurologist’s reports of the type of epilepsy syndrome were coded in two ways,
broadly (focal vs. generalized) and by specific subtype (generalized, absence, focal, benign
epilepsy of childhood with rolandic spikes (BECRS), focal to bilateral tonic-clonic, BECRS +
focal to bilateral tonic-clonic, and undetermined). Neurologists’ reports at the 8- and 10-year
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follow-up were limited because majority of AYAs (72%) had not received epilepsy-related care
in the year preceding the last follow-up.
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Figure A-1. Detailed participant flow chart.
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Appendix B: Questionnaires Used in Dissertation

Quality of Life in Childhood Epilepsy Questionnaire (QOLCE; 76-item)
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Quality of Life in Epilepsy for Adolescents (QOLIE-48 AD)
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Patient Weighted Quality Of Life In Epilepsy (QOLIE-31P)
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Short Form Health Survey (SF-12v2)
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Center for Epidemiologic Studies Depression Scale (CES-D)
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Family Inventory of Resources for Management (FIRM)
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Family Inventory of Life Events & Changes (FILE)
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Family Adaptability, Partnership, Growth, Affection and Resolve (APGAR)
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Demographic Characteristics
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Neurologists’ Questionnaire
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